SOUTH-SOUTH TRADE PROMOTION PROGRAMMEs3.amazonaws.com/zanran_storage/ · RP’s Top importers of pharmaceutical products ... Ten leading causes of morbidity, ... PHAP Pharmaceutical

SOUTH-SOUTH TRADE PROMOTION PROGRAMME

PHILIPPINES

SUPPLY AND DEMAND SURVEY ON PHARMACEUTICALS AND NATURAL PRODUCTS

May 2004

Supply and demand survey on pharmaceuticals and natural products – Philippines

- ii -

The designations employed and the presentation of the material in this document do not imply the expression of any opinion whatsoever on the part of the International Trade Centre (ITC) concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. While every effort has been made to verify the information contained in this document, ITC cannot accept any responsibility for any errors that it may contain.

This report has not been formally edited by the International Trade Centre (ITC).


- iii -

Table of content

Page Notes iv I. INTRODUCTION 1 A. Product coverage 1 B. Objectives of the demand survey 2 C. Methodology 2 II. SUMMARY OF CONCLUSIONS AND RECOMMENDATIONS 3 III. MAIN REPORT 9 A. Market size 9 B. RP’s distribution system 15 C. Market prospects 16 D. Regulatory environment 18 E. Useful addresses 23


- iv -

Page List of tables 1. RP’s Top importers of pharmaceutical products (based on 2002 figures) 52. Country’s health expenditure share to Gross National Product from 1991 to

2000 10

3. Country’s health expenditure Per Capita 104. Governments fiscal allocation for health 115. 2000 and 2001 regional distribution of pharmaceutical establishments 136. Consumer profile 167. Health and vital statistics 178. Ten leading causes of morbidity, number and crude rates – 1992-1996 and

1998 17

9. Mortality: Ten leading causes, number and crude rates and percent of total deaths – 1997 and 1998 (Crude death rate per 100,000 population)

18

Annexes I. Product coverage for pharmaceutical products 27II. Product coverage for natural products 33III. Philippine’s top importers of pharmaceutical products 37IV. Price list of Presyong Tama, Gamot Pampamilya (right price for family med.) 43V. Philippine imports of pharmaceutical products (1999-2003) 49VI. Philippine supplying countries of pharmaceutical products (1999-2003) 59VII Philippine imports of natural products (1999-2003) 63VIII. Philippine supplying countries of natural products (1999-2003) 69IX. Philippine exports of pharmaceutical products (1999-2003) 71X. Philippine markets of pharmaceutical products (1999-2003) 77XI. Philippine exports of natural products (1999-2003) 81XII. Philippine exports markets of natural products (1999-2003) 85XIII. Directory of Chamber of Filipino Drug manufacturers and distributors 89XIV. Company/product profile forms 99


- v -

NOTES The following abbreviations are used: BFAD Bureau of Food and Drug

BOI Board of Investment

BTRCP Bureau of Trade Regulation and Consumer Protection

CFDMD Chamber of Filipino Drug Manufacturers and Distributors, Inc.

CHIP, Inc. Chamber of Herbal Industries of the Philippines

ITC International Trade Centre

ITH Income Tax Holiday

LDA Developed Areas

OFW Overseas Filipino Workers

OTCs Over-The-Counter Drugs

PHAP Pharmaceutical Healthcare Association of the Philippines, Inc.

PITAHC Philippine Institute of Traditional and Alternative Health Care

PITC Philippine International Trading Corporation

PNDF Philippine National Drug Formulary

R&D Research and Development

USP-NF United States Pharmacopoeia / National Formulary


- 1 -

I. INTRODUCTION

The Philippine pharmaceutical industry is one of the vital sectors in the economy. As in all other economies, there should always be an ample supply chain of drugs and medicines made available to consumers in good quality and at reasonable and affordable prices. Through this, lives can be made better or even saved.

The industry is engaged in the manufacture, distribution and wholesale and retail sales of medicines and pharmaceutical specialties. The industry produces all forms of medicines and vaccines as, but not limited to, tablets, capsules, powders/suspension, liquids, creams/ointments, fine liquid and suppositories.

In the Philippine pharmaceutical industry, basic research in terms of extracting and producing raw materials and chemicals from local sources is not present. While almost 90% of all drugs sold are locally produced, the pharmaceuticals companies are mainly compounders, formulators and packagers. Their establishments are engaged in the importation, repacking, marketing and distribution of proprietary medicines and preparations.

As such investments along this activity are needed and being encouraged. As a support, the 2004 Investments Priority Projects of the Board of Investments (BOI), the manufacture of essential drugs including herbal medicines and supplements, food supplements limited to the manufacture of Vitamin A, iron and iodine and active substances of these drug has been included. This means investments in these activities will enjoy incentive package under the BOI guidelines.

A. Product coverage This demand survey covers all pharmaceutical import and export products (including active ingredients, starting materials and formulations) classified under the heading 54 of the Philippine Standard Classification Code and all import and export of natural products (including herbal medicines). The complete product coverage is in Annex I for pharmaceutical products and Annex II for natural and herbal products. 1. Industry products and product classification

Products of the industry include all forms of medicines and vaccines that are useful in the identification (diagnostic), prevention (prophylactic) and treatment (therapeutic) of illness or the mitigation of disease symptoms. The following are the classification of drug products:

• Therapeutic class – the more common therapeutic categories are analgesics, antacids, antirheumatics, antibiotics, antidiarrheals, cardio-vascular preparations, cold/cough preparations, dermatological preparations, vitamins/minerals and hypertensives.

• Method of dispensing – drug products are classified as either ethical (promoted only to

medical professionals and can be bought and sold only upon physician’s prescription) or proprietary (freely dispensed to the public and promoted over-the-counter).


- 2 -

• Dosage form – refers to the final form of a drug when it reaches the user. Examples are

syrups, injectibles, ointments, capsules, pills, tablets, powders, lozenges, solutions, suspensions, mixtures, tinctures, elixirs, extracts, fluid extracts, emulsions, lotions, sprays, aerosols and suppositories.

• Dosage strength – maybe purchased in various dosage strengths with the specific needs of

the patients.

• Sources of basic raw materials – maybe classified as synthetic-based, plant-derived, animal-derived, vaccines and antibiotics and related fermented medicinal products.

B. Objectives of the demand survey

The survey is intended to pursue the following objectives:

• To give an overview of the Philippine pharmaceutical and natural products market by presenting the import profiles vis-à-vis supply capabilities of the local industries.

• To identify products under these sectors with high import potentials with sources of imports.

• To identify companies which could be targeted as potential importers/buyers.

• To identify companies which could targeted as potential suppliers especially in the natural / herbal sector.

C. Methodology

In preparing this survey the methodology utilized is as follows:

1. Desk research on:

• Qualitative industry data using past studies and existing reports.

• Statistical data on Philippine imports of pharmaceutical and natural products for the last five (5) years.

• Statistical data on Philippine exports of pharmaceutical and natural products for the last five (5) years.

• Existing data of the National Statistics Office, Bureau of Food and Drugs, Department of Health, Bureau of Import Services, Board of Investments, and Bureau of Export Trade Promotion, all of the Department of Trade and Industry.

2. Field Research:

• Interviews with industry players and industry experts

• Updating of companies contact information by telephone


- 3 -

II. SUMMARY OF CONCLUSIONS AND RECOMMENDATIONS

The Philippine pharmaceutical industry cannot be considered a true drug industry since basic research in terms of extracting and producing raw materials and chemicals from local sources is absent. Most local drug firms are thus confined to: importing raw materials and finished goods in bulk, formulating and processing these into various dosage forms, packaging finished products and distributing drugs to drugstores, physicians, hospitals and other retailers.

Basic drug chemicals are not manufactured locally and about 80% to 90% of the raw materials of the industry is imported, a situation which has persisted for the last few decades. Only minor components such as sugar, flour, cornstarch, alcohol, glucose and glycerin are locally produced. Aside from medicinal products, there are other imports, such as packaging materials, used by the drug industry, which have added to high import costs. Imported packaging materials include specialized items such as aluminum tubes and vial caps, glass vials, rubber droppers, intravenous solution bottles, and ampoules. Only packaging materials such as bottle caps, foils and blister foils are produced locally. In view of this situation, prospective investors are being encouraged in the aforementioned areas to enable the industry to be self-sufficient. Under the government’s 2004 Investments Priorities Plan (IPP), firms engaged in the manufacture of essential drugs (including herbal medicine and supplements) listed in the current Philippine National Drug Formulary (PNDF) and active substances of drugs are qualified to avail of fiscal and non-fiscal incentives as follows: 1. Fiscal incentives

• Income Tax Holiday (ITH) – a BOI-registered enterprise shall be exempt from the payment

of income taxes reckoned from the scheduled start of commercial operations as follows:

- New projects with pioneer status six (6) years - New projects with non-pioneer status four (4) years - Expansion projects three (3) years - New/expansion projects in Less six (6) years - Developed Areas (LDA), regardless of status

• Tax deduction for labor expense;

• Exemption from wharfage dues and export tax, duty, import and fees;

• Tax credit on raw materials and supplies. 2. Non-fiscal incentives

• Employment of foreign nationals;

• Simplification of custom procedures;

• Importation of consigned equipment; and

• Operation of bonded manufacturing/trading warehouse.


- 4 -

The Philippine pharmaceutical industry is controlled by a few transnationals, that 68% of the pharmaceutical market belongs to these foreign companies with the remaining 32% shared by Filipino enterprises with foreign investors. The size of the local pharmaceutical market could be measured by sales to trade outlets. In 2003, sales to trade outlets reached Php 72.4 billion or US$ 1.45 billion and the local market posted an average of 10% annual growth. To better understand the demand of pharmaceuticals, it is necessary to study the interplay between the pharmaceutical industry and its market. From the viewpoint of the industry, sales are determined by the following factors:

• The economy’s performance in terms of Gross National Product and purchasing power, and

the resultant family and institutional budgets made available for medical care, including pharmaceuticals;

• The size of the population and its rate of growth, as well as disease incidence which determine requirements for drug therapy;

• The government’s priorities and fiscal allocations for health, which define the level of pharmaceutical sales to the public sector.

From the viewpoint of the market, the nature of the demands differ among the proprietary and ethical segments:

• Proprietary drugs are similar to consumer items in terms of the dynamics of demand. End-

users suffering from ailments not requiring professional medical care recognize their condition (e.g. cough or cold), then purchase the proprietary products deemed most appropriate.

• The demand for prescription medicines is markedly different as it is not end-users but

medical professionals who decide on the choice of drug therapy. To comply with the Generic Act of 1988, the physician provides the patient with a prescription containing a drug’s generic name and if desired, a recommended brand name. The pharmacist must dispense according to the physician’s prescription with regard to generic name. The patient, is however, free to choose among various brand names with the same generic name or active ingredient.

The Generics Act of 1988, an act to promote, require and ensure the production of an adequate supply, distribution, use and acceptance of drugs and medicines identified by their generic names, exerts a competitive influence between higher-priced branded drugs and lower-priced generic products with the aim of lowering drug prices. However, there is still no marked evidence of increased market share of generic drugs. Its share has constantly been placed at 8% notwithstanding the 10% average growth of the total pharmaceutical market. The main reason cited is the perception that lower prices may mean lower efficacy.


- 5 -

The country’s top 20 importers of pharmaceutical products are important business leads. The listing on the country’s top importers of pharmaceutical products was generated using year 2002 data of the Bureau of Import Services, Department of Trade and Industry and is presented in Table I below. These companies could be potential buyers for pharmaceutical products. Contact information on these companies and other top importers are provided somewhere in this report. (Annex III) Table 1. RP’s Top importers of pharmaceutical products (based on 2002 figures)

1. NOVARTIS Healthcare Phils. 2. PFIZER Inc. 3. GLAXO Smithkline Phils. Inc. 4. VITACHEM Industries 5. ASTRAZENECA Pharmaceutical (Philippines), Inc. 6. UNITED LABORATORIES, INC. 7. ROCHE (Philippines), Inc. 8. BASF Philippines, Inc. 9. BOEHRINGER Ingelheim (Philippines), Inc. 10. BAYER Philippines, Inc. 11. SANOFI-Synthelabo 12. SCHERING-PLOUGH Corporation 13. MERCK SHARP and DOHME Philippines 14. BRISTOL MYERS SQUIBB Philippines, Inc. 15. ZUELLIG Pharma Corporation 16. SERVIER Philippines, Inc. 17. ABBOTT Laboratories Philippines 18. MERIAL Philippines Inc. 19. AVENTIS Pharma, Inc. 20. WYETH Philippines

Philippine importers of pharmaceutical products and/or active raw materials generally prefer sourcing from Europe and USA as some of them have had experiences of fluctuating quality levels from other sources. The Philippine International Trading Corporation (PITC), the trading arm of the government is another potential buyer. PITC is presently importing mainly from India, pharmaceutical products under the following therapeutic categories:

- Anti-bacterials - Anti-hypertensives - Non-steroidal anti-inflammatory drugs - Oral hypoglycemic/anti-diabetes agents - Anti-anginal agents - Anti-cholesterol agents - Bronchodilators - Anti-diarrheals - Anti-psychotics - Anti-epileptics

The pharmaceutical products are for most common ailments and diseases in the country. The prime consideration is lower cost. The price list is in Annex IV for guidance of prospective suppliers.


- 6 -

Competition in the drug market is intense and dynamic and this is best seen in the large number of competitors carrying various brand names and product lines. Prices of pharmaceutical products in the Philippines are generally higher by as much as ten (10) times, higher than in other Asian countries next to Japan. A significant factor contributing to the generally high drug prices is the import-dependent nature of the industry. Another factor is due to industry’s dependence on marketing, advertising and promotions as tools to ensure steady sales. Suppliers wishing to enter the Philippine market need to be able to prove quality at competitive prices to gain considerable success. The easiest and fastest way to penetrate the market is through acquiring a local partner who is already active in the industry. This partner has familiarity in handling all aspects of the business. The Directory of Chamber of Filipino Drug Manufacturers and Distributors presented somewhere in the report would be useful in finding local partners when necessary. Mercury Drug Stores is the largest pharmaceutical chain in the Philippines with about half or 50% of the overall pharmacy business. The drug store could be contacted at this address:

Mercury Ave., cor E. Rodriguez Jr. Bagumbayan 1110 Quezon City Telephone No. : (632) 911.5071 Fax No. : (632) 911.6673 Email address : [email protected] Website : www.mercurydrug.com

Since the country is an archipelago, it is uneconomical and inefficient for most pharmaceutical companies to distribute their products. Only a limited number of companies have their own distribution network, the rest avails of the service of the professional distributors. The pharmaceutical industry is profitable since there is very little price elasticity associated with price increases. A patient will not change the demand for a product with a small change in price when there are no close or available substitutes. The long-term outlook is promising since demand for medicines and drugs is interdependent on the demographics of the country’s population. The growth of the population (81.1 million in 2003) at an annual average of 2.36% will surely cause an increased demand for drugs, along with the prevalence of communicable and infectious diseases and the rising incidence of degenerative diseases. There is an emerging local market for herbal medicines/ food supplements. Initial estimate from the industry players of the local market size is placed at US$ 40 million. The market is expected to grow dramatically in the coming years. People take herbal medicines for a number of reasons: faith in tradition, fear of artificial chemicals and attraction to anything that is billed as natural. At present, imported herbal supplements proliferated and sold at mostly high prices in health shops.

Reported local sales from herbal are estimated to be from PhP 17 million in 2000 to PhP 27 million in 2002. Annual average sales growth was from 30% to 70%. 1 1 Figures were given by industry players


- 7 -

The factors which are expected to contribute to the dramatic growth of the natural / herbal remedies are:

• The increase in ageing population, trend towards self-medication, emergence of unknown diseases and allergies due to widespread use of synthetic drugs and biotech products; increasing health consciousness of the population.

• The rising health costs and more focus on disease prevention rather than cure.

• The growing healthy lifestyle and the consumer demand for all natural products as a way of

life.

• The growing consciousness for environment-friendly products. The most common and lately most demanded herbal medicine/supplement product which is produced locally is Ampalaya (Momordica Charantia) which the current sales is estimated at PhP5 million a day or translated to PhP 1.8 billion a year. This is attributed to its effectiveness for lowering blood sugar. Some ampalaya products which are mixed with other herbals are sold in capsules (crude extracts) and tea.

The other most common herbal personal care product is the Papaya ( Carica Papaya) based skin whitening soap which is being sold by different companies. The skin whitening soap category is worth at least PhP2 Billion a year and Filipinos buy as many as 200 million pieces a year. Again this is attributed to the effectiveness of the herbal products and partly since many Filipinos wanted to look fairer or white.

The Philippines has the potential to develop into one of the world’s largest growers of medicinal plants, given the country’s rich biodiversity and long tradition of use and intimate knowledge of herbal medicine. Five (5) percent of the world’s plant species can be found in the country. There are 13,500 plant species where 3,500 species are endemic. Around 1,500 were identified as medicinal plants. 850 medicinal plants were discussed in a book, “Medicinal Plants of the Philippines by Dr. Eduardo Quisumbing (reprinted in 1978) and more than 200 medicinal plants with identified phytochemical in a book, “Philippines Medicinal Plants in Common Use: Their Phytochemistry and Pharmacology (Michael L. Tan / AKAP 1980) Only 120 medicinal plants have been scientifically validated for safety and efficacy of which 10 medicinal plants have been promoted by the Department of Health. The ten (10) are as follows:

• Lagundi (Vetex Negundo) – for asthma, coughs and colds; • Yerba Buena (Mentha Cordifolia) for body aches; • Sambong (Blumea Balsamifera) for dissolving urinary tract stones; • Tsaang Gubat (Ehnetia Microphylla) for stomach aches and diarrhea; • Niyug-niyogan (Qusiqualis Indica) – ascaris antihelminthic; • Bayabas (Psidium Guajava) – astringent; • Akapulko )Cassia Alata) – antifungal; • Ulasimang Bato (Peperonia Pellucida) for gout and lowering blood uric acid; • Bawang (Allium Sativa) – for lowering blood cholesterol; • Ampalaya (Momordica Charantia) – for lowering blood sugar.


- 8 -

Of these ten (10), only 4 are available in commercial formulation namely Lagundi, Sambong, Akapulko and Ampalaya. Two medicinal plants Tsaang Gubat and Yerba Buena have also received regulatory approval. The absence of the technology is a hindrance to the export potential of well-researched and proven herbal medicines. Research and development (R&D) has not caught up with the pace that the local pharmaceutical industry needs. Governments’ support to R&D is almost nil. The natural and herbal products are exported to countries with large concentration of Overseas Filipino Workers (OFW) through regular channels. The products have not reached the mainstream markets for the simple reason that promotion of the products has been limited to the domestic market.


- 9 -

III. MAIN REPORT

A. Market size

1. Domestic industry The Philippine pharmaceutical market as indicated by sales to trade outlets amounted to Php 72.4 billion or approximately US$ 1.45 billion in 2003. The local market registered an estimated annual growth of 10% in sales. However, due to the country’s high poverty threshold coupled with escalating population growth of about 2.4 percent annually and the meager annual health budget, placed the life saving commodity beyond the reach of many Filipinos because of its high cost and inequitable distribution. To address the heavy burden of high medicine prices on the Filipino consumers, the Philippine government under President Gloria Macapagal-Arroyo has directed the implementation of a program that will improve public access to quality healthcare. The program is called, Presyong Tama, Gamot Pampamilya (Right Price for Family Medicines) Program. The program involves the importation of widely recognized, off patent branded medicines, which are usually prescribed for the most common ailments and diseases. The medicines shall be made available to Filipino consumers at very affordable prices. Studies showed that prices of medicines in the Philippines are as much as ten (10) times higher that in other Asian countries next only to Japan. When the program began in 2000, there were seven (7) brands available in the country’s Department of Health retained hospitals nationwide. Today, this range has been expanded to a total of 25 brands from the following therapeutic categories: antibacterials, anti-hypertensives, non-steroidal, anti-inflammatory drugs, oral hypoglycemic/ anti-diabetes agents, anti-anginal agents, anti-cholesterol agents, bronchodilators, anti-motility agents/ anti-diarrheals, anti-psychoticsand anti-epileptics. Medicines sold are from 27% to 87% cheaper compared to those sold in local drug stores, yet these are not subsidized prices.

Medicines are sourced only from original manufacturers/multinational subsidiaries or authorized licensees and are of the same quality and efficacy as the higher-priced counterparts sold in local drugstores.

The importation of these medicines is made by the Philippine International Trading Corporation, a government trading company. 2. Apparent consumption The tables below will provide the reader an estimation of past and future demands for pharmaceutical products.


- 10 -

Table 2. Country’s health expenditure share to Gross National Product from 1991 to 2000

Source : National Statistical Coordination Board Table 3. Country’s health expenditure Per Capita

Source : National Statistical Coordination Board

STATISTICS 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 Average Annual Growth

Rate

Total Health Expenditure (in million pesos) at current prices

35.9 39.6 47.4 54.6 65.2 76.2 87.1 95.7 108.3 113.5 13.7

GNP at Current Prices (in billion pesos)

1,254.6 1,374.8 1,500.3 1,736.4 1,958.6 2,261.3 2,528.3 2,815.3 3,155.6 3,491.1 12.0

Share of Health Expenditure to GNP (%)

2.86 2.88 3.16 3.14 3.33 3.37 3.44 3.40 3.43 3.25

STATISTICS 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 Average Annual Growth

Rate

Health Expenditure Per Capita (in pesos at current prices)

575 621 725 817 954 1,089 1,217 1,308 1,449 1,486 11.1

Health Expenditure Per Capita (in pesos at 1985 prices)

334 332 363 378 408 427 451 441 459 451 3.4

Population (M) 62.4 63.8 65.3 66.8 68.3 70.0 71.5 73.1 74.7 76.3 2.3

Total Health Expenditure Growth Rate (%)

10.4 19.6 15.3 19.4 16.9 14.3 9.9 13.2 9.7 13.7

Population Growth Rate (%) 2.2 2.4 2.3 2.3 2.3 2.3 2.2 2.2 2.1 2.3


- 11 -

Table 4. Governments fiscal allocation for health

Percent Share Source of Funds

1991 1992 1993 1994 1995 1996 1997 1998 1999

All Sources 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00

Government 38.51 43.17 36.60 37.21 35.33 36.30 38.30 38.66 37.91 National 34.66 38.80 24.07 21.26 19.33 19.93 20.52 20.53 20.04 Local 3.85 4.37 12.53 15.95 16.00 16.37 17.78 18.13 17.87

Social Insurance 5.44 5.97 6.37 5.71 4.53 5.06 5.13 3.73 4.86 Medicare 5.17 5.71 6.07 5.37 4.25 4.79 4.87 3.46 4.61 Employee 0.27 0.26 0.30 0.34 0.28 0.27 0.26 0.27 0.25

Private Source 56.05 58.85 57.03 57.06 60.13 58.64 56.58 57.62 57.24 Out-of-pocket 47.69 49.58 47.75 47.47 50.43 48.71 46.88 47.96 46.26 Private Insurance 2.88 2.83 2.41 2.09 1.77 1.68 1.94 1.98 2.14 HMOs 1.25 1.31 1.42 1.64 1.98 2.28 2.50 2.88 3.84 Employer 3.41 4.18 4.53 4.89 4.98 5.06 4.42 3.95 4.01 Private 0.82 0.95 0.92 0.97 0.97 0.91 0.84 0.85 0.99

Source : National Statistical Coordination Board

3. Industry players Industry players in the pharmaceutical industry are classified into two (2), to wit: (a) Drug establishments Companies engaged in the manufacture, importation, re-packing and distribution of drugs and medicines.

• Manufacturers

- Technically, these are formulators, who formulate from imported active raw materials according to a specific recipe

- They manufacture their own products.

• Toll Manufacturers

- Technically, these are formulators, they formulate from imported active raw

materials according to a specific recipe.

- They manufacture for third party companies or traders.


- 12 -

• Traders

- They are registered owners of drug products.

- They supply the raw materials and packaging components and provide products’ monographs, quality control standards and procedures.

- They subcontract the manufacture of such products to licensed manufacturers.

• Importers

- Import raw materials, active ingredients and/or finished products for their own use

for wholesale distribution to other pharmaceutical establishments and outlets.

• Distributors

- For a fee they distribute other companies’ products nationwide.

- They also act as agents of some small foreign companies. (b) Drug outlets Drug stores, pharmacies, and other establishments that sell drugs and medicines at retail level or dispense medicines for direct use of consumers.

• Drugstores, Pharmacies, Boticas including Hospital Pharmacies – these are drug outlets

where registered drugs, chemical products, active principles, proprietary medicines or pharmaceutical specialties and dental medicines, or veterinary preparations are compounded and/or dispensed.

• Retail Outlets for Non-prescription drugs – these includes non-traditional outlets such as

supermarket and stores, drug outlets where registered non-prescription or over-the-counter (OTC) drugs are sold in their original packages, bottle or containers or in small original containers.

4. Regional distribution of pharmaceutical establishments Table 5 below shows the number of companies registered by the Bureau of Food and Drugs (BFAD) and their regional distribution.


- 13 -

Table 5. 2000 and 2001 regional distribution of pharmaceutical establishments

REGION 2000 DRUG

ESTABLISHMENTS

2001 DRUG ESTABLISHMENTS

Drug

Manufacturers

Drug Traders

Drug

Manufacturers

Drug Traders

NCR 123 348 113 314 CAR 0 2 0 2 I. Ilocos Region 4 2 4 2 II. Central Valley 1 1 1 1 III. Central Luzon 17 7 19 7 IV. Southern Tagalog 34 24 35 24 V. Bicol Region 1 0 1 0 VI. Western Visayas 7 5 9 4 VII. Central Visayas 18 5 20 5 VIII. Eastern Visayas 2 0 2 0 IX. Western Mindanao 2 5 2 5 X. Northern Mindanao 3 1 3 2 XI. Southern Mindanao 10 0 10 0 XII. Central Minadanao 1 0 1 0 CARAGA 2 0 2 0

Total 225 400 222 366 The concentration of drug manufacturers was in Metro Manila with 51% of the 222 drug manufacturers registered in 2001. The concentration is higher among drug traders of which 86% was in Metro Manila from the 366 registered drug traders. 5. RP’s imports of pharmaceutical products Bulk of the importations of the pharmaceutical industry is mainly composed of medicinal and pharmaceutical products for retail sale. This composed more than 50% of the total importations. The rest of the importations are chemicals, semi-finished products and other raw materials for the manufacture of drugs and pharmaceuticals for all types of ailments and diseases.. Imports grew at 2.1% from the years 1999 to 2003. The country’s pharmaceutical imports totaled to US$ 362.1 million in 1999 and reached US$ 388.8 million in 2003. Imports of pharmaceutical products constituted a mere .98% of the country’s total imports from around the world in 2003. (Please refer to Annex V for details) 6. RP’s supplying countries of pharmaceutical products Major suppliers of pharmaceutical products in 2003 are Switzerland (11.6% share), Germany (9.9% share), France (9.3% share), United Kingdom (8.4% share), Australia (8.3% share) and USA (6.0% share). These countries are the centers of medicinal research and manufacture and the home bases of multinational pharmaceutical firms operating in the country. (Please refer to VI for details)


- 14 -

7. RP’s imports of natural products Imports of natural products registered an average growth rate of 3.43% during the five-year period 1999 to 2003. Imports were valued at US$ 34.9 million in 1999 and grew to US$ 39.4 million in 2003. The biggest import was hydrogenated vegetable fats which accounted for 16.8% of the country’s total imports. This was followed by carrageenan (10.8%); seaweeds and other algae (9.4%) and natural gum and gum resins (8.3%). (Annex VII gives more details) 8. RP’s supplying countries of natural products Major suppliers of natural products in 2003 were USA which accounted for (21.1%); Malaysia (17.5%), Indonesia (9.9%), Denmark (9.3%), and Singapore (8.8%). (Other supplying countries are presented in Annex VIII)

9. RP’s Exports of pharmaceutical products The country’s exports of pharmaceutical products achieved a negative growth rate of 2.2% during the period 1999 to 2003. Exports in 1999 were valued at US$ 19.4 million and dropped to US$ 17.5 million in 2003. Bulk of the pharmaceutical exports was composed mainly of medicines and pharmaceutical products for retail sale, which accounted for over 70% of the total exports in 2003. (Please refer to Annex IX)

10. RP’s export markets of pharmaceutical products Major export markets for the country’s pharmaceutical exports are Vietnam (accounting for 14.8%), Australia (12.3%), Malaysia (10.2%), Thailand (8.4%), and Myanmar (8.4%). Most of the markets are neighboring Asian countries. (Please refer to Annex X)

11. RP’s Exports of natural products Exports of natural products, on the other hand, posted an average growth rate of 10.4% over the period 1999 to 2003. Exports in 1999 totalled to US$438.6 million and increased to US$ 598.2 million in 2003. Exports were made up mostly of coconut/copra oil crude and refined that accounted for a combined 84.4%. Another important export is carrageenan and seaweeds for a combined 13.4%. (Please refer to Annex XI) 12. RP’s export markets of natural products These natural products were exported mostly to the Netherlands that absorbed 32.9% of the country’s total exports. This was followed by USA (30.6%), Malaysia (7.5%), PR China (5.4%) and Japan (4.6%). (Please refer to Annex XII for more details)


- 15 -

B. RP’s distribution system

The diagram below illustrates how the pharmaceutical products distribution system works. I. MULTINATIONAL COMPANIES (MNC)

II NATIONAL COMPANIES (NC)

II IMPORTERS OF FINISHED PRODUCTS Distribution network of natural / Herbal products.

• Natural / Herbal companies distribute their products through finding partners, exclusive distributorships or otherwise

• Some companies distribute products directly to drugstores, supermarkets/groceries

MKTG PROMO

Mother companies /Foreign Suppliers oraw materials

Domestic Formulators: own ortoll formulators

Marketing Dept of companies w/ formulation facilities

Drug Dept Trader: Companies w/o formulation facilities

Third Party Distribution

Drugstores Hospitals

Clinics MD’s

CONSUMERS

Foreign Suppliers oraw materials

Domestic Formulators: own products toll formulator

Marketing Dept of companies w/ formulation facilities

Drug Dept Trader: Companies w/o formulation facilities

Third Party Distribution

Drugstores Hospitals

Clinics MD’s

CONSUMERS

Own Distribution

Suppliers MNC: Mother Companies

Domestic Companies 1. MNC: 2. NC

1. MNC Scheme

2. NC Scheme

Distribution System of Pharmaceutical Products


- 16 -

• Some companies distribute products directly through their own shops/outlets

• In terms of market reach, companies distribute on a national and regional level as well

C. Market prospects 1. Consumer profile (Table 6) INCOME AND EXPENDITURE (At current prices) 2000

1997

1994

Annual average family income (PhP) 144,039 123,168 83,161Annual average family expenditure (PhP) 118,002 99,537 67,661Annual average family saving (PhP) 26,037 23,61 15,500 POPULATION

2000

1995

1990

Total 76,504,077 68,616,536 60,703,206 Male 38,524,266 37,979,811 30,538,285 Female 37,979,811 34,032,366 30,164,921 0-14 years 37.0% 38.4% 39.6%15-64 years 59.2% 58.1% 57.0%65 years and over 3.8% 3.5% 3.4%Sex ratio 101.4 101.6 101.2

Density (persons per square kilometer) 255 229 202Growth rate 2.4% 2.3% 2.4%Average household size 5.0 5.1 5.3

2005

2004

2003

Population projection (medium assumption) 84,241,341 82,663,561 81,081,457Source: National Statistics Office 2. State of health Tables 7 to 9 provide information regarding the state of health of the Filipinos. This will serve as guide to determine the types and kinds of pharmaceutical/medicines with big potential.


- 17 -

Table 7. Health and vital statistics

2000 1999 1998

Births 1,766,440 1,613,335 1,632,859 Male 918,243 840,528 853,304 Female 848,197 772,807 779,555

Marriages 577,387 551,445 549,265 Death 366,931 347,989 352,992

Male 217,404 207,610 210,592 Female 149,527 140,379 142,400

2005 2004 2003Crude birth rate (per thousand population) 24.09 24.63 25.16 Crude deathe rate (per thousand population) 5.60 5.66 5.72 Crude rate of natural increase (per thousand pop.) 18.49 18.97 19.45 Total fertility rate (number of children per woman) 3.00 3.08 3.15 Life expectancy at birth ( in years)

Male 67.83 67.53 67.23

Female 73.08 72.78 72.48 Source: National Statistics Office Table 8. Ten leading causes of morbidity, number and crude rates - 1992 – 1996 and 1998 (Rate per 100,000 population)

5-Year Average (1992-1996) 1997 1998 Leading Causes of

Morbidity Number Rate Number Rate Number Rate

1 Diarrheal Diseases

1,124,395

1,693.8

899,409

1,257.0

931,655

1,273.7

2 Pneumonias

565,687

851.7

672,681

940.2

646,789

884.2

3 Bronchitis

890,972

1,341.7

637,905

891.6

635,089

868.2

4 Influenza

654,496

9,585.1

574,748

803.3

563,674

770.6

5 Tuberculosis, all forms

149,963

225.1

240,509

336.1

151,650

207.3

6 Malaria

55,815

83.9

69,248

96.8

72,309

98.9

7 Chicken pox

59,109

88.9

64,085

89.5

70,589

96.9

8 Diseases of the heart

103,600

156.1

63,794

89.2

44,532

60.9

9 Measles

51,548

77.1

37,857

52.9

32,613

44.6

10 Dengue / Dengue H-Fever

16,405

24.5

13,290

18.6

23,591

32.3

Source : Department of Health


- 18 -

Table 9. Mortality: Ten leading causes, number and crude death rates and percent of total deaths - 1997 and 1998 (Crude death rate per 100,000 population)

1997 1998

Causes Number Rate

Percent of

Total Deaths

Number Rate

Percent of

Total Deaths

1. Diseases of the circulatory system

72,250

101.0

21.3

55,830

76.3

15.8

2. Diseases of the respiratory system

50,160

70.1

14.8

41,380

56.6

11.7

3. Accidents

28,563

39.9

8.4

33,709

46.1

9.5

4. Malignant neoplasms

26,842

37.5

7.9

32,090

43.9

9.1

5. Tubercolosis, all forms

23,056 32.2

6.8

29,874

40.8

8.5

6. Diabetes Mellitus

6,749

9.4

2.0

28,041

38.3

7.9 7. Nephritis, Nephrotic Syndrome and

Nephrosis

6,704

9.4

2.0

14,228

19.5

4.0 8. Respiratory condition of foetus and

new born

5,578

7.8

1.6

8,819

12.1

2.5

9. Congenital anomalies

4,912

6.9

1.4

7,516

10.3

2.1

10. Septicemia

4,417

6.2

1.3

7,453

10.2

2.1 Source: Department of Health

D. Regulatory environment 1. Product registration The Department of Health through its Bureau of Food and Drugs (BFAD) is the regulatory body that governs the industry to insure safe, effective and quality pharmaceutical drugs to the market. All establishments engaged in the manufacture, importation or distribution of drugs must apply for a License to Operate (LTO) issued by BFAD. Other specific requirements depending on the type of activity to be undertaken are summarized below:

CHECKLIST OF REQUIREMENTS FOR REGISTRATION OF

PHARMACEUTICAL PRODUCTS

TYPE OF APPLICATION REQUIREMENTS INITIAL RENEWAL 1. Letter of application and Accomplish Form No. 8 (Application

for registration of Pharmaceutical Product)

2. Suggested Retail Price (as per AO#48-C s. 1999)


- 19 -

TYPE OF APPLICATION REQUIREMENTS INITIAL RENEWAL

3. Copy of valid agreement between manufacturer and trader, distributor / importer / exporter

4. Unit dose and batch formulation 5. Technical specifications of finished product 6. Certificate of analysis of active raw materials 7. Certificate of analysis of finished product 8. Technical specifications of finished product 9. Full description of the methods used, the facilities and controls

in the manufacture, processing and packaging of the product

10. Details of the assay and other test procedures for finished product including data analysis

11. Detailed report of stability studies to justify claimed shelf life (accelerated or long term) 3 batches

12. Representative sample in market or commercial presentation. 13. Unattached generic labeling materials, label, box, insert,

blister / strip oil

14. For imported product: Certificates of free sale from country of origin Government certificate attesting to the status of the manufacture as to competency, reliability of personnel and facilities Both should be authenticated by territorial Philippine consulate

15. For product in plastic container: 15.1 Studies done on the plastic to substantiate claim that

product is safe to use: Components of the plastic used Chemical Test Physical tests Biological tests (cell toxicity, tissue implantation,

etc.) for parenteral and ophthalmic preparations. 15.2 Methodology on how different tests were conducted

and include limits (results) of each test. 15.3 Empty plastic containers and closures

16. For New Drug (if applicable) Pre-clinical studies Clinical studies (Phase I, II and III) Protocol for monitored release.

17. Certificate of approval of PMS (if applicable) 18. Bioavailability / bioequivalence studies (for Rifampicin

products)

19. Dissolution profile for drug product under List B (B Prime) 20. Copy of latest Certificate of Product Registration (CPR)


- 20 -

CHECKLIST OF REQUIREMENTS FOR DRUG DISTRIBUTOR

1. Accomplished Notarized Petition Form / Joint Affidavit of Undertaking 2. List of products identified by generic names and brand names, to be distributed 3. Reference Materials:

Philippine National Drug Formulary R.A. 3720 Foods, Drugs & Devices & Cosmetics Act R.A. 6675 Generics Act of 1988 and relevant implementing rules and regulations R.A. 5921, Pharmacy Law as amended and relevant implementing rules and regulations R.A. 8203, Special Law on Counterfeit Drugs and its implementing rules and regulations Any one of the following reference books: United States Pharmacopoeia / National Formulary (USP-NF) latest edition Remington’s Pharmaceutical Sciences (latest edition) Goodman & Gilman Pharmacological Basis of Therapeutics (latest edition)

4. Batch Distribution Record Book 5. Copies of Pharmcist’s Registration Certificate, PRC-ID, valid PRT, ID picture, Duties and

Responsibilities, Certificate of Attendance of owner/pharmacist to a BFAD seminar on Licensing of Drug Establishments and outlets

6. Location Plan / Floor Plan (Office & Storage Room) with dimensions Photocopies of the following: If Corporation, Registration with SEC and Articles of Incorporation or Partnership If Single Proprietorship, Certificate of Business Name Registration with the Bureau of Trade Regulation and Consumer Protection (BTRCP) Contract of Lease for the space of the office and storage if the applicant does not own the building If Importer:

Foreign Agency Agreement from each supplier duly authenticated by the Territorial Philippine Consulate

Certificate of Registration of manufacturer and its conformity with GMP from Health Authority (for finished products only)

If Wholesaler:

A Valid contract with BFAD licensed supplier / manufacturer Certificate that the products it sells are registered with BFAD LTO of manufacturer

If Exporter: A valid contract with BFAD licensed supplier / manufacturer Certification that the product it sell are registered with BFAD LTO of manufacturer


- 21 -

2. Product labelling BFAD sets specific standards and requirements for pharmaceutical firms to comply in labeling their products in order to have a clear presentation of the products minus fraudulent and misleading representations. In all cases, the generic name shall be the prominently printed element on the label, defined as the one with the highest point size among the various printed elements in the label. Information must include Generic name of a particular pharmaceutical must appear above its brand name on all packaging Registered trade or brand name; Duly registered trademark; Duly registered business name; Philippine address of the manufacturer, importer or repacker of the consumer product; General make or active ingredients; Net quantity of contents, in metric terms of weight, measure or numerical count; Country of manufacture, if imported; and Statement that the consumer product is manufactured, refilled or repacked under license from a

principal, if applicable. Directions for use; Warning toxicity;

3. Import duties

As of January 1, 2003, all pharmaceutical products except those under the headings 29.36 and 29.37 have tariff rates of 3% while the other have 5%.

4. Customs valuation

The Philippines has been implementing the transaction value method of customs valuation since year 2000.

5. Prohibited and regulated drugs

(a) Prohibited drugs

• Drugs and substances designed, intended or adapted for producing unlawful abortion;

• Any adulterated or misbranded drug in violation of the provisions of the “Food and Drugs Act”;

• Marijuana, opium, poppies, coca leaves, heroin or any other narcotics or synthetic drugs which are or may hereafter be declared habit-forming by the President of the Philippines, or any compound, manufactured salt, derivative or preparation thereof, except when imported by the government of the Philippines or any person duly authorized by the Dangerous Drugs Board, for medicinal purposes only;


- 22 -

(b) Regulated drugs

• Certain commodities require clearance/permits from appropriate government agencies prior to

importation into the Philippines. These commodity groups are:

- Acetic anhydride (Dangerous Drugs Board) - Penicillin/derivatives (BFAD)

6. Regulatory guidelines

There are certain laws and administrative orders which are in force relative to the pharmaceutical industry and there are as follows:

REPUBLIC ACTS

R.A. No. 3720

AN ACT TO ENSURE THE SFETY AND PURITY OF FOODS, DRUGS, AND COSMETICS BEING MADE AVAILABLE TO THE PUBLIC BY CREATING THE FOOD AND DRUG ADMINISTRATION WHICH SHALL ADMINISTER AND ENFORCE THE LAWS PERTAINING THERETO.

R.A. No. 6675

AN ACT TO PROMOTE, REQUIRE AND ENSURE THE PRODUCTION OF AN ADEQUATE SUPPLY, DISTRIBUTION, USE AND ACCEPTANCE OF DRUGS AND MEDICINES IDENTIFIED BY THEIR GENERIC NAMES

R.A. No. 8203 AN ACT OF PROHIBITING COUNTERFEIT DRUGS, PROVIDING PENALTIES FOR VIOLATIONS AND APPROPRIATING FUNDS THEREFOR

ADMINISTRATIVE ORDERS

A.O. No. 99 s. 2000

BANNING AND WITHDRAWAL OF THE FIXED – DOSE – COMBINATION DRUG PRODUCT LORATADINE + PSEUDOEPHEDRINE (CLARINASE) FROM THE MARKET

A.O. No. 98 s. 2000 VOLUNTARY WITHDRAWAL OF ASTEMIZOLE (HISMANAL) FROM THE MARKET

A.O. No. 97 s. 2000 BANNING AWITHDRAWAL OF CISAPRIDE (PREPULSID) FROM THE MARKET

A.O. No. 85 s. 2000

REGISTRATION, REQUIREMENTS FOR A GOVERNMENT AGENCY IMPORTING A PHARMACEUTICAL PRODUCT WITH A REGISTERED COUNTERPART BRAND IN THE PHILIPPINES

A.O. No. 23-C s. 2000 POLICIES AND GUIDELINES ON OVER-THE-COUNTER (OTC) DRUG PRODUCTS

A.O. No. 41 s. 1991 GUIDELINES ON ADVERTISEMENT AND PROMOTIONS OF VETERINARY DRUGS AND PRODUCTS


- 23 -

A.O. No. 99 s. 1990

REQUIREMENTS FOR LABELLING MATERIALS OF CATEGORIES OF PHARMACEUTICAL PRODUCTS CONTAINING FOUR OR MORE ACTIVE INGREDIENTS OUTSIDE THE COVERAGE OF A.O. 85 S. 1990

A.O. No. 85 s. 1990

REQUIREMENTS FOR LABELLING MATERIALS OF CATEGORIES OF PHARMACEUTICAL PRODUCTS CONTAINING TWO OR MORE ACTIVE INGREDIENTS

A.O. No. 56 s. 1989 REVISED REGULATIONS FOR THE LICENSING OF DRUG ESTABLISHMENTS AND OUTLETS

A.O. No. 55 s. 1988 REQUIREMENTS FOR LABELLING MATERIALS OF PHARMACEUTICAL PRODUCTS

A.O. No. 99-A s. 1984 REGULATION PART C-11: LISTING OF LOCAL HERBAL AND/OR TRADITIONAL DRUGS

A.O. No. 42 s. 1982 REGULATION PART C-10: DRUGS REGISTRATION OF HEALTH AND/OR TRADITIONAL DRUGS BOTH LOCAL AND IMPORTED

E. Useful addresses 1. Department of Trade and Industry

Bureau of Export Trade Promotion 5-8th Floor, New Solid Bldg.,

357 Sen. Gil J. Puyat Avenue, Makati City, Contact Number/s : Phone: (63-2) 7593381, 8953654, 8990133 Fax : (63-2) 8904707, 8904716 Board of Investments 5th Floor, Industry & Investments Bldg. 385 Sen. Gil J. Puyat Avenue, Makati City Contact Number/s : Phone : (63-2) 8909330, 8909332, 8976682 loc 248 Fax : (63-2) 8953512

Bureau of Import Services

3rd Floor, Oppen Bldg. 349 Sen. Gil J. Puyat Avenue, Makati City Contact Number/s : Phone : (63-2) 8964430 Fax : (63-2) 8957466


- 24 -

Center for International Trade Expositions and Missions Golden Shell Pavilion, Roxas Blvd. corner Sen. Gil J. Puyat Avenue, Pasay City Contact Number/s : Phone : (63-2) 8312382, 8323956, 8312201 loc 236 Fax : (63-2) 8323965, 8340177

2. Department of Health

San Lazaro Compound, Tayuman, Sta. Cruz, Manila Philippines 1003 Phone : (632) 743.8301 to 23 Fax : (632) 743.1829 Email : [email protected] Bureau of Food and Drugs Civic Drive, Filinvest Corporate City Alabang, Muntinlupa City Philippines 1781 Contact Number/s : Phone: (63-2) 807.0721 / 842.5606 Philippine Institute of Traditional and Alternative Health Care (PITAHC) Unit 2402 Atlanta Centre, 31 Annapolis Street, Greenhills San Juan, Metro Manila Contact Number/s : Phone : (63-2) 727.2113 / 726.3225 / 726.6377 Fax : (63-2) 727.7621 / 727.6199

3. Industry associations

Pharmaceutical Healthcare Association of the Philippines, Inc. (PHAP) U-502 5/F One Corporate Plaza 845 Pasay Road, Makati City 5299 Contact Number/s : Phone: (63-2) 815.0325 / 816.7334 Fax : (63-2) 819.2702 Mr. Leo P. Wassmer EVP - CEO


- 25 -

Chamber of Filipino Drug Manufacturers and Distributors, Inc. (CFDMD) 404 Jovan Condo 600 Shaw Blvd., cor Samat Street Mandaluyong City Contact Number/s : Phone : (63-2) 535.4835 Email : [email protected] Ms. Ma. Lourdes Buensuceso President Chamber of Herbal Industries of the Philippines, Inc. (CHIP, Inc.) 2281 2/F DMCI Complex Pasong Tamo Extension Makati City Contact Number/s : Phone : (63-2) 888.3944 Fax : (63-2) 816.7185 Mr. Horacio Abelarde President


- 26 -


- 27 -

ANNEX I

PRODUCT COVERAGE FOR PHARMACEUTICAL PRODUCTS

HDG. HS PSCC PRODUCT DESCRIPTION

29.36 Provitamins and vitamins, natural or reproduced by synthesis (including natural concentrates), derivatives thereof used primarily as vitamins, and intermixtures of the foregoing, whether or not in any solvent

29361000 5411100 provitamins, unmixed (NK) 29362100 5411200 vit a & their derivatives,unmixd (NK) 29362200 5411301 vit b1 & its derivatives,unmixed (NK) 29362300 5411302 vitamin b2 & its derivatives, unmixed (NK) 29362400 5411303 d-/dl-pantothenic acid(vitamin b3/b5) & its derivatives,

unmixed (NK) 29362500 5411304 vit b6 & its derivatives,unmixed (NK) 29362600 5411305 vit b12 & its derivatives,unmixd (NK) 29362700 5411400 vit c & its derivatives,unmixed (NK) 29362800 5411500 vit e & its derivatives,unmixed (NK) 29362900 5411600 oth vits & their derivtv;unmixed (NK) 29369000 5411700 intermixtures of provitamins & vitamins wtr/not in any

solvent (NK) 29.37 Hormones, natural or reproduces by synthesis; derivatives

thereof, used primarily as hormones, other steriods used primarily as hormones

29371000 5415200 pituitary(anterior)/simlr hormones, & their derivtv, not as medicment (NK)

29372100 5415301 cortisone,hydrocortisone,prednisone & prednisolone,not as medicaments (NK)

29372200 5415302 halogenated derivtv of adrenal cortical hormones,not as medicaments (NK)

29372900 5415309 oth adrenal cortical homrones & their derivtv, not as medicaments (NK)

29379100 5415100 insulin & its salts, not put up as medicaments (NK) 29379200 5415901 oestrogens & progestogens, not put up as medicaments

(NK) 29379900 5415909 oth hormones & oth hormone derivtv; oth steroids as

hormone,not as medic (NK) 29.38 Glycosides, natural or reproduced by synthesis , and their

salts, ethers, esters and other derivatives 29381000 5416101 rutoside(rutin) & its derivtv, not put up as medicaments

(NK) 29389000 5416109 oth glycosided,nat'l/reproduced by synthesis&their

dervtv,not as medic (NK)


- 28 -


29.39 Vegetable alkaloids, natural or reproduced by synthesis and their salts, ethers, esters and other derivatives

29391000 5414100 alkaloids of opium & derivtv; salts, not put up as medicaments (NK)

29392100 5414201 quinine & its salts, not put up as medicaments (NK) 29392900 5414209 oth alkaloids of cinchona & derivtv; salts, not put up as

medicaments (NK) 29393000 5414300 caffeine & its salts,not put up as medicaments (NK) 29394100 5414401 Ephedrine and its salts (NK) 29394900 5414409 other ephedrines and their salts, not put up as medicaments

(NK) 29395000 5414500 theo-/amino- phylline & their derivtv; salts, not put up as

medicaments (NK) 29396200 5414602 ergotamine (inn) and its salts (NK) 29396900 5414609 other alkaloids of rye ergot and their derivatives; salts

thereof, not put up as medicaments (NK) 29397000 5414700 nicotine & its salts, not put up as medicaments (NK) 29399000 5414909 oth veg alkaloids; derivtv of alkaloids nes, & their salts, nes

(NK) 29.41 Antibiotics 29411000 5413100 penicillins&derivtv w/ penicillanic acid stru; salts,not as

medicmnt (NK) 29412000 5413200 streptomycins & their derivtv; salts, not put up as

medicaments (NK) 29413000 5413301 terramycin; salts, not put up as medicaments (NK) 29413000 5413309 oth tetracyclines & their derivtv; salts, not put up as

medicaments (NK) 29414000 5413901 chloramphenicol&derivtv, chloromycetin; salts, not put up

as medicaments (NK) 29415000 5413902 erythromycin&derivtv, incldg ilotycin, erythrocin,salts,not

as medicmnt (NK) 29419000 5413903 bacitracin; salts, not put up as medicaments (NK) 29419000 5413904 neomycin;salts,not as medicmnt (NK) 29419000 5413905 antibiotics for veterinary use; salts, not put up as

medicaments (NK) 29419000 5413909 oth antibiotics, & salts, nes, not put up as medicaments

(NK)


- 29 -


30.01 Glands and other organs for organo-therapeutic uses, dried, whether or not powdered; extracts of glands or other organs or of their secretions for organo-therapeutic uses; heparin and its salts; other human animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included

30011000 5416201 glands & oth organs, for organo-therapeutc uses,dried,powdered/not (NK)

30012000 5416202 xtract of glands/oth organs/their secretions for organo-therapeutc (NK)

30019000 5416203 heparin & its salts (NK) 30019000 5416209 oth human/animal subs preprd for therapeutic/prophylactic

uses (NK) 30.02

Human blood; animal blood preapred for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or ot obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products

30021000 5416301 antisera [, bulk] (NK) 30021000 5416303 blood globulins, serum globulins & hemoglobin (NK) 30021000 5416309

other blood fractions and modified immunological products, whether or not obtained by means of biote (NK)

30022000 5416311 Cholera, dysentery & typhoid vaccine, (bulk) NK 30022000 5416313 rabies vaccine [, bulk] (NK) 30022000 5416321 Poliomyelitis & staphylococci vaccines (bulk) NK 30022000 5416329 other vaccines for human medicine [, bulk] (NK) 30023000 5416341 veterinary vaccines against foot and mouth disease [, bulk]

(NK) 30023000 5416349 other veterinary vaccines [,bulk] (NK) 30029000 5416401 human blood (NK) 30029000 5416402 animal blood preprd for therapeutic, prophylactic/diagnostic

uses (NK) 30029000 5416405 toxins, cultures of micro-organisms (excluding yeasts) and

similar products [, bulk] (NK) 30029000 5416403 antitetanic serum [, bulk] (NK) 30.03

Medicaments (excluding goods of hdg 30.03, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale


- 30 -

HDG. HS PSCC PRODUCT DESCRIPTION 30031000 5421101 medicmnt containing penicillin, not put in

doses(/form/packgs for retail (NK) 30031000 5421104 medicmnt contg Erythromycin, not put up in

doses/form/packgs for retail, (NK) 30031000 5421105 medicmnt w/ penicillin/derivtv,penicillanic acid stru,for

veterinary (NK) 30031000 5421109 oth medicmnt w/ penicillins/derivtv, w/ penicillanic acid

stru, etc (NK) 30032000 5421202 medicmnt contg chloramphenicol,not in doses/form/packg

for retail (NK) 30032000 5421203 medicmnt contg terramycin,not put up in

doses/forms/packings for retail (NK) 30032000 5421204 medicmnt contg oth antibiotics for vete rinary,not

doses/form for retail (NK) 30032000 5421209 medicmnt contg oth antibiotics (NK) 30033100 5422100 medicmnt contg insulin, not put up in doses/forms/packings

for retail (NK) 30033900 5422201 medicmnt w/ antidiabetic preptn, not in doses/packings for

retail (NK) 30033900 5422209 medicmnt w/ oth-hormone/prodct FO 54145, not in

doses/packg for retail (NK) 30034000 5423109 medicmnt w/ alkaloids & derivtv, nes, not in doses/packg

for retail (NK) 30039000 5429101 medicmnt contg sulfonamides & sulfonamide comp, in

doses/packg for retail (NK) 30039000 5429102 medicmnt contg enzymes, not put up in doses/forms/packg

for retail (NK) 30039000 5429107 medicmnt w/ analgesics & antipyretics, not in doses/packg

for retail (NK) 30039000 5429108 medicmnt w/ shcistosomiasis medicine, not in doses/packg

for retail (NK) 30039000 5429111 veterinary medicmnt, not in doses/form/ packg for retail,oth

thn 5429104 (NK) 30039000 5429119 oth medicmnt, nes, not put up in doses/forms/packings for

retail (NK) 30.04

Medicaments (excluding goods of hdg 30.03, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale

30041000 5421301 medicmnt contg penicillin, put up in doses/forms/packings for retail (NK)


- 31 -


5421302 medicmnt contg erythromycin/dihydrostrep-tomycin in doses/oth for retail (NK)

30041000 5421304 medicmnt contg erythromycin,put up in doses/forms/packings for retail (NK)

30041000 5421305 medicmnt w/ penicillins/derivtv, etc, for retail sale, for veterinary (NK)

30041000 5421309 oth medicmnt w/ penicillins/derivtv,etc in doses/form/packing for retail (NK)

30042000 5421901 medicmnt contg bacitracin, put up in doses/forms/packings for retail (NK)

30042000 5421902 medicmnt contg chloramphenicol, put up in doses/forms/packg for retail (NK)

30042000 5421903 medicmnt contg terramycin, put up in doses/forms/packings for retail (NK)

30042000 5421904 medicmnt w/ oth antibiotics for veterinary use,in doses/oth for retail (NK)

30042000 5421909 medicmnt w/ oth antibiotics,nes, in doses/forms/packg for retail (NK)

30043100 5422300 medicmnt contg insulin, put up in doses/forms/packings for retail (NK)

30043200 5422400 medicmnt contg adrenal cortex hormones, in doses/forms/packg for retail (NK)

30043900 5422900 medicmnt w/ oth-hormone/prodct of 5415, in doses/forms/packgs for retail (NK)

30044000 5423201 medicmnt contg opium alkaloids,in doses forms/packings for retail sale (NK)

30044000 5423202 medicmnt w/ alkaloids, of cinchona bark, in doses/form/packing for retail (NK)

30044000 5423209 medicmnt w/ alkaloids&alkaloids derivtv ,in doses/form/packg for retail (NK)

30045000 5429200 medicmnt w/ vit/oth prodct of 5411, in doses/forms/packings for retail (NK)

30049010 5429314 specialized medicines for cancer, aids and other dreaded diseases (NK)

30049020 5429316 closed sterile water system for inhalation, pharmaceutical grade (usp, nf or bp) (NK)

other 30049090 5429301 sulfonamides & sulfonamide comp, in doses/forms/packings for retail (NK)

30049090 5429303 Medicated candies,cough-syrups&drops,in doses/forms/packings for retail (NK)

30049090 5429305 veterinary medicine for eradication of parasites, for retail sale (NK)


- 32 -


30049090 5429306 veterinary medicmnt doses/forms/packg/ for retail sale, oth thn 5429305 (NK)

30049090 5429307 anaesthetics, put up in measured doses/ forms/packings for retail sale (NK)

30049090 5429308 glucose, preprd as medicmnt, put up in doses/forms packing for retail sale (NK)

30049090 5429311 trypanocidal and antiluetic preptn, in doses/forms/packings for retail (NK)

30049090 5429312 analgesics & antipyretics, put up in doses/forms/packings for retail (NK)

30049090 5429315 water, medicinal, distilled, packed for retail (NK) 30049090 5429319 oth medicmnt w/ oth medicinal & pharmaceutical prodct,

nes, for retail sale (NK) Source : Bureau of Export Trade Promotion


- 33 -

ANNEX II

PRODUCT COVERAGE FOR NATURAL PRODUCTS HDG. HS PSCC PRODUCT DESCRIPTION

12.11

Plants and parts of plants (including seeds and fruits), of a kind used primarily in perfumery, in pharmacy or for insecticidal, fungicidal or similar purposes, fresh or dried, whether or not cut, crushed or powdered.

12111000 2924100 liquorice roots (nk) 12112000 2924200 ginseng roots (nk) 12119000 2924901 eucalyptus leaves (nk) 12119000 2924902 cinchona bark (nk) 12119000 2924903 cedar powder (nk) 12119000 2924904 pyrethrum (nk)

12119000 2924909 other plants and parts of plants (including seeds and fruits) of a kind used primarily in perfumery, (nk)

121220 12122000 2929700 seaweeds and other algae (nk)

13.01 Lac, natural gums, resins, gum-resins and oleoresins (for example, balsams)

13011000 2922101 shellac (nk) 13011000 2922109 oth lac (nk) 13012000 2922200 gum arabic (nk) 13019000 2922901 resin, copal(almaciga) (nk) 13019000 2922902 gum, elemi (nk) 13019000 2922903 gum, tragacanth (nk) 13019000 2922904 gum, guar (nk) 13019000 2922905 resin, natural (nk) 13019000 2922906 incense & myrrh (nk) 13019000 2922909 oth nat gum,gum-resins & balsam (nk)

1302

Vegetable saps and extracts; pectic substances, pectinates and pectates, agar-agar and other mucilages and thickeners, whether or not modified, derived from vegetable products.

Vegetale saps and extracts 13021100 2929401 opium sacs & extracts 13021200 2929402 liquorice saps & extracts (nk) 13021300 2929403 extracts of hops (nk) 13021400 2929404 extracts of pyrethrum/roots of plants contg rotenone (nk) 13021900 2929409 oth vegetable saps & extracts (nk) 13022000 2929500 pectic substances, pectinates&pectates (nk) 13023100 2929601 agar-agar, whether or not modified (nk)

mucilages and thickeners, whether or not modified, derived from vegetable products

13023200 2929602 mucilages and thickeners derived from locust beans, locust bean seeds or guar seed, whether or not m (nk)

13023910 2929603 carrageenan (nk)


- 34 -


13023990 2929609 mucilages and thickeners derived from vegetable products, n.e.s., whether or not modified (nk)

15.08 Ground-nut oil and its fractions, whether or not refined, but not chemically modified

1508.1 4213100 groundnut(peanut) oil, crude (nk) 15089000 4213900 groundnut(peanut) oil, refined & its fractions (nk)

15.13 coconut (copra), palm kernel or babassu oil and fractions thereof, whether or not refined, but not chemically modified

15131100 4223100 coconut(copra)oil, crude (gk) 15131900 4223900 coconut(copra) oil, refined & its fractions (gk) 15132100 4224100 palm kernel/babassu oil, crude (nk) 15132900 4224900 palm kernel/babassu oil, refined and fractions thereof (nk)

15.15

Other fixed vegetable fats and oils (including jojoba oil) and their fractions, whether or not refined, but not chemically modified

15151100 4221100 linseed oil, crude (nk) 15151900 4221900 linseed oil, refined & its fractions (nk) 15152100 4216100 maize(corn) oil, crude (nk) 15152900 4216900 maize(corn) oil, refined & its fractions (nk) 15153000 4225000 castor oil & its fractions (nk)

15154000 4229100 tung oil and its fractions, whether or not refined, but not chemically modified (nk)

15155000 4218000 sesame(sesamum) oil & its fractions (nk)

15159000 4229902 jojoba oil and its fractions, whether or not refined, but not chemically modified (nk)

15159000 4229901 tobacco seed oil and its fractions, whether or not refined, but not chemically modified (nk)

15159000 4229903 oiticica oil and its fractions, [refined, solidified or hardened by mechanical means] whether or not (nk)

15159000 4229909 other fixed vegetable fats and oils, and their fractions, [crude, refined or fractionated, n.e.s.] w (nk)

1516

Animal or vegetable fats and oils and their fractions, partly or sholly hydrogenated, inter-esterified, re-esterified or elaidinised, whether or not refined, but not further prepared.

15161000 4312100 animal fats&oils&fractions,hydrogenated inter-/re-esterified/elaidinized (nk)

151620 Vegetable fats and oils and their fractions 15162010 4312201 hydrogenated vegetable fats in flakes (nk)

15162090 4312209 other vegetable fats and oils and their fraction partly or wholly hydrogenated (other than in flakes (nk)


- 35 -


1521

Vegetable waxes (other than triglycerides), bees wax, other insect waxws and spermaceti, whether or not refined or coloured

15211000 4314101 carnauba wax (nk) 15219000 4314109 oth veg waxes, wtr/not colored (nk) 15219000 4314201 beeswax (nk)

15219000 4314202 spermaceti, crude, pressed/refined, wtr/not colored (nk) 15219000 4314209 oth insect waxes, wtr/not refined/ colored (nk) 1804 18040000 724000 cocoa butter, fat/oil (nk)

3203 32030000

Coloring matter of vegetable or animal origin (including dyeing extracts but excluding animal black) whether or not chemically defined

32030000 5322201 natural indigo (nk) 32030000 5322202 annatto(achuete) (nk) 32030000 5322203 food color, of veg/animal origin (nk)

32030000 5322209 oth coloring matter of veg/animal origin & preptns based thereon (nk)

33.01

Essential oils (terpeneless or not) including corncretes and absolutes; resinoids; extracted oleoresins; concentrates of essential oilsin fats, in fixed oils, in waxes or the like, obtianed by enfleurage or maceration; terpenic by -productsof the deterpenation of essential oils, aqueous distillates and aqueous solutions of essential oils.

Essential oils of citrus fruit 33011100 5513121 bergamot oil (nk) 33011200 5513103 orange oil for mfr of medicine (nk) 33011200 5513113 orange oil oth for mfr of medicn (nk) 33011300 5513101 lemon oil for mfr of medicine (nk) 33011300 5513111 lemon oil oth for mfr of medcine (nk) 33011400 5513102 lime oil for mfr of medicine (nk) 33011400 5513112 lime oil oth for mfr of medicine (nk)

33011900 5513109 oth essetial oils of citrus fruits for manufacture of medicine (nk)

33011900 5513119 oth essential oils of citrus fruits oth for the manufacture of medicine (nk)

Essential oils other than those of citrus fruit 33012200 5513225 jasmin oil (nk) 33012300 5513226 lavender/lavandin oil (nk) 33012600 5513227 vetiver oil (nk)

Source : Bureau of Export Trade Promotion


- 36 -


- 37 -

ANNEX III

PHILIPPINE’S TOP IMPORTERS OF PHARMACEUTICAL PRODUCTS (Contact information updated as of April 2004)

1. NOVARTIS HEALTHCARE PHILS. Address : Asian Reinsurance Building

Salcedo cor. Gamboa Sts. Legaspi Village, Makati City 1229

Contact : Telephone : (632) 815.9371 Facsimile : Email Address : Novartis.com 2. PFIZER, INC. Address : 23/F Ayala Life – FGU Center,

6811 Ayala Avenue, Makati City

Contact : Mr. Gerry Bacaro Country Manager

Telephone : (632) 888-6001 Facsimile : (632) 864-3708 Email Address : [email protected] 3. GLAXOSMITHKLINE PHILIPPINES INC. Address : 2266 Chino Roces Avenue,

Makati City Contact : Mr. Amado Tuzon Tadena

President and Managing Director Telephone : (632) 892-0761 Facsimile : (632) 893-8019 Email Address : [email protected] 4. VITACHEM INDUSTRIES Address : 44 Zamboanga Street,

Nayon Kanluran 1104 Quezon City Contact : Mr. Felix Co

General Manager Telephone : (632) 372-8210 Facsimile : (632) 372-8218 Email Address : [email protected] 5. ASTRA ZENECA PHARMACEUTICALS (PHILIPPINES), INC. Address : Km. 14 South Superhighway

Parañaque City, Metro Manila Contact : Mr. Rodrigo Bayna

Business Development Director Telephone : (632) 823-8169 Facsimile : (632) 824-1298 Email Address : [email protected]


- 38 -

6. UNITED LABORATORIES, INC. Address : No. 66 United Street

Mandaluyong City Contact : Mr. Carlos C. Ejercito

President Telephone : (632) 631-8501 to 50 Facsimile : (632) 631-6036 / 631-6017 Email Address : [email protected] 7. ROCHE (PHILIPPINES) INC. Address : Roche Building, 2252 Don Chino Roces Avenue

1231 Makati City Contact : Mr. Warwick Bedwell

General Manager Telephone : (632) 893-4567 Facsimile : (632) 893-3030 Email Address : Business Line : diagnostic analytical systems 8. BASF PHILIPPINES INC. Address : Road 5, Phase 1 G12 Carmelray Industrial Park I

4028 Calubang, Calamba, Laguna Contact : Telephone : (649) 549-0001 Facsimile : (649) 549-1026 Email Address : 9. BOEHRINGER INGELHEIM (PHILIPPINES) INC. Address : 23F Citibank Tower, Citibank Plaza,

8741 Paseo De Roxas, Salcedo Village, Makati City

Contact : Mr. Stefan Kilian President and Managing Director

Telephone : (632) 867-0800 Facsimile : (632) 848-0506 Email Address : [email protected] 10. BAYER PHILS., INC. Address : Bayer House, Canlubang Industrial Estate

Calamba, Laguna Contact : Mr. Gregorio V. Pangan

Vice President, Business Telephone : (649) 549-7375 loc. 3760 Facsimile : (649) 549-2905 Email Address : [email protected]


- 39 -

11. SANOFI-SYNTHELABO Address : 3/F Feliza Building VA Rufino Street,

Legaspi Village, Makati City Contact : Mr. Peter Dolinsky

President Telephone : (632) 840-3888 Facsimile : (632) 813-1676 Email Address : [email protected] 12. SCHERING-PLOUGH CORP. Address : 12/F San Miguel Properties Centre

St. Francis Street, Ortigas Center Mandaluyong City

Contact : Mr. Leo Riconalla Division Manager

Telephone : (632) 637-0594 Facsimile : (632) 638-7709 Email Address : www.schering-plough.com.ph 13. MERCK, SHARP & DOHME PHILS. Address : 26/F Philamlife Tower,

8767 Paseo de Roxas, Makati City Contact : Mr. Michael Harris

Managing Director Ms. Grace Pitco Customer Service Officer

Telephone : (632) 885-0700 to 29 Facsimile : (632) 885-07773 to 75 Call Center : (632) 878-6338 Email Address : www.msd.com.ph 14. BRISTOL MYERS SQUIBB MEAD JOHNSON Address : 2309 Pasong Tamo Extension,

Makati City Contact : Telephone : (632) 841-8181 Facsimile : Email Address : 15. ZUELLIG PHARMA CORPORATION Address : Zuellig Building,

Malugay Street corner Sen. Gil J. Puyat Avenue Makati City

Contact : Telephone : (632) 819-1561 Facsimile : Email Address :


- 40 -

16. SERVIER, PHILS Address : 2 corner Orion and Merceds Streets,

Bel Air Subdivision, Makati City Contact : Mr. Philippe Molhant

Managing Director Telephone : (632) 897-8990 Facsimile : (632) 897-9027 Email Address : [email protected] 17. ABBOTT LABORATORIES (PHILIPPINES) Address : 102 E. Delos Santos Ave., cor Madison St., Mandaluyong City Contact : Mr. Edwin D. Feist

President Telephone : (632) 631-8471 to 87 Facsimile : (632) 631-8488; (02) 634-0041 Email Address : N/A 18. MERIAL PHILIPPINES, INC. Address : Unit 2504 25th Floor Discovery Center

#25 ADB Ave., Ortigas Center, Pasig City Contact : Dr. Daniel Rodriguez

General Manager Telephone : (632) 689-1030 to 35 Facsimile : (632) 910-6840 Email Address : [email protected] 19. AVENTIS PHARMA, INC. Address : 12/F The Orient Square,

Emerald Ave., Ortigas Center, Pasig City 1605, Metro Manila

Contact : Mr. Jean-Marie Arnaud Chairman of the Board/President & General Manager

Telephone : (632) 638-1369 to 74 Facsimile : (632) 638-6907 Email Address : [email protected] 20. WYETH PHILIPPINES Address : 2236 Chino Roces Ave.,

Makati City Contact : Mr. Andrew Santos

Sales Director/Marketing Telephone : (632) 843-0941 to 50/884-6600 to 05 Facsimile : (632) 817-3523/813-2162 (Mr. Santos) Email Address : N/A


- 41 -

21. ELI LILLY PHILIPPINES, INC. Address : 18TH Floor, Robinson’s Galleria Center,

EDSA cor. Ortigas Avenue, Quezon City Contact : N/A Telephone : (632) 634-5704/634-5646 Facsimile : (632) 634-7334 Email Address : N/A 22. AVENTIS PASTEUR Address : 5TH Floor, Gammon House,

110 Rada Street, Legaspi Village, Makati City Contact : Mr. Paul-Alan Dollinger

President Telephone : (632) 816-1709 Facsimile : (632) 815-2979 Email Address : [email protected] 23. MERCK, INC. Address : 7TH Floor, Vernida IV Building,

128 Alfaro Street, Makati City Contact : N/A Telephone : N/A Facsimile : (632) 812-6241 to 50; 817-5408 Email Address : (632) 810-3024;818-6262 24. ALCON LABORATORIES (PHILS.), INC. Address : 3/F LGI Bldg., Ortigas Ave.,

Greenhills, San Juan, Metro Manila Contact : Mr. Gnoy Daguimol

Production Planning Manager Telephone : (632) 721-3957 to 59 Facsimile : (632) 722-4167 Email Address : N/A 25. SOLVAY PHARMA, INC. PHILIPPINES Address : 2/F Port Royal Place,

118 Rada St., Legaspi Village, Makati City Contact : Mr. Marcus P.M. Wondergem

President / CEO Telephone : (632) 894-0688 Facsimile : (632) 894-1071 Email Address : [email protected]


- 42 -


- 43 -

ANNEX IV PRICE LIST OF PRESYONG TAMA, GAMOT PAMPAMILYA (RIGHT PRICE FOR FAMILY MEDICINES)

- 44 -

Supply and demand survey on pharm

aceuticals and natural products – Philippines

(Prices in Philippine Pesos per Table / Bottle / Unit )

S A V I N G S DRUG / DOSAGE GENERIC

NAME MANUFACTURER SUGGESTED RETAIL PRICE

CURRENT MARKET PRICE PHP %

ANTI – BACTERIALS BACTRIM ADULT 400/80mg tab Cotrimoxazole Nicholas Piramal (Roche) 2.80 14.80 12.00 81% BACTRIM DS 800/160mg tab Cotrimoxazole Nicholas Piramal (Roche) 5.10 26.00 20.90 80% BAYCIP (Ciprobay) 250 mg tab Ciprofloxacin Bayer 19.50 54.50 35.00 64% BAYCIP (Ciprobay) 500 mg tab Ciprofloxacin Bayer 32.50 75.75 43.25 57% PHEXIN (Ceporex) 250mg cap Cefalexin Glaxo 11.80 18.25 6.45 35% PHEXIN (Ceporex) 500mg cap Cefalexin Glaxo 21.55 33.75 12.20 36% PHEXIN (Ceporex) 250mg/5ml, 30ml susp Cefalexin Glaxo 99.75 165.50 65.75 40% AUGMENTIN 375mg tab Co-amoxiclav Medreich Sterilab (Glaxo) 51.20 69.75 18.55 27% AUGMENTIN 625mg tab Co-amoxiclav Medreich Sterilab (Glaxo) 63.50 87.25 23.75 27% ANTI-HYPERTENSIVES ADALAT RETARD 20 mg tab Nifedipine Bayer 5.75 29.75 24.00 81% IONOZEM (Dilzem) 30mg tab Diltiazem Parke Davis 9.65 25.40 15.75 62% IONOZEM (Dilzem) 60mg tab Diltiazem Parke Davis 15.25 35.70 12.20 36% TENORIM 50mg tab Atenolol ICI 8.70 22.00 13.30 60% BETALOC 50mg tab Metoprolol Astra-IDL 4.70 10.20 5.50 54% BETALOC 100mg tab Metoprolol Astra-IDL 8.20 17.70 9.50 54%

- 45 -



S A V I N G S

DRUG / DOSAGE GENERIC NAME MANUFACTURER SUGGESTED RETAIL PRICE


NON-STEROIDAL ANTI-INFLAMMATORY DRUGS PONSTAN 250mg tab Mefenamic Acid Parke Davis 5.40 10.50 5.10 49% PONSTAN 500mg tab Mefenamic Acid Parke Davis 8.65 20.85 12.20 59% VOVERAN (Voltaren) 50mg tab Diclofenac Novartis 5.85 17.20 11.35 66% VOVERAN (Voltaren) 75mg tab Diclofenac Novartis 7.80 23.00 15.20 66% VOVERAN (Voltaren) 100mg tab Diclofenac Novartis 10.40 33.50 23.10 69% ORAL HYPOGLYCEMIC/ANTI-DIABETES AGENTS DAONIL 5mg tab Glibenclamide Hoechst Marrion Roussel 3.10 8.90 5.80 65% EUGLUCON 5mg tab Glibenclamide Hoechst Marrion Roussel 5.20 9.25 4.55 49% ANTI-ANGINAL AGENTS ISORDIL 5mg tab SL tab Isosorbide Dinitrate Wyeth 2.60 11.254 8.65 77% ISORDIL 10mg tab SL tab Isosorbide Dinitrate Wyeth 3.50 9.75 6.25 64% ANTI-CHOLESTEROL AGENTS LOPID 300mg cap Gemfibrozil Parke Davis 19.15 36.50 17.35 48% LOPID 600mg cap Gemfibrozil Parke Davis 38.35 67.75 29.40 43%

- 46 -



S A V I N G S

DRUG / DOSAGE GEN??ERIC NAME MANUFACTURER

SUGGESTED RETAIL PRICE


BRONCHODILATORS BRICANYL 2.5mg tab Terbutaline Sulfate Astra-IDL 3.60 8.25 4.65 56% BRICANYL 5mg tab Terbutaline Sulfate Astra-IDL 5.85 19.75 13.90 70% BRICANYL 250mcg x 200doses inh Terbutaline Sulfate Astra-IDL 217.15 438.00 242.60 53% BRICANYL 1.5mg/5ml, 100ml syr Terbutaline Sulfate Astra-IDL 80.85 155.20 81.85 50% VENTORLIN (Ventolin) 100mcgx200doses inh

Salbutamol Glaxo 159.60 314.25 154.65 49%

VENTORLIN (Ventolin) 2mg/5ml, 100ml syr

Salbutamol Glaxo 72.10 151.85 79.75 53%

ANTI-MOTILITY AGENTS/ANTI-DIARREHALS BUSCOPAN 20mg/ml inj Hyoscine-N-

butylbromide Gremedies (Boehringer) 28.60 68.75 40.15 58%

BUSCOPAN 10mg tab Hyoscine-N-butylbromide

Gremedies (Boehringer) 4.85 9.00 4.15 46%

IMODIUM 2mg cap Loperamide J & J (Janssen) 4.75 9.75 5.50 54% ANTI-PSYCHOTICS SERENACE 1.5mg tab Haloperidol RPG (Searle) 3.25 7.00 3.75 54% SERENACE 5mg tab Haloperidol RPG (Searle) 8.10 20.00 11.90 60% SERENACE 10mg tab Haloperidol RPG (Searle) 11.30 20.50 9.20 45% SERENACE 20mg tab Haloperidol RPG (Searle) 16.80 40.00 23.20 58% SERENACE 5mg/ml inj Haloperidol RPG (Searle) 17.80 138.00 120.20 87%

- 47 -



S A V I N G S

DRUG / DOSAGE GENERIC NAME MANUFACTURER SUGGESTED RETAIL PRICE


ANTI-EPILEPTICS TEGRITAL (Tegretol) 200mg tab Carbamazepine Novartis 6.05 15.00 13.95 70% TEGRITAL CR (Tegretol) 400mg tab

Carbamazepine Novartis 11.15 38.00 26.85 71%

TEGRITAL (Tegretol) 100mg/5ml, 100ml syr

Carbamazepine Novartis 119.20 275.00 155.80 57%

DILANTIN 100MG CAP Phenytoin Parke Davis 4.80 21.40 16.60 78% ANTI-BACTERIALS CEFTUM (Zinacef) 125mg tab Cefuroxime Glaxo 33.30 33.50 0.20 1% CEFTUM (Zinacef) 250mg tab Cefuroxime Glaxo 65.75 78.50 12.75 16% CEFTUM (Zinacef) 500mg tab Cefuroxime Glaxo 126.00 140.25 14.25 10% DALACIN-C 150mg cap Clindamycin Pharmacia 32.55 34.75 4.10 11% DALACIN-C 300mg cap Clindamycin Pharmacia 47.00 52.00 7.75 14% SEPTRAN (Septrin) 200/40mg/5ml,50ml susp

Cotrimoxazole Burroughs Wellcome 67.60 88.40 20.40 23%

ORAL HYPOGLYCEMIC/ANTI-DIABETES AGENTS DIAMICRON 80mg tab Gliclazide Serdia (Servier) 9.45 11.50 2.05 18

%


- 48 -


- 49 -

ANNEX V

PHILIPPINE IMPORTS OF PHARMACEUTICAL PRODUCTS CIF Value in US Dollars

1999 – 2003



-50-

2003 2002 2001 2000 1999

PSCC DESCRIPTION Quantity Value %Share Quantity Value Quantity Value Quantity Value Quantity Value Ave. Growth Rate

TOTAL 388,820,537 100.00 361,632,590 336,369,863 325,404,975 362,128,667 2.06

1 5429319 oth medicmnt w/ oth medicinal & pharmaceutical prodct, nes, for retail sale (nk)

7,447,271 205,359,508 52.82 7,777,533 180,495,577 6,536,186 169,226,103 4,971,445 147,644,228 5,099,741 167,669,175 5.78

2 5413909 oth antibiotics, & salts, nes, not put up as medicaments (NK)

673,371 18,959,291 4.88 1,153,473 20,055,543 517,739 16,899,597 315,103 20,075,270 239,073 28,271,721 -7.90

3 5421909 medicmnt w/ oth antibiotics,nes, in doses/forms/packg for retail (NK)

588,172 17,934,748 4.61 511,347 22,326,691 770,953 18,643,547 734,120 26,468,933 531,238 38,751,158 -15.29

4 5429314 specialized medicines for cancer, aids and other dreaded diseases (nk)

1,864,736 14,079,831 3.62 1,431,446 15,006,763 1,155,274 12,283,700 2,118,082 12,477,922 1,207,173 10,841,257 7.38

5 5421309 oth medicmnt w/ penicillins/derivtv,etc in doses/form/ packing for retail (NK)

822,519 14,061,646 3.62 339,872 7,308,250 196,727 3,706,821 238,789 4,369,032 308,817 6,992,694 34.22

6 5416349 other veterinary vaccines [,bulk] (NK) 214,714 13,156,917 3.38 227,497 14,775,399 248,812 14,346,794 239,221 13,670,029 172,399 15,533,176 -3.75

7 5422900 medicmnt w/ oth-hormone/prodct of 5415, in doses/forms/packgs for retail (NK)

443,307 13,006,709 3.35 328,017 10,449,714 137,092 9,385,707 129,566 6,145,134 53,101 6,619,382 20.35

8 5411400 vit c & its derivatives,unmixed (NK) 1,136,479 9,330,823 2.40 984,075 5,060,451 1,020,493 5,807,647 1,052,808 6,492,880 866,119 6,216,528 16.36



-51-

9 5416329 other vaccines for human medicine

[, bulk] (NK) 111,899 9,058,532 2.33 135,417 11,646,507 111,595 11,700,778 83,880 9,738,928 62,172 7,753,814 5.77

10 5429200 medicmnt w/ vit/oth prodct of 5411, in doses/forms/packings for retail (nk)

554,601 7,911,805 2.03 642,084 6,325,350 677,705 10,907,697 486,722 8,881,632 467,194 11,840,371 -4.78

11 5416309 other blood fractions and modified immunological products, whether or not obtained by means of biote (NK)

43,176 7,844,504 2.02 49,378 10,991,587 35,923 5,836,997 131,004 4,879,898 63,408 3,742,986 27.42

12 5429119 oth medicmnt, nes, not put up in doses/forms/packings for retail (nk)

1,177,107 6,237,711 1.60 1,046,909 6,339,203 2,087,824 6,390,282 582,549 5,752,770 626,625 4,278,616 10.78

13 5421301 medicmnt contg penicillin, put up in doses/forms/ packings for retail (NK)

106,967 6,184,229 1.59 59,858 5,254,943 67,723 4,261,282 52,747 2,975,706 56,753 1,869,768 35.84

14 5411700 intermixtures of provitamins & vitamins wtr/not in any solvent (NK)

365,275 4,734,936 1.22 443,584 4,851,938 443,986 4,336,536 243,980 3,131,115 211,713 2,877,956 14.20

15 5411600 oth vits & their derivtv;unmixed (NK)

753,117 4,430,287 1.14 409,531 5,998,340 318,204 4,558,902 260,600 2,677,709 245,083 2,593,094 19.74

16 5422300 medicmnt contg insulin, put up in doses/forms/ packings for retail (NK)

15,396 3,101,356 0.80 63,460 2,017,544 7,993 1,477,100 10,189 2,385,928 6,826 1,428,170 29.82

17 5411500 vit e & its derivatives,unmixed (NK) 435,610 2,913,127 0.75 424,341 2,790,452 261,931 2,512,347 157,517 1,916,417 127,416 2,734,156 4.17

18 5413100 penicillins&derivtv w/ penicillanic acid stru; salts,not as medicmnt (NK)

100,009 2,812,505 0.72 103,622 2,360,374 131,283 2,837,266 647,175 4,213,226 100,401 3,641,380 -3.65

19 5411200 vit a & their derivatives,unmixd (NK)

108,563 2,811,109 0.72 131,335 2,923,154 160,248 3,172,084 58,980 1,881,563 284,828 2,533,326 7.80

20 5413902 erythromycin&derivtv, incldg ilotycin, erythrocin,salts,not as medicmnt (NK)

25,740 2,687,986 0.69 30,196 1,947,960 23,892 3,084,316 25,610 4,128,819 99,068 3,927,738 -4.76



-52-

21 5416405 toxins, cultures of micro-organisms

(excluding yeasts) and similar products [, bulk] (NK)

115,090 2,413,495 0.62 58,087 1,658,687 51,684 1,510,988 36,090 810,302 15,225 726,813 38.31

22 5422400 medicmnt contg adrenal cortex hormones, in doses/forms/packg for retail (NK)

22,575 2,162,445 0.56 18,366 1,909,629 16,718 1,914,620 35,461 2,907,141 39,619 4,099,361 -12.56

23 5414300 caffeine & its salts,not put up as medicaments (NK)

281,470 1,957,388 0.50 240,314 1,757,687 246,776 1,850,621 164,335 1,308,946 268,035 2,108,965 2.45

24 5423209 medicmnt w/ alkaloids&alkaloids derivtv ,in doses/form/packg for retail (nk)

96,429 1,747,771 0.45 106,867 1,321,232 45,535 997,326 18,217 1,892,106 62,707 2,390,701 -0.85

25 5413309 oth tetracyclines & their derivtv; salts, not put up as medicaments (NK)

490,820 1,444,269 0.37 448,578 982,664 659,644 1,706,081 173,698 1,024,117 147,017 970,439 19.17

26 5421209 medicmnt contg oth antibiotics (NK) 47,047 1,369,802 0.35 36,790 2,253,766 29,919 1,059,370 64,174 1,663,118 21,111 2,306,272 2.34

27 5411303 d-/dl-pantothenic acid(vitamin b3/b5) & its derivatives, unmixed (NK)

129,055 1,329,698 0.34 199,955 1,876,007 109,719 1,441,445 1,599,277 1,473,829 86,186 1,607,067 -2.37

28 5422209 Medicmnt w/ oth-hormone/prodct FO 54145, not in doses/packg for retail

55,885 1,196,525 0.31 31,806 684,375 7,768 182,445 25,370 355,676 40,683 353,906 75.44

29 5411301 vit b1 & its derivatives,unmixed (NK)

43,552 794,432 0.20 52,499 744,041 66,095 881,951 58,217 840,165 68,105 1,135,470 -7.48

30 5411304 vit b6 & its derivatives,unmixed (NK)

87,263 688,046 0.18 69,269 822,475 49,330 713,876 35,676 615,494 41,325 886,286 -3.93

31 5411302 vitamin b2 & its derivatives, unmixed (NK)

43,698 619,131 0.16 50,787 846,377 40,291 844,653 43,929 899,703 77,548 1,280,870 -15.63

32 5411305 vit b12 & its derivatives,unmixd (NK)

14,186 598,021 0.15 56,527 1,133,708 61,859 1,100,236 26,918 836,512 47,619 813,738 -2.47



-53-

33 5429303 medicated candies,cough-

syrups&drops,in doses/forms/packings for retail (nk)

132,421 519,660 0.13 42,824 232,492 143,605 538,023 115,409 776,488 106,405 376,776 35.53

34 5415302 halogenated derivtv of adrenal cortical hormones,not as medicaments (NK)

2,100 430,672 0.11 3,783 1,150,896 3,445 1,801,829 1,542 1,546,696 849 2,364,589 -29.20

35 5416202 xtract of glands/oth organs/their secretions for organo-therapeutc (NK)

18,330 420,612 0.11 15,235 571,560 20,334 481,200 15,346 774,045 17,453 1,514,034 -23.59

36 5429316 closed sterile water system for inhalation, pharmaceutical grade (usp, nf or bp) (nk)

30,167 403,306 0.10 19,870 188,160 10,128 112,869 356,330 9,363,407 0 0 20.57

37 5414909 oth veg alkaloids; derivtv of alkaloids nes, & their salts, nes (NK)

42,299 358,525 0.09 23,040 336,754 28,224 500,878 7,275 455,341 5,539 326,394 5.80

38 5416402 animal blood preprd for therapeutic, prophylactic/diagnostic uses (NK)

68,937 358,041 0.09 25,394 115,032 7,518 219,284 48 791 1,169 80,450 6921.77

39 5429306 veterinary medicmnt doses/forms/packg/ for retail sale, oth thn 5429305 (nk)

26,357 353,190 0.09 13,855 211,429 3,672 218,479 14,391 239,158 15,640 183,033 21.46

40 5413901 chloramphenicol&derivtv, chloromycetin; salts, not put up as medicaments (NK)

20,567 349,833 0.09 19,505 335,266 85,815 638,849 127,901 839,583 25,921 889,125 -18.17

41 5413301 terramycin; salts, not put up as medicaments (NK)

49,384 302,100 0.08 15,200 20,187 20,415 25,471 2,265 32,772 921 9,465 399.93

42 5416401 human blood (NK) 1,734 252,068 0.06 532 120,689 41,673 126,508 1,532 76,254 898 153,379 29.97

43 5413905 antibiotics for veterinary use; salts, not put up as medicaments (NK)

17,340 247,213 0.06 9,847 95,583 2,524 26,688 76,678 39,487 0 0 96.10

44 5421109 oth medicmnt w/ penicillins/derivtv, w/ penicillanic acid stru, etc (NK)

8,448 221,402 0.06 35,740 132,782 0 0 6,367 36,677 63,079 330,097 -30.54



-54-

45 5423109 medicmnt w/ alkaloids & derivtv,

nes, not in doses/packg for retail (nk)

12377 184318 0.05 4310 76280 2858 74753 701 103444 3 335 7723.69

46 5415301 cortisone,hydrocortisone,prednisone & prednisolone,not as medicaments (NK)

1,179 141,635 0.04 1,462 165,059 6,844 442,622 446 329,227 425 333,416 -10.93

47 5415901 oestrogens & progestogens, not put up as medicaments (NK)

185 126,572 0.03 20,954 307,252 5,128 160,299 1,415 275,328 6,788 312,734 -5.22

48 5413200 streptomycins & their derivtv; salts, not put up as medicaments (NK)

4,536 113,235 0.03 29,038 372,411 34,314 416,931 47,002 1,330,047 61,911 3,355,662 -52.32

49 5421204 medicmnt contg oth antibiotics for vete rinary,not doses/form for retail (NK)

7,704 99,921 0.03 7,949 68,113 5,011 22,047 0 0 0 0 63.91

50 5421904 medicmnt w/ oth antibiotics for veterinary use,in doses/oth for retail (NK)

13,173 92,129 0.02 4,990 89,950 12,389 381,962 8,509 375,051 35,827 190,216 6.25

51 5416403 antitetanic serum [, bulk] (NK) 838 89,349 0.02 129 1,214 731 234,401 3,295 30,664 438 69,274 1942.27

52 5429315 water, medicinal, distilled, packed for retail (nk)

23,902 75,607 0.02 0 0 40 39,423 272 36,323 8,585 87,189 -37.45

53 5416109 oth glycosided,nat'l/ reproduced by synthesis&their dervtv,not as medic (NK)

9,229 73,029 0.02 42,509 247,132 11,074 166,408 6,677 123,537 1,080 105,151 7.56

54 5429305 veterinary medicine for eradication of parasites, for retail sale (nk)

2,000 67,600 0.02 0 0 0 0 1,171 10,481 0 0 -25.00

55 5416209 oth human/animal subs preprd for therapeutic/prophylactic uses (NK)

5,117 59,197 0.02 1,138 78,754 20,764 220,214 4,108 256,008 3,763 179,262 -15.06

56 5422100 medicmnt contg insulin, not put up in doses/forms/packings for retail (NK)

563 52,705 0.01 2,444 150,496 206 71,184 814 79,176 10 1,214 1614.57

57 5416101 rutoside(rutin) & its derivtv, not put up as medicaments (NK)

226 49,497 0.01 694 124,112 751 119,999 150 31,253 48,732 211,829 35.51



-55-

58 5421304 medicmnt contg erythromycin,put

up in doses/forms/packings for retail (NK)

293 43,090 0.01 0 0 0 0 1,363 18,499 0 0 -25.00

59 5415309 oth adrenal cortical homrones & their derivtv, not as medicaments (NK)

5 40,391 0.01 620 52,377 9,149 92,235 2,104 19,627 5,504 130,156 54.73

60 5414500 theo-/amino- phylline & their derivtv; salts, not put up as medicaments (NK)

2,753 39,615 0.01 152,925 200,072 3,182 216,542 2,196 265,601 4,363 259,289 -25.96

61 5416341 veterinary vaccines against foot and mouth disease [, bulk] (NK)

1,541 36,382 0.01 3,389 143,160 14,182 575,271 16,132 917,676 8,474 404,510 -15.04

62 5429301 sulfonamides & sulfonamide comp, in doses/forms/packings for retail (nk)

762 33,528 0.01 0 0 17,967 287,728 35 2,601 0 0 2715.55

63 5423201 medicmnt contg opium alkaloids,in doses forms/packings for retail sale (nk)

12377 28,858 0.01 481 25,113 1,216 101,705 663 131,176 0 0 -20.72

64 5415909 oth hormones & oth hormone derivtv; oth steroids as hormone,not as medic (NK)

2,764 27,870 0.01 7,155 148,650 19,326 152,765 834 102,991 279 102,577 -8.80

65 5411100 provitamins, unmixed (NK) 3,640 27,849 0.01 6,965 196,344 66,155 539,547 45,449 286,438 0 0 -15.27

66 5429111 veterinary medicmnt, not in doses/form/ packg for retail,oth thn 5429104 (nk)

4,060 27,433 0.01 1,288 13,738 266 12,122 46,542 165,766 3,055 59,866 49.31

67 5421901 medicmnt contg bacitracin, put up in doses/forms/packings for retail (NK)

2,027 20,905 0.01 806 73,206 7,361 172,256 3,280 84,359 0 0 -6.19

68 5414100 alkaloids of opium & derivtv; salts, not put up as medicaments (NK)

180 17,839 0.00 1,205 56,500 90,664 62,211 10,685 39,318 2,679 18,427 23.50

69 5414409 other ephedrines and their salts, not put up as medicaments (NK)

2,000 16,068 0.00 0 0 1,068 19,434 527 19,846 0 0 -25.52

70 5414602 ergotamine (inn) and its salts (NK) 3 15,908 0.00 0 0 0 0 158 23,106 0 0 -25.00



-56-

71 5414209 oth alkaloids of cinchona & derivtv;

salts, not put up as medicaments (NK)

501 14,351 0.00 200 7,736 400 51,748 461 57,557 1,782 70,805 -7.09

72 5414201 quinine & its salts, not put up as medicaments (NK)

105 7,575 0.00 100 6,500 197 11,111 477 9,087 31 3,827 33.69

73 5429312 analgesics & antipyretics, put up in doses/forms/packings for retail (nk)

3,072 7,206 0.00 0 0 7,397 79,594 610 29,143 0 0 18.28

74 5416201 glands & oth organs, for organo-therapeutc uses,dried,powdered/not (NK)

140 7,182 0.00 0 0 0 0 609 16,948 1,227 17,300 -25.51

75 5421305 medicmnt w/ penicillins/derivtv, etc, for retail sale, for veterinary (NK)

496 6,535 0.00 728 45,252 2,115 11,013 9,187 83,598 7,372 167,891 22.08

76 5421202 medicmnt contg chloramphenicol,not in doses/form/packg for retail (NK)

95 5,255 0.00 158 10,664 0 0 0 0 0 0 -12.68

77 5421203 medicmnt contg terramycin,not put up in doses/forms/ packings for retail (NK)

300 4,926 0.00 0 0 0 0 0 0 0 0 0.00

78 5423202 Medicmnt w/ alkaloids, of cinchona bark, in doses/form/packing for retail

20,080 4,800 0.00 0 0 0 0 0 0 0 0 0.00

79 5421902 medicmnt contg chloramphenicol, put up in doses/forms/packg for retail (NK)

1,634 3,690 0.00 132 3,116 14,252 220,346 218 25,380 8,993 92,265 153.88

80 5413904 neomycin;salts,not as medicmnt (NK)

200 2,148 0.00 699 5,811 1,187 13,977 3,735 61,914 104 3,167 414.02

81 5429307 anaesthetics, put up in measured doses/ forms/packings for retail sale (nk)

760 1,039 0.00 0 0 0 0 595 40,450 1,251 29,567 -15.80

82 5416203 heparin & its salts (nk) 60 95 0.00 198 699 1,603 5,761 1,067 7,023 1,304 94,590 -71.21

83 5413903 bacitracin; salts, not put up as medicaments (NK)

0 0 0.00 3,600 16,137 4,349 274,601 3 1,815 0 0 3708.85



-57-

84 5414401 Ephedrine and its salts (NK) 0 0 0.00 0 0 0 0 0 0 270 41,573 -25.00

85 5414609 other alkaloids of rye ergot and their derivatives; salts thereof, not put up as medicaments (NK)

0 0 0.00 4 3,745 90 912 86 3,630 0 0 33.94

86 5414700 nicotine & its salts, not put up as medicaments (NK)

0 0 0.00 1,000 5,983 0 0 0 0 0 0 -25.00

87 5415100 insulin & its salts, not put up as medicaments (NK)

0 0 0.00 4,982 12,783 477 83,158 13 3,016 494 92,235 593.97

88 5415200 pituitary(anterior)/simlr hormones, & their derivtv, not as medicment (NK)

0 0 0.00 150 3,556 82,000 73,445 16,329 82,610 0 0 -51.56

89 5416301 antisera [, bulk] (NK) 0 0 0.00 133 18,448 1,152 64,451 132 20,255 1,175 183,225 -10.53

90 5416303 blood globulins, serum globulins & hemoglobin (NK)

0 0 0.00 1,330 238,065 1,107 195,309 44,130 226,698 1,486 218,700 -22.08

91 5416311 Cholera, dysentery & typhoid vaccine, (bulk) NK

0 0 0.00 0 0 1,888 187,704 58 2,362 204 17,318 1915.12

92 5416313 rabies vaccine [, bulk] (NK) 0 0 0.00 327 204,501 284 47,140 1,252 544,546 0 0 35.62

93 5416321 Poliomyelitis & staphylococci vaccines (bulk) (NK)

0 0 0.00 0 0 314 21,473 1,389 134,207 589 80,956 -29.56

94 5421101 Medicmnt contg Penicillin, not put up in does/form/packgs for retail

0 0 0.00 0 0 0 0 850 25,237 0 0 -25.00

95 5421104 Medicmnt contg Erythromycin, not put up in doses/form/packgs for retail

0 0 0.00 0 0 0 0 240 48,275 0 0 -25.00

96 5421302 Medicmnt w/ Streptomycin/dihydrostrep-tomycin in doses/oth for retail

0 0 0.00 0 0 3,055 54,230 38,220 10,449 0 0 79.75

97 5421903 medicmnt contg terramycin, put up in doses/forms/packings for retail (NK)

0 0 0.00 838 20,925 630 3,558 4,471 67,376 1,734 44,297 86.37

98 5422201 Medicmnt w/ antidiabetic preptn, not in doses/forms/packings for retail

0 0 0.00 0 0 0 0 27 4,526 0 0 -25.00



-58-

99 5429101 medicmnt contg

sulfonamides&sulfonamide comp,in dose/packg for retail (nk)

0 0 0.00 0 0 106,600 117,898 57 7,770 0 0 329.34

100 5429102 medicmnt contg enzymes, not put up in doses/forms/packings for retail (nk)

0 0 0.00 0 0 0 0 4,384 1,987 0 0 -25.00

101 5429107 medicmnt w/ analgesics & antipyretics, not in doses/packg for retail (nk)

0 0 0.00 0 0 0 0 11,459 116,626 0 0 -25.00

102 5429108 medicmnt w/ shcistosomiasis medicine, not in doses/packg for retail (nk)

0 0 0.00 120 5,622 0 0 0 0 0 0 -25.00

103 5429308 glucose, preprd as medicmnt, put up in doses/forms/packings for retail (nk)

0 0 0.00 0 0 0 0 0 0 1,721 9,072 -25.00

104 5429311 trypanocidal and antiluetic preptn, in doses/forms/packings for retail (nk)

0 0 0.00 1,171 5,896 10 1,182 0 0 3,319 117,076 49.71



- 59 -

ANNEX VI

PHILIPPINE SUPPLYING COUNTRIES OF PHARMACEUTICAL PRODUCTS CIF Value in US Dollars

1999 - 2003

Country 2003 2002 2001 2000 1999 % Share 2003

Ave. Growth Rate

TOTAL 388,820,537 361,632,590 336,369,863 325,404,975 362,128,667 100.00 2.06

Top 10 283,900,448 258,497,919 237,962,881 232,231,062 257,159,505 73.02 2.81

Others 104,920,089 103,134,671 98,406,982 93,173,913 104,969,162 26.98 0.23

0.00 1 Switzerland 44,919,865 36,655,116 32,666,616 37,537,735 40,667,023 11.55 3.52 2 Germany 38,577,452 36,655,283 34,623,403 26,340,513 33,588,575 9.92 5.24 3 France 36,112,162 33,118,211 28,333,168 26,005,034 22,368,550 9.29 12.78 4 GB and North Ireland 32,519,186 33,725,135 29,323,847 26,536,101 29,436,399 8.36 3.02

5 Australia 32,247,545 23,305,190 26,679,636 30,874,415 34,016,152 8.29 0.73 6 USA (Ex. Hawaii, Alaska) 23,284,938 25,053,239 30,522,385 33,046,442 43,055,215 5.99 -13.97 7 Singapore 21,505,074 24,657,195 21,631,243 20,719,465 20,162,419 5.53 2.09 8 Italy 20,013,290 16,422,214 13,123,014 12,464,364 18,734,045 5.15 4.71 9 India 19,795,306 18,627,069 10,421,101 8,400,888 5,730,609 5.09 38.91 10 Netherlands 14,925,630 10,279,267 10,638,468 10,306,105 9,400,518 3.84 13.67 11 Sweden 12,397,106 14,811,885 11,112,321 5,780,613 7,960,382 3.19 20.46 12 Belgium 12,390,857 10,636,649 10,535,785 10,820,338 11,413,369 3.19 2.41 13 China, P. Rep. Of 10,310,774 7,655,341 7,493,841 4,731,815 5,331,431 2.65 20.99 14 Japan 9,022,673 9,845,556 7,898,338 9,568,553 12,088,166 2.32 -5.50 15 Hong Kong S.A.R. 7,593,989 4,882,496 8,089,366 15,745,597 20,235,692 1.95 -13.73 16 Austria 6,147,000 6,206,322 5,003,956 4,328,002 3,912,524 1.58 12.33 17 Korea, Rep. (South) 5,311,127 5,515,349 7,500,957 4,198,495 4,744,753 1.37 9.24 18 Spain 4,957,742 5,297,215 5,602,299 5,721,569 6,222,439 1.28 -5.50 19 Ireland 4,598,981 6,888,160 6,463,131 5,551,850 5,754,557 1.18 -3.44 20 Denmark 4,545,060 3,369,310 2,482,964 2,594,637 2,905,219 1.17 13.90 21 Puerto Rico 4,375,202 3,113,744 1,361,810 823,992 752,991 1.13 60.96 22 Thailand 4,243,333 8,759,978 8,233,552 5,797,018 7,166,167 1.09 -5.56 23 Indonesia (Incl. West

Irian) 4,002,520 3,996,083 5,183,959 4,712,596 5,275,752 1.03 -5.86

24 Taiwan 3,311,888 2,416,672 2,902,412 2,500,934 1,984,499 0.85 15.60 25 Malaysia 2,673,923 3,069,648 2,149,226 1,960,887 1,736,472 0.69 13.12 26 Mexico 1,380,267 1,953,129 917,133 908,215 847,019 0.35 22.96


- 60 -

27 Pakistan, Is.mic Rep. 1,380,234 1,186,623 960,957 1,664,410 1,117,741 0.35 11.61 28 Panama 1,308,524 123,416 398,260 658,937 456,103 0.34 224.04 29 Canada 1,012,482 650,468 1,020,481 600,303 2,039,955 0.26 4.70 30 Brazil 983,979 632,590 721,448 886,992 478,099 0.25 27.52 31 Finland 910,128 325,586 548,252 670,561 255,691 0.23 70.73 32 Bulgaria 448,923 123,059 0 11,934 0 0.12 41.20 33 Croatia 307,690 229,065 216,170 146,423 101,732 0.08 32.96 34 Hungary 256,070 216,811 237,491 493,802 493,980 0.07 -10.64 35 South Africa Rep. Of 189,785 236,015 219,573 271,097 205,777 0.05 0.16 36 Argentina 160,256 256,248 178,793 67,898 204,437 0.04 25.60 37 Turkey 113,197 0 95,992 1,758 0 0.03 1315.07 38 New Zealand

(Excludes Western Samoa)

102,519 46,767 117,865 57,469 204,584 0.03 23.02

39 Israel 97,839 58,100 211,324 155,761 217,697 0.03 0.78 40 Honduras 67,509 0 0 0 0 0.02 41 Afghanistan 66,533 0 0 0 0 0.02 42 Cyprus 46,156 11,170 15,233 17,302 0 0.01 68.65 43 Poland 41,685 0 0 11,462 0 0.01 44 Uruguay 30,150 0 60,341 0 53,037 0.01 -50.00 45 Norway 24,945 0 4,149 92,255 1,746 0.01 1247.07 46 Bangladesh 21,729 34,078 22,595 45,849 21,765 0.01 18.63 47 Paraguay 21,343 0 0 0 0 0.01 48 Vietnam 14,079 273 101 11,343 6,918 0.00 1298.07 49 Macau 10,000 0 0 60,001 30,046 0.00 -0.08 50 French Pacific Isl. 9,808 0 48,685 0 0 0.00 51 Canal Zone 8,323 0 0 0 0 0.00 52 Luxembourg 7,347 245,788 13,168 25,959 12,642 0.00 431.40 53 Greece 5,115 0 15,750 646,072 0 0.00 -49.39 54 Dominica 4,276 0 0 0 0 0.00 55 Colombia 4,100 0 0 65,183 101,074 0.00 -8.88 56 Alaska 1,581 0 0 0 0 0.00 57 Uzbekistan 1,342 0 0 0 472,200 0.00 58 Bahrain 0 0 0 0 21,095 0.00 59 Barbados 0 0 0 6,893 0 0.00 60 Belize (British

Honduras) 0 44,023 1,296 58,104 0 0.00 774.77

61 Burkina Faso 0 18,554 0 0 0 0.00 62 Canary Islands 0 0 0 161,164 0 0.00 63 Chile 0 0 910 298,926 0 0.00 -49.92 64 Christmas Island 0 0 0 33,103 0 0.00 65 Czech Republic 0 90,095 0 2,251 0 0.00 -50.00


- 61 -

66 Egypt 0 0 22,032 0 0 0.00 67 Equatorial Guinea,

Rep. Of 0 0 17,021 0 0 0.00

68 Fiji 0 17,572 0 0 0 0.00 69 French West Indies 0 2,495 0 92,538 0 0.00 -50.00 70 Gambia 0 0 0 12,576 0 0.00 71 Guam 0 0 0 0 2,161 0.00 72 Hawaii 0 0 0 0 636 0.00 73 Kuwait 0 0 0 2,000 0 0.00 74 Malta & Gozo 0 12,416 14,500 0 0 0.00 -28.59 75 Mozambique 0 0 1,806 0 0 0.00 76 Myanmar (Burma) 0 0 1,182 0 0 0.00 77 Peru 0 0 0 3,860 0 0.00 78 Portugal 0 0 16,597 17,009 51,345 0.00 -42.32 79 Romania 0 0 80,636 13,501 5,631 0.00 134.26 80 Russian Federation

(U.S.S.R.) 0 0 0 0 17,637 0.00

81 Sao Tome And Principe, Dem. Rep. Of

0 0 0 0 63,683 0.00

82 Saudi Arabia 0 0 0 33,901 0 0.00 83 Senegal 0 47,979 0 0 0 0.00 84 Slovak Republic

(Slovakia) 0 0 0 2,688 0 0.00

85 Slovenia 0 0 85,619 0 0 0.00 86 Somalia 0 284 0 0 0 0.00 87 South And Southeast

Asia, N.E.S. 0 28,999 0 0 0 0.00

88 Sri Lanka (Ceylon) 0 4,018 0 0 0 0.00 89 Suriname 0 0 0 7,050 0 0.00 90 Swaziland 0 0 0 7,749 0 0.00 91 Tanzania, United

Rep. Of 0 0 66,364 0 0 0.00

92 Trust Territory Of The Pacific Islands

0 0 434 7,776 0 0.00

93 Tunisia 0 0 0 0 318 0.00 94 Ukraine (Ukrainian

S.S.R) 0 74,467 0 0 0 0.00

95 United Arab Emirates 0 175 60,907 4,942 0 0.00 233.18 Source : Bureau of Export Trade Promotion


- 62 -


- 63 -

ANNEX VII

PHILIPPINE IMPORTS OF NATURAL PRODUCTS CIF Value in US Dollars

1999 - 2003



-64-

2003 2002 2001 2000 1999 PSCC DESCRIPTION

Quantity Value % Share Quantity Value Quantity Value Quantity Value Quantity Value

Ave. Growth Rate

TOTAL 39,425,960 100.00 34,266,281 34,600,838 32,245,687 34,974,263 3.40

1 4312201 hydrogenated vegetable fats in flakes (nk)

13,732,449 6,618,030 16.79 13,943,690 6,325,136 16,908,730 5,999,830 9,703,068 4,076,352 10,696,330 6,134,172 5.92

2 2929603 carrageenan (nk) 489,836 4,277,463 10.85 600,869 3,099,797 907,943 3,446,758 348,842 2,728,647 285,418 1,601,352 31.16

3 2929700 seaweeds and other algae (nk) 5,455,330 3,694,690 9.37 2,167,030 1,756,320 2,796,671 2,088,961 1,397,214 1,378,362 1,294,907 1,034,528 44.81

4 2922909 oth nat gum,gum-resins & balsam (nk) 4,111,410 3,273,459 8.30 4,096,365 3,658,625 3,650,895 3,587,690 2,119,110 2,363,576 2,499,069 2,609,834 8.45

5 4312209 other vegetable fats and oils and their fraction partly or wholly hydrogenated (other than in flakes (nk)

5,233,722 2,422,712 6.14 5,018,751 2,716,256 2,367,667 1,580,597 2,013,728 1,190,483 2,681,836 1,801,849 14.97

6 5513119 oth essential oils of citrus fruits oth for the manufacture of medicine (nk)

124,655 2,085,778 5.29 129,002 2,365,182 135,876 1,866,060 53,221 750,745 67,692 431,970 59.33

7 4221900 linseed oil, refined & its fractions (nk) 2,220,281 1,808,019 4.59 2,319,537 1,432,073 2,644,019 1,563,480 2,017,221 1,269,721 2,492,716 1,945,306 1.57

8 2929402 liquorice saps & extracts (nk) 179,581 1,792,498 4.55 859 117,964 2,075 23,438 266,596 2,296,739 216,514 1,459,618 445.30

9 2929403 extracts of hops (nk) 110,498 1,658,894 4.21 123,648 2,313,616 85,940 1,791,157 107,267 1,600,991 116,912 1,222,960 10.92

10 2929602 mucilages and thickeners derived from locust beans, locust bean seeds or guar seed, whether or not m (nk)

447,318 1,366,507 3.47 301,594 970,945 341,006 1,244,940 372,434 1,807,001 373,614 1,495,386 2.12



-65-

11 4312100 animal fats&oils&fractions,hydrogenated

inter-/re-esterified/elaidinized (nk) 1,357,497 1,251,606 3.17 1,404,798 933,149 2,246,042 1,390,848 1,958,105 1,597,397 1,407,639 1,371,879 1.18

12 4216900 maize(corn) oil, refined & its fractions (nk)

991,041 998,470 2.53 1,367,675 954,951 1,465,627 1,097,183 1,127,510 1,012,223 1,097,706 1,152,586 -3.05

13 2929500 pectic substances, pectinates&pectates (nk)

117,924 961,639 2.44 36,178 341,440 25,334 321,270 29,387 173,759 29,283 348,039 55.69

14 2922200 gum arabic (nk) 420,314 928,810 2.36 448,091 1,007,366 562,997 1,166,476 385,469 872,662 294,497 646,907 11.78

15 2929609 mucilages and thickeners derived from vegetable products, n.e.s., whether or not modified (nk)

118,114 722,463 1.83 273,661 1,214,545 254,289 1,073,713 270,428 1,200,499 511,060 2,447,687 -22.23

16 4229909 other fixed vegetable fats and oils, and their fractions, [crude, refined or fractionated, n.e.s.] w (nk)

395,163 674,856 1.71 1,072,083 402,220 2,678,621 1,264,568 2,168,458 1,486,423 1,809,052 1,102,927 4.86

17 4218000 sesame(sesamum) oil & its fractions (nk)

540,852 606,082 1.54 672,172 465,486 614,017 695,029 659,491 583,097 556,273 762,631 -1.79

18 2929409 oth vegetable saps & extracts (nk) 112,956 562,806 1.43 67,860 554,431 106,671 656,958 90,580 581,089 87,831 551,587 1.08

19 5513111 lemon oil oth for mfr of medcine (nk) 26,735 436,135 1.11 10,653 181,738 57,212 574,491 68,512 1,100,189 50,761 719,332 19.20

20 5513113 orange oil oth for mfr of medicn (nk) 30,273 392,687 1.00 28,875 279,766 27,146 187,352 45,734 241,620 13,548 276,177 13.68

21 4314109 oth veg waxes, wtr/not colored (nk) 854,035 332,263 0.84 1,676,599 448,809 129,728 83,701 45,276 73,329 54,607 123,038 96.00

22 5513109 oth essetial oils of citrus fruits for manufacture of medicine (nk)

19,644 322,215 0.82 61,417 621,694 102,826 524,956 1,907 95,525 40,478 296,891 88.00

23 4225000 castor oil & its fractions (nk) 158,086 298,469 0.76 169,670 149,989 56,834 99,729 125,236 172,494 60,858 83,385 53.52



-66-

24 2924909 other plants and parts of plants

(including seeds and fruits) of a kind used primarily in perfumery, (nk)

80,592 291,876 0.74 94,952 166,372 106,093 96,811 66,330 146,895 130,371 249,309 18.03

25 5513112 lime oil oth for mfr of medicine (nk) 46,100 229,278 0.58 410 26,276 2,103 44,479 1,180 67,942 2,299 59,894 177.64

26 5322209 oth coloring matter of veg/animal origin & preptns based thereon (nk)

65,096 215,894 0.55 113,887 449,055 223,529 759,530 84,797 462,044 72,079 484,368 -8.26

27 2922904 gum, guar (nk) 120,605 149,043 0.38 179,721 206,969 116,875 104,765 266,152 394,342 471,289 969,508 -15.80

28 5513103 orange oil for mfr of medicine (nk) 31,411 112,279 0.28 19,786 107,227 6,223 90,182 10,092 96,102 31,587 155,232 -5.16

29 5513101 lemon oil for mfr of medicine (nk) 4,894 103,684 0.26 3,569 86,444 4,243 83,183 5,771 62,151 14,519 233,821 -3.93

30 4314101 carnauba wax (nk) 21,828 103,345 0.26 425,990 161,368 74,640 97,262 35,731 118,603 32,106 136,855 -0.35

31 4314209 oth insect waxes, wtr/not refined/ colored (nk)

29,013 76,251 0.19 108,000 99,581 260,309 148,482 41,599 53,156 3,304 15,330 92.43

32 0724000 cocoa butter, fat/oil (nk) 51,929 76,023 0.19 289,423 259,496 24,697 46,282 16,921 21,329 5,900 3,608 249.53

33 2922109 oth lac (nk) 4,429 74,765 0.19 664 15,653 3,332 29,847 940 8,448 0 0 145.85

34 2922101 shellac (nk) 29,762 74,342 0.19 21,323 55,921 7,638 43,577 5,951 73,166 13,448 256,463 -12.66

35 4224900 palm kernel/babassu oil, refined and fractions thereof (nk)

258,929 53,320 0.14 184,685 15,311 1,037,618 368,176 791,388 408,201 1,158,738 749,895 24.26

36 4229100 tung oil and its fractions, whether or not refined, but not chemically modified (nk)

38,517 49,180 0.12 91,270 67,284 92,000 64,972 99,791 90,296 92,054 91,280 -13.12

37 4314201 beeswax (nk) 11,397 43,575 0.11 9,455 33,313 8,677 45,528 15,975 100,102 17,363 58,024 5.49

38 2922903 gum, tragacanth (nk) 3,000 41,143 0.10 1,000 9,250 61 509 640 7,895 6,740 74,890 469.77

39 5322202 annatto(achuete) (nk) 20,185 38,382 0.10 17,515 23,518 80 3,920 6,789 35,165 81,681 46,050 112.67

40 2929601 agar-agar, whether or not modified (nk) 5,817 38,278 0.10 8,717 45,441 9,272 105,343 32,105 377,727 31,338 76,790 61.79

41 5322201 natural indigo (nk) 2,000 22,962 0.06 0 0 0 0 0 0 700 9,379 -25.00

42 4221100 linseed oil, crude (nk) 22,800 21,504 0.05 0 0 767 533 65,260 38,540 18,369 15,541 -12.66



-67-

43 5322203 food color, of veg/animal origin (nk) 1,429 18,594 0.05 1,999 22,024 44 2,019 220 10,514 857 27,755 208.09

44 5513102 lime oil for mfr of medicine (nk) 360 17,261 0.04 320 11,637 1,089 19,050 1,283 5,532 2,880 31,979 42.77

45 4216100 maize(corn) oil, crude (nk) 21,942 14,530 0.04 0 0 10,003 5,866 787 822 0 0 128.41

46 4229903 oiticica oil and its fractions, [refined, solidified or hardened by mechanical means] whether or not (nk)

2,010 13,448 0.03 0 0 0 0 0 0 0 0 0.00

47 5513121 bergamot oil (nk) 245 10,519 0.03 949 7,922 2,243 11,521 0 0 1,198 635 -24.62

48 2924200 ginseng roots (nk) 5,733 9,728 0.02 0 0 91 2,169 906 2,783 6,323 43,185 -53.91

49 2922901 resin, copal(almaciga) (nk) 18,000 8,867 0.02 544 806 1,196 7,085 0 0 761 3,249 202.88

50 2924901 eucalyptus leaves (nk) 5,847 8,696 0.02 0 0 72 925 800 481 0 0 -1.92

51 4229901 tobacco seed oil and its fractions, whether or not refined, but not chemically modified (nk)

14,232 7,658 0.02 98,641 19,157 393,468 22,316 0 0 0 0 -18.55

52 4223900 coconut(copra) oil, refined & its fractions (gk)

42,303 6,868 0.02 930,697 12,789 19,498 8,107 147,999 83,694 17,829 24,125 42.02

53 5513226 lavender/lavandin oil (nk) 275 3,778 0.01 292 4,595 638 11,358 191 2,668 361 5,595 49.02

54 4213900 groundnut(peanut) oil, refined & its fractions (nk)

2,942 2,347 0.01 8,437 7,388 5,209 8,649 16,118 13,594 34,210 32,886 -44.46

55 2924100 liquorice roots (nk) 1,000 1,500 0.00 0 0 0 0 1,309 3,081 0 0

56 4229902 jojoba oil and its fractions, whether or not refined, but not chemically modified (nk)

16 491 0.00 16 385 0 0 116 371 800 578 -27.07

57 2922902 gum, elemi (nk) 0 0 0.00 1,200 1,296 0 0 27,360 96,307 0 0 -50.00

58 2922905 resin, natural (nk) 0 0 0.00 31,400 20,530 51,557 12,482 54,895 82,537 0 0 -30.10

59 2922906 incense & myrrh (nk) 0 0 0.00 500 8,680 52,500 17,325 4,011 1,180 184 3,133 289.00

60 2929404 extracts of pyrethrum/roots of plants contg rotenone (nk)

0 0 0.00 0 0 0 0 26,006 19,460 25,946 29,323 -33.41

61 4213100 groundnut(peanut) oil, crude (nk) 0 0 0.00 0 0 3,400 9,400 955 473 0 0 446.83

62 4223100 coconut(copra)oil, crude (gk) 0 0 0.00 0 0 0 0 264,355 110,502 0 0 -25.00



-68-

63 4224100 palm kernel/babassu oil, crude (nk) 0 0 0.00 24,065 9,095 0 0 933,699 596,661 1,994,920 1,464,968 -64.82

64 4314202 spermaceti, crude, pressed/refined, wtr/not colored (nk)

0 0 0.00 0 0 0 0 0 0 207 214 -25.00

65 5513225 jasmin oil (nk) 0 0 0.00 0 0 0 0 0 0 65 360 -25.00



- 69 -

ANNEX VIII

PHILIPPINE SUPPLYING COUNTRIES OF NATURAL PRODUCTS

CIF Value in US Dollars 1999 - 2003

Country 2003 2002 2001 2000 1999 % Share 2003

Ave. Growth Rate

TOTAL 39,425,960 34,266,281 34,600,838 32,245,687 34,974,263 100.00 3.40 Top 10 33,137,706 27,759,209 27,161,166 24,193,500 27,765,365 84.05 5.24 Others 6,288,254 6,507,072 7,439,672 8,052,187 7,208,898 15.95 -2.95 1 U.S.A. (Excl. Hawaii &

Alaska) 8,295,870 6,919,045 6,961,258 8,303,810 7,093,993 21.04 5.04

2 Malaysia 6,911,169 5,387,966 5,277,706 4,002,421 6,326,855 17.53 6.37 3 Indonesia (Includes

West Irian) 3,914,184 2,245,434 3,136,944 1,195,477 2,230,578 9.93 40.47

4 Denmark 3,682,772 2,415,554 2,624,377 2,171,870 1,999,865 9.34 18.48 5 Singapore 3,483,449 5,365,512 4,290,504 3,751,145 3,859,474 8.84 0.39 6 Germany 1,943,100 2,205,335 1,532,128 1,563,466 1,999,658 4.93 2.06 7 Belgium 1,471,010 339,256 73,479 30,836 27,391 3.73 211.54 8 France 1,234,242 804,848 1,359,958 1,180,864 1,072,913 3.13 9.44 9 Hong Kong S.A.R. 1,124,143 1,134,359 852,177 852,127 947,374 2.85 5.54 10 India 1,077,767 941,900 1,052,635 1,141,484 2,207,264 2.73 -13.04 11 China, People'S Rep. Of 735,423 595,459 427,246 381,911 172,572 1.87 49.01 12 Norway 630,928 402,626 459,516 227,894 358,084 1.60 27.40 13 Great Britain And

Northern Ireland 591,088 1,140,108 1,324,100 1,618,489 2,374,400 1.50 -28.02

14 Australia 584,280 767,969 941,308 924,946 371,317 1.48 27.13 15 Japan 578,039 334,226 353,019 438,620 477,089 1.47 10.01 16 Thailand 430,596 647,677 556,376 522,220 640,060 1.09 -7.24 17 Chile 417,010 631,536 961,300 1,387,339 487,448 1.06 21.41 18 Netherlands 319,818 136,086 154,680 266,680 51,633 0.81 124.37 19 Italy 253,944 147,339 184,794 198,720 205,000 0.64 10.50 20 Morocco 155,614 0 222,220 76,470 60,000 0.39 29.51 21 Brazil 148,139 71,447 30,266 150,584 50,274 0.38 90.76 22 Vietnam 142,574 112,737 0 0 657,044 0.36 -18.38 23 Taiwan 142,084 435,616 569,237 390,552 321,066 0.36 -5.87 24 Mexico 139,710 161,823 129,583 101,683 161,033 0.35 0.45 25 Canada 126,021 275,462 87,563 277,500 28,647 0.32 240.14 26 South Africa Rep. Of 121,955 97,629 0 0 0 0.31 6.23 27 Argentina 114,075 2,114 15,788 0 38,061 0.29 1302.39 28 Pakistan, Islamic Rep. 106,359 122,937 116,811 94,839 485 0.27 4867.34 29 Spain 84,303 232,288 406,090 203,930 275,698 0.21 -8.35 30 Switzerland 79,908 63,513 107,274 214,468 211,895 0.20 -15.94 31 Hungary 75,566 0 348 0 0 0.19 -25.00 32 Peru 64,055 0 0 0 0 0.16 0.00 33 Austria 62,400 0 61,920 62,785 0 0.16 -25.34 34 Nepal 51,521 0 0 0 0 0.13 0.00 35 Malta & Gozo 50,425 0 1,806 0 0 0.13 -25.00


- 70 -

36 Korea, Rep. Of (South) 34,251 32,055 277,699 452,631 118,758 0.09 40.22 37 Israel 20,398 10,199 9,822 8,598 21,059 0.05 14.73 38 Benin 12,400 0 0 0 0 0.03 0.00 39 New Zealand (Excludes

Western Samoa) 6,607 14,733 13,190 0 0 0.02 -10.86

40 St. Helena 4,366 0 0 0 0 0.01 0.00 41 Guatemala 3,148 0 0 0 0 0.01 0.00 42 Sweden 771 4,101 4,965 5,407 4,814 0.00 -23.61 43 Turkey 327 221 415 496 0 0.00 -3.78 44 Trust Territory Of The

Pacific Islands 151 0 0 0 0 0.00 0.00

45 Bahrain 0 0 0 0 8,845 0.00 -25.00 46 Bulgaria 0 0 0 0 15,378 0.00 -25.00 47 Ceuta And Melilla 0 37,620 0 0 0 0.00 -25.00 48 Christmas Island 0 1,543 0 0 0 0.00 -25.00 49 Finland 0 0 0 0 8,795 0.00 -25.00 50 Iceland 0 0 0 2,035 0 0.00 -25.00 51 Ireland 0 0 0 6,334 64,657 0.00 -47.55 52 Kenya 0 0 0 15,000 7,500 0.00 0.00 53 Mozambique 0 23,378 0 0 0 0.00 -25.00 54 Myanmar (Burma) 0 0 650 8,700 0 0.00 -48.13 55 Portugal 0 0 18,225 12,225 0 0.00 -12.73 56 Saudi Arabia 0 0 3,036 0 0 0.00 -25.00 57 Sudan 0 4,630 425 0 0 0.00 222.35 58 Tokelau 0 0 0 0 14,974 0.00 -25.00 59 United Arab Emirates 0 0 0 1,131 1,734 0.00 -33.69 60 Venezuela 0 0 0 0 578 0.00 -25.00 Source : Bureau of Export Trade Promotion


- 71 -

ANNEX IX

PHILIPPINE EXPORTS OF PHARMACEUTICAL PRODUCTS FOB Value in US Dollars

1999 - 2003


aceuticals and natural products – Philippines Supply and dem

and survey on pharmaceuticals and natural products – Philippines

-72-

2003 2002 2001 2000 1999

HS PSCC Description Quantity Value %Share Quantity Value Quantity Value Quantity Value Quantity Value % Ave.

Growth Rate

TOTAL 17,467,789 100.00 16,739,713 16,483,186 16,231,188 19,431,615 -2.25

1 3004909

0 5429319 oth medicmnt w/ oth medicinal &

pharmaceutical prodct, nes, for retail sale (NK)

13,041,985 12,304,140 70.44 9,845,385 10,909,655 7,190,322 10,295,723 5,893,923 9,221,126 6,134,040 12,048,937 1.73

3 30045000

5429200 medicmnt w/ vit/oth prodct of 5411, in doses/forms/packings for retail (NK)

418,693 2,513,667 14.39 420,596 3,194,454 457,146 2,860,914 676,575 3,684,877 597,264 3,633,742 -7.65

4 30049090

5429312 analgesics & antipyretics, put up in doses/forms/packings for retail (NK)

103,088 777,859 4.45 134,491 1,015,466 110,521 832,218 163,528 1,304,987 195,279 1,609,764 -14.14

5 30049090

5429303 medicated candies,cough-syrups&drops,in doses/forms/packings for retail (NK)

174,418 725,724 4.15 173,742 687,259 373,510 1,399,268 238,139 990,472 162,293 705,869 9.08

7 30042000

5421909 medicmnt w/ oth antibiotics,nes, in doses/forms/packg for retail (NK)

48,761 533,523 3.05 27,107 312,259 44,724 693,812 48,188 611,054 82,725 636,394 6.36

8 30049090

5429306 veterinary medicmnt doses/forms/packg/ for retail sale, oth thn 5429305 (NK)

68,377 118,602 0.68 52,991 280,307 5,999 145,652 2,467 37,634 5,509 116,698 63.51

9 29362700

5411400 vit c & its derivatives,unmixed (NK) 14,579 111,214 0.64 50 3,450 266 11,239 475 3,563 0 0 817.43




-73-

10 30049090 5429305 veterinary medicine for eradication of

parasites, for retail sale (NK) 6,986 94,400 0.54 218 6,320 572 6,444 1,300 14,041 0 0 334.41

11 30039000 5429119 oth medicmnt, nes, not put up in doses/forms/packings for retail (NK)

143,925 92,671 0.53 256,922 131,465 8,025 9,585 285 1,475 335,214 200,060 423.16

12 30022000 5416313 rabies vaccine [, bulk] (NK) 119 60,000 0.34 0 0 0 0 0 0 0 0 0.00

13 30041000 5421309 oth medicmnt w/ penicillins/derivtv,etc in doses/form/packing for retail (NK)

1,040 31,579 0.18 139 620 0 0 0 0 0 0 1248.35

14 30041000 5421305 medicmnt w/ penicillins/derivtv, etc, for retail sale, for veterinary (NK)

287 25,448 0.15 1,000 900 0 0 177 4,115 0 0 656.89

15 30049010 5429314 specialized medicines for cancer, aids and other dreaded diseases (NK)

9,500 16,115 0.09 71 2,829 104 11,631 539 14,884 485 9,400 107.61

16 30023000 5416349 other veterinary vaccines [,bulk] (NK) 152 14,364 0.08 34 5,239 0 0 24 2,600 7,314 55,617 -5.29

17 30043200 5422400 medicmnt contg adrenal cortex hormones, in doses/forms/packg for retail (NK)

685 11,400 0.07 0 0 0 0 0 0 0 0 0.00

18 30022000 5416329 other vaccines for human medicine [, bulk] (NK)

44 11,177 0.06 0 0 0 0 264 23,953 0 0 -25.00

20 29393000 5414300 caffeine & its salts,not put up as medicaments (NK)

500 5,295 0.03 2,500 25,947 481 4,940 4,500 25,719 12,100 67,618 50.73

21 30023000 5416341 veterinary vaccines against foot and mouth disease [, bulk] (NK)

58 4,617 0.03 472 6,609 0 0 0 0 324 18,060 -32.54

22 30029000 5416405 toxins, cultures of micro-organisms (excluding yeasts) and similar products [, bulk] (NK)

720 4,576 0.03 76 605 0 0 76 561 0 0 139.09




-74-

23 30043900 5422900 medicmnt w/ oth-hormone/prodct of

5415, in doses/forms/packgs for retail (NK)

537 4,398 0.03 118 1,045 1 790 207 5,121 0 0 67.14

24 29361000 5411100 provitamins, unmixed (NK) 3,500 4,332 0.02 5,693 20,584 0 0 0 0 0 0 -19.74

26 29362900 5411600 oth vits & their derivtv;unmixed (NK) 75 969 0.01 492 8,568 3,388 123,880 167 5,213 10 1,136 613.37

27 30031000 5421105 medicmnt w/ penicillin/derivtv,penicillanic acid stru,for veterinary (NK)

262 710 0.00 0 0 0 0 1,442 7,025 0 0 -25.00

28 30029000 5416402 animal blood preprd for therapeutic, prophylactic/diagnostic uses (NK)

192 709 0.00 0 0 0 0 0 0 0 0 0.00

29 30019000 5416209 oth human/animal subs preprd for therapeutic/prophylactic uses (NK)

1 300 0.00 0 0 0 0 0 0 0 0 0.00

30 30042000 5421904 medicmnt w/ oth antibiotics for veterinary use,in doses/oth for retail (NK)

0 0 0.00 623 50,256 138 4,155 70 975 0 0 333.92

31 30041000 5421304 medicmnt contg erythromycin,put up in doses/forms/packings for retail (NK)

0 0 0.00 2,838 30,759 786 11,199 988 10,948 6,025 68,733 -1.78

32 29369000 5411700 intermixtures of provitamins & vitamins wtr/not in any solvent (NK)

0 0 0.00 9,867 24,552 350 3,766 36,750 164,688 1,420 39,447 167.93

33 30032000 5421209 medicmnt contg oth antibiotics (NK) 0 0 0.00 1,604 10,953 0 0 0 0 0 0 -25.00

34 30042000 5421903 medicmnt contg terramycin, put up in doses/forms/packings for retail (NK)

0 0 0.00 454 9,396 6 110 1,417 25,599 24 11,294 2092.23




-75-

35 30049090 5429301 sulfonamides & sulfonamide comp, in

doses/forms/packings for retail (NK) 0 0 0.00 39 216 0 0 0 0 0 0 -25.00

36 30022000 5416311 cholera, dysentery and typhoid vaccine [, bulk] (NK)

0 0 0.00 0 0 9 32,645 0 0 0 0 -25.00

37 29362800 5411500 vit e & its derivatives,unmixed (NK) 0 0 0.00 0 0 870 25,027 1,244 30,531 25 5,481 84.75

38 29362600 5411305 vit b12 & its derivatives,unmixd (NK) 0 0 0.00 0 0 61 5,069 0 0 297 2,172 -50.00

39 29419000 5413909 oth antibiotics, & salts, nes, not put up as medicaments (NK)

0 0 0.00 0 0 236 3,195 239 6,750 736 26,352 -56.77

40 30032000 5421203 medicmnt contg terramycin,not put up in doses/forms/packings for retail (NK)

0 0 0.00 0 0 109 1,924 0 0 0 0 -25.00

41 30049090 5429315 water, medicinal, distilled, packed for retail (NK)

0 0 0.00 0 0 0 0 5,770 28,682 0 0 -25.00

42 30021000 5416309 other blood fractions and modified immunological products, whether or not obtained by means of biote (NK)

0 0 0.00 0 0 0 0 252 4,195 0 0 -25.00

43 29362100 5411200 vit a & their derivatives,unmixd (NK) 0 0 0.00 0 0 0 0 261 400 0 0 -25.00

45 30042000 5421902 medicmnt contg chloramphenicol, put up in doses/forms/packg for retail (NK)

0 0 0.00 0 0 0 0 0 0 5,500 174,809 -25.00

46 30039000 5429108 medicmnt w/ shcistosomiasis medicine, not in doses/packg for retail (NK)

0 0 0.00 0 0 0 0 0 0 8 32 -25.00



- 76 -


- 77 -

ANNEX X

PHILIPPINE EXPORT MARKETS OF PHARMACEUTICAL PRODUCTS FOB Value in US Dollars

1999 - 2003

Country 2003 2002 2001 2000 1999 % Share (2003)

Ave. Growth Rate

TOTAL 17,467,789 16,739,713 16,483,186 16,231,188 19,431,615 100.00 -2.25

Top 10 14,079,833 15,021,300 14,731,000 14,226,454 17,067,437 80.60 -4.35

Others 3,387,956 1,718,413 1,752,186 2,004,734 2,364,178 19.40 16.86

1 Vietnam 2,577,554 2,243,450 2,052,117 1,903,982 3,864,462 14.76 -4.68

2 Australia 2,146,801 2,872,482 3,991,715 2,827,455 2,360,480 12.29 1.91

3 Malaysia 1,774,829 2,299,603 1,811,272 1,886,775 1,650,786 10.16 3.61

4 Thailand 1,474,793 1,349,810 1,112,361 702,561 278,333 8.44 60.34

5 Myanmar (Burma) 1,460,504 1,491,846 1,429,642 1,692,097 1,218,679 8.36 6.40

6 Hong Kong S.A.R. 1,305,704 1,306,177 1,492,252 2,072,369 2,220,229 7.47 -11.79

7 Singapore 1,270,672 1,504,865 1,341,441 1,361,786 1,432,078 7.27 -2.45

8 Cambodia (Democratic Kampuchea)

903,425 439,030 322,371 314,443 587,255 5.17 24.51

9 Sri Lanka (Ceylon) 732,020 639,172 605,814 732,710 1,239,208 4.19 -9.54

10 Taiwan 433,531 874,865 572,015 732,276 2,215,927 2.48 -21.59

11 Indonesia (Includes West Irian) 391,480 353,434 128,769 136,361 71,834 2.24 67.37

12 United Arab Emirates 390,112 102,285 138,384 191,891 142,557 2.23 65.51

13 Japan 378,921 109,747 73,393 102,797 221,274 2.17 53.16

14 Sudan 359,991 0 157,978 33,683 0 2.06 67.25

15 India 251,697 176,466 10,674 120,352 66,360 1.44 396.52

16 South Africa Rep. Of 239,796 0 0 0 378 1.37

17 Korea, Rep. Of (South) 195,014 163,270 37,315 2,000 213,985 1.12 505.92

18 Germany 178,568 0 2,100 25,882 649,175 1.02 -71.97

19 Pakistan, Islamic Rep. 131,844 36,036 3,761 23,775 5,391 0.75 345.21

20 Dominican Republic 96,987 0 0 0 0 0.56

21 U.S.A. (Excl. Hawaii & Alaska) 83,959 157,585 184,530 347,636 350,170 0.48 -27.24

22 Uganda 70,682 14,157 0 19,556 9,784 0.40 99.79

23 Netherlands 58,366 191,445 63,824 33,634 34,998 0.33 54.08

24 Switzerland 57,433 0 5,462 4,620 2,469 0.33 1.34

25 Guam 47,763 7,403 3,140 5,042 2,781 0.27 181.13

26 New Zealand (Excludes Western Samoa)

45,394 97,336 17,967 58,160 24,231 0.26 114.83


- 78 -

27 Bahrain 35,039 20,444 9,363 35,270 12,688 0.20 73.57

28 Laos 33,379 22,277 20,334 14,474 12,194 0.19 29.64

29 Trinidad And Tobago 31,740 14,522 27,157 51,294 60,907 0.18 2.30

30 Austria 29,760 0 0 29 136 0.17 -44.67

31 Italy 28,500 419 57,635 0 66,104 0.16 1625.66

32 Kenya 28,461 30,854 13,306 49,022 14,627 0.16 71.60

33 Trust Territory Of The Pacific Islands

26,658 23,515 13,556 8,340 1,886 0.15 122.89

34 Jamaica 22,201 4,217 10,648 14,898 11,820 0.13 90.90

35 Marshall Islands Rep. Of 20,417 0 64 209 0 0.12 -42.34

36 Papua New Guinea 16,530 0 2,738 3,854 12,197 0.09 -49.34

37 China, People'S Rep. Of 14,895 6,823 10,647 24,014 11,048 0.09 36.02

38 Micronesia Federated States Of 14,525 388 2,979 7,480 35 0.08 6191.96

39 Spain 13,767 20,929 129,687 60,038 1,219 0.08 1205.78

40 Chile 12,059 0 26,634 0 0 0.07

41 Saudi Arabia 11,641 45,135 0 360,504 136 0.07 66200.57

42 Egypt 9,819 0 7,527 0 1,186 0.06 -50.00

43 Colombia 9,207 0 1,187 0 0 0.05

44 Ethiopia 8,678 0 0 0 0 0.05

45 Belgium 6,990 0 137,001 4,876 152,585 0.04 628.22

46 Hawaii 5,859 1,643 3,090 1,643 8,850 0.03 54.10

47 Gibraltar 5,818 0 0 0 0 0.03

48 Mexico 5,222 0 132 37,166 0 0.03 -49.91

49 Canada 5,141 3,637 3,599 10,104 14,615 0.03 -13.21

50 Brazil 4,332 0 0 0 0 0.02

51 Qatar 2,123 1,030 2,205 0 7,155 0.01 -11.79

52 Great Britain And Northern Ireland

1,828 8,486 178,451 6,138 5,101 0.01 663.49

53 Oman 1,621 7,200 2,397 0 0 0.01 30.72

54 Norway 1,536 0 0 2,019 0 0.01

55 Palau, Rep. Of 1,112 1,739 1,106 17,258 855 0.01 461.52

56 Vanuatu (New Hebrides) 530 412 0 0 0 0.00

57 France 168 0 17,970 456 19,103 0.00 910.79

58 Lebanon 166 191 3,013 0 0 0.00 -26.69

59 Brunei Darussalam 105 2,117 4,207 17,547 1,971 0.00 142.38

60 Kuwait 50 0 0 0 0 0.00

61 Ireland 42 254 5,401 0 0 0.00 -44.69

62 Cyprus 30 259 457 1,744 289 0.00 74.48

63 Algeria 0 8,829 0 0 0 0.00

64 American Samoa 0 0 207 291 0 0.00 -32.22

65 Aruba 0 0 0 192 613 0.00 -42.17


- 79 -

66 Bahamas 0 0 0 11,858 0 0.00

67 Bangladesh 0 0 66,084 1,500 0 0.00 1051.40

68 Barbados 0 349 0 0 729 0.00 -50.00

69 Canary Islands 0 0 0 0 64,881 0.00

70 Christmas Island 0 0 3,600 0 0 0.00

71 Cuba 0 0 70,786 0 0 0.00

72 Ecuador 0 0 0 0 226 0.00

73 El Salvador 0 0 0 0 4,645 0.00

74 Fiji 0 0 0 0 1,960 0.00

75 French West Indies 0 10,222 0 0 0 0.00

76 Honduras 0 0 23,778 0 0 0.00

77 Macau 0 0 496 0 0 0.00

78 Malawi 0 18,674 3,309 0 0 0.00 91.08

79 Malta & Gozo 0 0 0 0 700 0.00

80 Mozambique 0 13,000 0 0 0 0.00

81 Netherlands Antilles 0 0 3,087 0 0 0.00

82 Nigeria 0 0 42,004 13,459 26,531 0.00 15.70

83 Puerto Rico 0 204 2,653 0 0 0.00 -48.08

84 Solomon Islands (British) 0 0 0 0 1,680 0.00

85 Swaziland 0 0 375 0 0 0.00

86 Sweden 0 10,080 0 143,668 35,762 0.00 25.43

87 Tuvalu 0 0 0 0 13,377 0.00

88 Virgin Islands (British) 0 23,012 0 0 0 0.00

89 Virgin Islands (U.S.) 0 0 0 0 980 0.00

90 Zambia 0 8,388 16,019 0 0 0.00 -36.91



- 80 -


- 81 -

ANNEX XI

PHILIPPINE EXPORTS OF NATURAL PRODUCTS

FOB Value in US Dollars 1999 - 2003




-82-

2003 2002 2001 2000 1999

HS PSCC Product Description

Quantity Value % Share Quantity Value Quantity Value Quantity Value Quantity Value Ave. Growth Rate (%)

Total 598,228,117 100.00 433,740,837 497,061,503 557,499,280 438,585,896 10.36

1 15131100 4223100 coconut(copra)oil, crude (gk) 960,323,997 399,435,958 66.77 766,811,048 279,672,033 1,191,860,716 340,853,510 832,952,113 350,912,292 318,118,755 220,088,784 20.36

2 15131900 4223900 coconut(copra) oil, refined & its fractions (gk)

223,781,454 105,424,316 17.62 177,850,087 72,953,171 226,113,791 76,695,525 227,997,970 113,183,312 159,884,951 122,194,180 0.00

3 13023910 2929603 carrageenan (nk) 10,068,951 46,953,481 7.85 8,053,702 38,383,091 8,539,935 38,239,377 7,658,265 38,353,940 8,176,372 41,543,047 3.68

4 12122000 2929700 seaweeds and other algae (nk)

31,364,419 33,385,854 5.58 31,063,629 33,859,858 31,720,996 32,950,471 48,313,520 46,409,802 32,552,261 44,107,266 (5.61)

5 18040000 0724000 cocoa butter, fat/oil (nk) 3,072,392 10,285,163 1.72 2,838,874 6,899,586 3,318,716 6,456,152 2,678,363 6,358,861 2,811,392 8,974,355 7.08

6 33012900 5513209 oth essential oils, nes, for the manuf of medicine (nk)

197,201 684,821 0.11 29,426 218,410 25 1,126 0 0 0 0 4,877.63

7 33012900 5513219 other essential oils, n.e.s., other than for the manufacture of medicine (nk)

123,053 501,737 0.08 29,796 81,915 6,171 26,258 245 7,150 2,135 51,675 226.39

8 12119000 2924909 other plants and parts of plants (including seeds and fruits) of a kind used primarily in perfumery, (nk)

83,509 351,561 0.06 116,168 203,312 118,080 183,184 70,525 75,138 25,479 29,289 96.06

9 32030000 5322202 annatto(achuete) (nk) 66,707 309,614 0.05 78,589 462,769 41,907 332,539 28,660 347,778 31,418 273,245 7.24

10 15153000 4225000 castor oil & its fractions (nk) 334,210 288,365 0.05 142,400 105,480 94,840 60,460 351,405 250,534 423,200 403,983 33.50

11 13019000 2922902 gum, elemi (nk) 180,500 264,168 0.04 135,850 240,830 296,168 528,342 376,842 695,597 244,610 464,335 (4.74)

12 13019000 2922901 resin, copal(almaciga) (nk) 199,159 174,809 0.03 209,080 149,893 203,500 160,659 319,368 241,508 336,365 246,769 (6.42)




-83-

13 13021900 2929409 oth vegetable saps &

extracts (nk) 20,383 77,620 0.01 80,250 238,292 23,886 342,485 7,245 25,822 0 0

14 13019000 2922909 oth nat gum,gum-resins & balsam (nk)

29,308 53,685 0.01 34,689 94,239 134,742 137,894 23,101 39,199 7,329 4,199 252.65

15 33019090 5513503 aqueous distillates and aqueous solutions of essential oils (including such products suitable for me (nk)

1,573 13,728 0.00 0 0 9,892 33,312 0 0 0 0

16 15154000 4229100 tung oil and its fractions, whether or not refined, but not chemically modified (nk)

9,500 12,762 0.00 0 0 0 0 0 0 0 0

17 15159000 4229909 other fixed vegetable fats and oils, and their fractions, [crude, refined or fractionated, n.e.s.] w (nk)

16,000 4,440 0.00 0 0 0 0 0 0 0 0

18 32030000 5322209 oth coloring matter of veg/animal origin & preptns based thereon (nk)

100,000 4,015 0.00 0 0 0 0 106 273 0 0

19 15155000 4218000 sesame(sesamum) oil & its fractions (nk)

450 1,362 0.00 0 0 0 0 0 0 0 0

20 33011900 5513119 oth essential oils of citrus fruits oth for the manufacture of medicine (nk)

10 298 0.00 135 727 3,154 5,227 1 47 0 0 2,719.04

21 12119000 2924901 eucalyptus leaves (nk) 51 153 0.00 0 0 0 0 0 0 0 0

22 33012500 5513221 oil of eucalyptus (nk) 17 75 0.00 0 0 808 9,864 0 0 0 0

23 33012900 5513223 citronella oil (nk) 15 49 0.00 15 236 119 1,224 36 294 0 0 39.09

24 33012300 5513226 lavender/lavandin oil (nk)

15 49 0.00 0 0 177 2,193 0 0 0 0

25 13021300 2929403 extracts of hops (nk) 4 34 0.00 0 0 0 0 0 0 0 0

26 13011000 2922109 oth lac (nk) 0 0 0.00 0 0 0 0 285 360 0 0

27 13012000 2922200 gum arabic (nk) 0 0 0.00 0 0 100 393 0 0 0 0

28 13019000 2922903 gum, tragacanth (nk) 0 0 0.00 250 5,015 0 0 0 0 0 0

29 13019000 2922904 gum, guar (nk) 0 0 0.00 0 0 0 0 0 0 3,750 12,750




-84-

30 13019000 2922905 resin, natural (nk) 0 0 0.00 0 0 0 0 0 0 1,022 4,713

31 13019000 2922906 incense & myrrh (nk) 0 0 0.00 200 500 0 0 0 0 0 0

32 13021400 2929404 extracts of pyrethrum/roots of plants contg rotenone (nk)

0 0 0.00 0 0 0 0 9,016 541,120 0 0

33 13023990 2929609 mucilages and thickeners derived from vegetable products, n.e.s., whether or not modified (nk)

0 0 0.00 7,575 44,518 0 0 0 0 7,600 2,800

34 15152900 4216900 maize(corn) oil, refined & its fractions (nk)

0 0 0.00 0 0 55,860 38,264 0 0 0 0

35 15151900 4221900 linseed oil, refined & its fractions (nk) 0 0 0.00 3,900 3,315 0 0 0 0 0 0

36 15159000 4229902 jojoba oil and its fractions, whether or not refined, but not chemically modified (nk)

0 0 0.00 0 0 0 0 8 301 0 0

38 15162090 4312209 other vegetable fats and oils and their fraction partly or wholly hydrogenated (other than in flakes (nk)

0 0 0.00 0 0 0 0 0 0 9,000 4,048

39 15211000 4314101 carnauba wax (nk) 0 0 0.00 164 1,227 2 50 279 2,327 2 62 1,452.34

40 15219000 4314109 oth veg waxes, wtr/not colored (nk) 0 0 0.00 0 0 0 0 543 2,716 0 0

41 15219000 4314201 beeswax (nk) 0 0 0.00 35 117 0 0 0 0 0 0

42 33011200 5513103 orange oil for mfr of medicine (nk) 0 0 0.00 0 0 30 1,242 60 2,392 0 0 (37.02)

43 33011300 5513111 lemon oil oth for mfr of medcine (nk) 0 0 0.00 22,529 122,303 182 910 618 11,106 16,665 151,678 3,263.85

44 33011400 5513112 lime oil oth for mfr of medicine (nk) 0 0 0.00 0 0 25 693 2,096 34,332 30 150 5,647.50

45 33011200 5513113 orange oil oth for mfr of medicn (nk) 0 0 0.00 0 0 0 0 0 0 8,212 26,827 46 33011100 5513121 bergamot oil (nk) 0 0 0.00 0 0 0 0 0 0 50 1,741

47 33012400 5513202 peppermint(mentha piperita) oil for the manufacture of medicine (nk)

0 0 0.00 0 0 2 149 96 3,079 0 0 (48.79)



- 85 -

ANNEX XII

PHILIPPINE EXPORT MARKETS OF NATURAL PRODUCTS FOB Value in US Dollars

1999 - 2003

Country 2003 2002 2001 2000 1999 % Share (2003)

Ave. Growth Rate

TOTAL 598,228,117 433,740,837 497,061,503 557,499,280 438,585,896 100.00 10.36

Top 10 549,449,737 384,393,977 441,074,199 494,438,935 365,754,862 91.85 13.62

Others 48,778,380 49,346,860 55,987,304 63,060,345 72,831,034 8.15 -9.41

0.00

1 Netherlands 196,563,218 116,913,944 174,804,631 147,321,120 101,508,511 32.86 24.70

2 U.S.A. (Excl. Hawaii & Alaska) 183,174,580 150,362,480 136,952,327 215,161,324 181,079,399 30.62 3.52

3 Malaysia 44,755,757 28,419,536 41,661,442 32,051,476 3,216,583 7.48 238.03

4 China, People'S Rep. Of 32,042,638 16,069,184 18,115,097 17,022,275 7,341,130 5.36 56.60

5 Japan 27,505,438 20,094,269 12,085,845 21,925,563 25,089,245 4.60 11.41

6 Italy 15,671,798 14,735,589 8,781,245 11,577,508 10,349,573 2.62 15.47

7 Denmark 15,304,252 15,570,242 15,108,739 14,016,118 12,506,126 2.56 5.30

8 Indonesia (Includes West Irian) 14,121,484 2,826,370 10,148,015 16,730,896 405,714 2.36 1077.99

9 France 13,258,685 13,044,528 11,626,732 12,588,121 19,466,458 2.22 -7.28

10 Korea, Rep. Of (South) 7,051,887 6,357,835 11,790,126 6,044,534 4,792,123 1.18 21.51

11 Germany 6,551,418 1,344,575 2,163,809 2,491,264 8,376,794 1.10 66.50

12 Spain 5,533,515 4,091,002 5,434,778 4,855,976 3,086,999 0.92 19.94

13 Taiwan 5,058,392 2,287,664 7,522,936 5,025,665 4,388,626 0.85 28.93

14 Great Britain And Northern Ireland

3,767,742 4,811,479 6,401,920 17,065,749 14,388,085 0.63 -22.60

15 Thailand 3,667,531 2,049,883 1,406,619 1,911,080 2,006,073 0.61 23.38

16 Canada 3,112,211 4,943,589 5,313,322 4,100,614 3,998,516 0.52 -2.97

17 Australia 2,886,642 2,665,768 4,634,001 5,386,420 6,887,209 0.48 -17.49

18 Singapore 2,381,865 14,014,957 5,507,912 4,347,283 14,872,161 0.40 6.84

19 Belgium 2,042,183 1,450,759 2,432,973 2,009,918 3,466,001 0.34 -5.14

20 Mexico 1,978,957 1,895,247 1,613,900 2,701,029 1,113,025 0.33 31.07

21 New Zealand (Excludes Western Samoa)

1,799,584 1,634,849 1,647,864 1,750,954 1,865,211 0.30 -0.68

22 Russian Federation (U.S.S.R.) 1,639,899 1,094,050 288,878 0 0 0.27 82.15

23 Chile 1,549,053 1,518,286 1,712,709 1,857,866 1,616,884 0.26 -0.56

24 Sri Lanka (Ceylon) 1,131,372 1,093 0 0 750 0.19 25827.68

25 Brazil 1,089,049 1,321,988 733,421 1,025,046 1,518,607 0.18 0.42


- 86 -

26 Hong Kong S.A.R. 1,006,590 2,049,374 3,814,266 4,177,629 2,930,264 0.17 -15.82

27 Israel 620,616 207,375 152,106 82,888 146,686 0.10 68.91

28 Argentina 530,500 232,959 199,984 177,813 95,550 0.09 60.69

29 Ireland 382,340 556,004 281,337 1,014,128 825,507 0.06 4.25

30 Colombia 290,215 0 6,188 0 118,354 0.05 -50.00

31 Kuwait 275,453 306 866 1,422 2,169 0.05 22444.78

32 Norway 207,684 3,858 5,280 0 73 0.03 1289.07

33 Portugal 173,930 0 127,229 0 0 0.03

34 India 118,115 113,374 1,666,329 658,794 55,472 0.02 287.88

35 Austria 110,400 0 121,695 202,990 0 0.02 -35.01

36 Venezuela 96,836 36,000 127,959 123,681 109,811 0.02 28.30

37 Guam 96,216 37,240 25,060 33,072 20,995 0.02 60.07

38 Vietnam 89,205 27,736 743 3,885 12,812 0.01 926.01

39 El Salvador 66,200 82,400 44,582 13,023 0 0.01 76.88

40 Mauritius 63,304 94,347 0 46,568 95,230 0.01 -46.00

41 Saudi Arabia 57,696 16,756 99,591 85,224 66,254 0.01 51.66

42 Nigeria 48,000 13,000 8,790 0 0 0.01 79.28

43 Barbados 47,606 0 0 0 0 0.01

44 Finland 42,065 0 26,521 19,361 0 0.01 -15.75

45 Pakistan, Islamic Rep. 36,411 20,719 559,828 106,659 21,431 0.01 200.50

46 Hawaii 30,976 31,034 19,548 27,458 20,235 0.01 16.36

47 South Africa Rep. Of 27,023 16,650 12,223 10,762 52,215 0.00 8.18

48 Uruguay 26,600 0 25,214 0 0 0.00

49 Turkey 21,750 9,000 9,198 10,783 0 0.00 31.20

50 Peru 20,670 11,540 8,300 0 9,353 0.00 4.54

51 Madagascar, Rep. Of 19,440 0 0 0 0 0.00

52 United Arab Emirates 17,103 6,056 347,860 254,684 24,910 0.00 260.79

53 Switzerland 14,660 292 17,978 135 14,568 0.00 4485.03

54 Brunei Darussalam 11,160 2,132 1,596 640 25 0.00 766.60

55 Egypt 8,200 0 0 223,959 84,980 0.00 15.89

56 Trust Territory of Pac.ic Islands 6,635 10,163 36,961 58,608 5,915 0.00 186.67

57 Ecuador 6,000 0 12,000 0 0 0.00

58 Greece 5,610 0 158 173 379 0.00 -40.76

59 Bahrain 3,017 1,413 0 0 878 0.00 3.38

60 Aruba 1,948 0 0 0 0 0.00

61 Cambodia (Dem. Kampuchea) 1,660 0 0 0 665 0.00

62 Cyprus 1,652 25 0 0 376 0.00 1602.00

63 Czech Republic 1,650 0 39,600 142,454 0 0.00 -43.05

64 Lebanon 1,362 649 1,790 1,000 0 0.00 31.28

65 Sweden 918 649 0 0 0 0.00


- 87 -

66 Poland 630 0 0 128,944 330,844 0.00 -40.26

67 Qatar 538 627 1,188 183 128 0.00 132.68

68 Papua New Guinea 200 190 0 0 0 0.00

69 Oman 183 1,082 2,916 985 1,915 0.00 0.37

70 Alaska 0 11,408 0 0 0 0.00

71 Algeria 0 17,250 0 16,808 0 0.00 -50.00

72 Bangladesh 0 0 9,913 75,900 0 0.00 -46.73

73 Bermuda 0 0 0 598,402 0 0.00

74 Bhutan 0 0 0 29,500 0 0.00

75 Bulgaria 0 88,400 0 0 534 0.00 -50.00

76 Canary Islands 0 0 73,279 1,200 0 0.00 1476.65

77 Cape Verde 0 0 28,800 0 0 0.00

78 Cuba 0 205,600 0 0 62,593 0.00 -50.00

79 Equatorial Guinea, Rep. Of 0 0 60,859 0 0 0.00

80 Guatemala 0 8,783 0 8,265 0 0.00 -50.00

81 Hungary 0 89,343 78,900 148,125 28,400 0.00 72.02

82 Iceland 0 2,448 0 0 0 0.00

83 Iran 0 8,050 6,325 0 22,413 0.00 -43.18

84 Jordan 0 0 0 0 14,250 0.00 0.00

85 Kenya 0 0 1,218 0 4,530 0.00 -50.00

86 Micronesia Federated States of 0 285 0 522 0 0.00 -50.00

87 Myanmar (Burma) 0 136,800 0 0 0 0.00

88 Nauru, Rep. Of 0 1,254 0 0 0 0.00

89 Nepal 0 27,500 0 0 0 0.00

90 Netherlands Antilles 0 41,600 0 0 0 0.00

91 Nicaragua 0 0 18,014 0 0 0.00

92 Palau, Rep. Of 0 0 170 0 292 0.00 -50.00

93 Puerto Rico 0 0 0 0 41,712 0.00

94 Reunion 0 0 0 27,500 0 0.00

95 St. Helena 0 0 0 154 0 0.00

96 Syrian Arab Republic 0 0 1,072,700 0 0 0.00

97 Ukraine (Ukrainian S.S.R) 0 0 17,200 17,200 17,200 0.00 -25.00

98 Zimbabwe 0 0 0 0 6,175 0.00



- 88 -


- 89 -

ANNEX XIII

DIRECTORY OF CHAMBER OF FILIPINO DRUG MANUFACTURERS AND DISTRIBUTORS (as of January 2004)



-90-

Contact Person Member Company Tel. No./s Fax No. First Name MI Last Name Position

ASIAN ANTIBIOTICS, INC. 634-0912 6340881 CLAUDERIA C. DE LEON PLANT DIRECTOR (M) 130 PIONEER STREET 634-0882 MANDALUYONG CITY [email protected]

ALMAN PHARMACEUTICALS, INC. ALEJANDRO M. GARCIA PRESIDENT (D) MLA. OFF: UNIT 1A PATRICIA BLDG. 853-1005/851-4608 845-5356 1050 EDSA, MAGALLANES VILL. MAKATI CITY 851-4690

ASHFORD PHARMA. LABS, INC. 658-3969 6584298 GREGORIO C. DIZON PRESIDENT (M) 145 P. P. OLIVEROS ST. 660-4095 ANTIPOLO CITY

BASIC PHARMACEUTICAL CORP. 724-0647 OR 2931 7234151 TERESITA T. CHAN PRESIDENT (D) 38 BARASOAIN, LITTLE BAGUIO 723-9942 SAN JUAN,M.M. 7234159

[email protected]

BIO-STRATA PHARMACEUTICALS, INC. 631-6726 631-6726 JESUS LUIS T. ALDEA PRESIDENT (D) 101 SHAW BOULEVARD PASIG CITY [email protected] BLOOMING FIELDS PHILS.,INC. 722-4637 7224915 MAIZE FRANCES S QUA CHAIRMAN (D) CROMWELL ROAD 724-9319 CITY OF MANDALUYONG, M.M. [email protected]

BOIE, INCORPORATED 8077695 7725102 GONZALO C. GALANG VP & GEN.MGR. (D) 520 ALABANG-ZAPOTE ROAD 8079675 ALMANZA,REAL STREET 8076303 LAS PINAS,M.M. 8079735 [email protected]



-91-


CISTRON PHILS., INC. 807-4291 807-4247 ANTONIO B. PENALOZA C.E.O. (D) 19 VICENTE RECTO STREET PARANAQUE, M.M.

DIAMOND LABORATORIES, INC. 932-7555 932-7551 JASON P CABRERA EXECUTIVE OFFICE (M) 8 PERIA ROAD 931-1843 931-1826 COMMONWEALTH AVENUE 931-1179 932-9539 DILIMAN. QUEZON CITY 931-1838 http://diamondlabs.com/home.html [email protected] ELIN PHARMACEUTICALS, INC. 633-7185 TO 86 6337189 MA. LOURDES B. BUENSUCESO PRESIDENT (M) 10/F JMT CORPORATE CONDOMINIUM ADB AVENUE, ORTIGAS CENTER, PASIG CITY WAREHOUSE [email protected] 929-5367

FILADAMS PHARMA, INC. 922-2284 TO 88 921-0868 ARMI ENCARNITA A. BUAN PURCHASING OFFICER (D) 37 MAPAGKUMBABA COR. MATIPID ST. SIKATUNA VILLAGE, QUEZON CITY [email protected] FORAMEN PRODUCTS CORP. 373-3966 373-0585 MA. CRISTINA S PALOMARA GEN. MANAGER (D) 67 SCOUT FUENTEBELLA 373-3922 QUEZON CITY [email protected] GENERAL DRUG & CHEM'L. CO., INC. 631-85.01 LOC 8808 631-6021 LEONARD M. BERBA VP/GM MFG SUBS/AFFILIATES (M) 82 MAYFLOWER STREET MANDALUYONG CITY GX INTERNATIONAL, INC. 842-7155 TO 58 842-0376 WILFREDO C. OREJOLA PRESIDENT & C.E.O (D) 8/F ALPAP II BLDG. TRADE ST. COR INVESTMENT DRIVE MADRIGAL BUSINESS PARK, AYALA ALABANG, MUNTINLUPA, M.M. www.gxonline.com HEXAGON CHEMICAL CORP. 781-1447 781-1979 PERSEVERANO L. CRUZ PRESIDENT & G EN MGR. (D) RM302 SGS FOUNDATION BLDG. 781-5835 1335 G. ARANETA AVENUE, SMH 731-4875 QUEZON CITY 740-7604 [email protected]



-92-


HIZON LABORATORIES, INC. 697-5933 697-5937 ANNALEE H. CARINGAL EXEC.DIR.-BUS.MGT&ADMIN (M) MKTG OFFICE: 29 QUEZON AVE., QUEZON CITY PLANT: ASSUMPTION ROAD SUMULONG HIGHWAY, ANTIPOLO CITY [email protected] INTEGRATED PHARMA., INC. 241-8501 to 04 241-3846 KATHERYN C. TANTIANSU VICE PRESIDENT (D) 416 DASMARINAS STREET BINONDO. MANILA www.integrated.com.ph [email protected]

KAMIRE, INC. 718-1188 TO 90 7182535 KATIPUNAN REY P. DELOS REYES, JR PRESIDENT

(D) 429-C 2/F MIRANDA BLDG. SHAW BOULEVARD MANDALUYONG CITY LARGEN MED, INC. 373-7054 373-7050 ROGEN B. REYES PRESIDENT/CEO D) UNIT 202-203 METRO SQUARE BLDG. 373-7050 35 SCT. DE GUIA COR SCT. TUAZON STS. 373-7520 BRGY. LAGING HANDA, QUEZON CITY [email protected] LE JUMONT PHARMA., INC. 413-7247 3734691 ELNORE B. MONTANO OPERATIONS MGR. (D) SUITE 502 5/F WEST TRADE CENTER BLDG. 373-4690 TO 91 132 WEST AVE., QUEZON CITY [email protected] LEMA PHARMACEUTICALS, INC. 032-255-5144 032-253-0181 ALEJANDRO M. GARCIA PRESIDENT (D) ROOM 201 MENCHAVEZ BLDG. 032-253-0181 ESCARIO ST., CEBU CITY [email protected]



-93-


LLOYD LABORATORIES, INC. 636-2992 TO 95 636-3699 JESUS R. SOLOMON PRESIDENT (M) CORPORATE OFFICE: WAREHOUSE: UNIT 2205-A WEST TOWER, PHIL. STOCK 372-3984 EXCHANGE CENTER BLDG. ORTIGAS CENTER PASIG CITY MFG. COMPLEX 044-7940159 044-794-0499 10 LLOYD AVE., 1ST BULACAN INDUSTRIAL CITY BO. TIKAY, MALOLOS , BULACAN [email protected] www.lloydlab.com/stats/ MACROPHARMA CORPORATION 634-8790 637-7596 SALVADOR O. RIVERA C.E.O (D) SUITE 3204-B, TEKTITE EAST TOWER 634-8783 PHILIPPINES STOCK EXCHANGE CENTER 632-9070 ORTIGAS CENTER, PASIG CITY MARKET WORLD DISTRIBUTORS, CORP. HEAD OFFICE 634-4839 ROMEO S. DELAVIN PRESIDENT (D) HEAD OFFICE: 3/F THE CENTERPOINT BLDG. 634-4845 TO 46 GARNET RD. COR. JULIA VARGAS AVE. ORTIGAS CENTER PASIG CITY 1605 DISTRIBUTION: SALES & DISTRIBUTORS OFC. 671-0890 146 PASIG BOULEVARD, BAGONG ILOG 671-2117 PASIG CITY MAXWELL BYRD SPECIALTY PHARMACEUTICALS & 687-3529 687-3375 CHRISTOPHER M. GONZALES COMPANY PHARMACIST PRODUCTS CORP. 687-3006 (D) UNIT E -510, 5/F EAST TOWER, PSE BLDG. PSE CENTRE, EXCHANGE ROAD ORTIGAS CENTER, PASIG CITY [email protected] MEDHAUS PHARMA, INC. 911-2067 911-5459 GAUDENCIO M. AQUINO PRESIDENT & GM (D) 36-A MAIN AVENUE CUBAO, QUEZON CITY MEDECIA MED, INC. (045) 963-4698 (045) 322-0846 JAIME V. CAPIL PRESIDENT (D) MOLAVE STREET, AGUAS SUBDIVISION MANIBAAG, PORAK PAMPANGGA



-94-


MEDIC AID DISTRIBUTORS, INC. 723-0071 TO 76 724-8639 AMADO A. NGKING PRESIDENT & GM (D) 202 ELCO BUILDING, E. RODRIGUEZ AVENUE LOC.120to122 QUEZON CITY 410-3250 MERCURY DRUG CORPORATION 911-5071 TO 87 911-6673 VIVIAN Q. AZCONA PRESIDENT (D) 7 MERCURY AVENUE COR. E. R ODRIGUEZ JR. 911-6654

AVENUE, BAGUMBAYAN, QUEZON CITY

www.mercurydrug.com [email protected] METROPOLITAN PHARMACEUTICAL PRODUCTS, INC. 8072782 807-2113 RUDY A. VERANO PRESIDENT/ C.E.O (D) 2/F MENESES HOLDINGS BLDG. 807-9756 G. PUYAT COR. C. ARAGON STS. BF HOMES, SUCAT, PARANAQUE, M.M. [email protected] www.metropolitanpharma.com MT. SINAI SCIENTIFIC & PHARMACEUTICAL SUPPLY 912-2123 912-2119 DAVID R. SANSANO PRESIDENT (D) CARILLO-SANSANO BLDG. 912-2117 47-A ANNAPOLIS ST. CUBAO, Q.C. NOVOMED, INC. 032-345-9147 032-3459147 HECTOR T. ROSELLO GENERAL MANAGER PROV'L: 3/F DYZON BLDG. 032-422-5711 246 WIRELESS, MANDAUE CITY MLA: 566 SHAW BLVD., MANDALUYONG CITY novomed_island.com.ph ONE PHARMA COMPANY, INC. 871-2941 to 43 872-4292 DANILO R. OLANOSA PRESIDENT & C.E.O. (D) A. LIWANAG COR. G. DIAZ STS. 871-2537 871-7399 BFRV, CLASSI 1 LAS PINAS CITY

[email protected] www.onepharma.com.ph

ORO LABORATORIES, INC. 712-4969 712-3576 MARIETTA G. HOLMGREN PRESIDENT (M) 370 QUEZON AVENUE, QUEZON CITY 712-3556

PAREN PHARMA, INC. 822-34-11 821-5022 ARTURO L. XAVIER PRES.& MANAGING DIRECTOR

(D) GROUND FLOOR IDM BLDG. 822-3438 A55 ARMSTRONG AVENUE PARANAQUE CITY [email protected]



-95-


PHAREX HEALTH CORPORATION 924-2158/70 924-2145 RANDOLFO S. DEL ROSARIO NAT'L. SALES MANAGER (D) 817 EDSA SOUTH TRIANGLE, QUEZON CITY www.pascuallab.com PHARMA DYNAMIC, INC. 532-2021 TO 23 532-2024 JOSEPH MICHAEL G. MAGBAG GENERAL MANAGER (D) PDI BUILDING, 71 MAYSILO STREET 534-8241 MANDALUYONG CITY

PHARMA MEDICA, INC. 687-07-06 687-08-75 GELACIO C. CRUZ PRESIDENT/C.O.B (D) SUITE 1708, 17/F ANTEL GLOBAL CORPORATE 687-0875 CENTER, JULIA VARGAS ST. COR MERALCO AVE., ORTIGAS CENTER, PASIG CITY [email protected]

PHARMA NUTRIA N.A., INC. 371-0143 371-0143 ALBERTO A. SANTILLANA PRES. & C.E.O. (D) 2/F MARREN BLDG. 1157 QUEZON AVE 373-6240 3711428 [email protected]

PHARMASPEC N.A., INC. 743-2880 743-7602 NILO S. VALENTE GENRAL MANAGER

(D) 3RD FLOOR, HIZON BUILDING

29 QUEZON AVE., QUEZON CITY

PHILIPPINE HEALTH FOOD MFG. CORP (049)5412391 (049)5412390 ILDEFONSO C. RAMOS OPERATIONS OFFICER (M) STA.ROSA BUSSINES PARK BARANGAY DON JOSE, STA. ROSA LAGUNA [email protected] DL746-8893

PROHEALTH PHARMA PHILS.,INC. 637-6971 to 72 637-6963 VILLAMOR A. CANDO PRESIDENT (D) 2603, 26/F EAST TOWER 637-4907 PHIL. STOCK EXCHANGE CENTER ORTIGAS CENTER, PASIG CITY 1600 [email protected]/ http://www.prohealth.com.ph

PROSEL PHARMACEUTICALS, INC. 895-4357; 895-4358 895-4358 MA. LUISA C. PARUNGAO OPERATIONS MANAGER (D) 9724 PILILIA ST., SANTIAGO VILLAGE 890-2278 MAKATI CITY [email protected]



-96-


RANDRIL INTERNATIONAL CO., INC. 372-6637 to 39 372-6639 RODOLFO B. CALMA MANAGING DIRECTOR (D) SUITE 401 4/F CEDAR EXECUTIVE BLDG. loc19 26 TIMOG AVE. COR SCOUT TOBIAS ST. QUEZON CITY [email protected] RX CONSULTANTS, INC. 687-1472 687-1471 SANG JE SOK PRESIDENT (D) UNIT 809 PRESTIGE TOWER CONDOMINIUM 687-1471 EMERAL AVENUE, ORTIGAS CENTER PASIG CITY [email protected]

SONIX PHARMACEUTICALS, INC. 813-2508, 8138579 8138508 MARCIANITO M. JISON CHAIRMAN & PRESIDENT (D) PENTHOUSE, ACE BUILDING RADA, CORNER DE LE ROSA ST. LEGASPI VILLAGE, MAKATI

[email protected]

S.V. MORE PHARMA CORPORATION (M.M.L.) 373-6240 371-1428 NILO S. VALENTE PRESIDENT 4/F MARREN BUILDING 373-6242

1157 QUEZON AVENUE, QUEZON CITY 373-6591

SYDENHAM LABORATORIES, INC. 533-9329 533-9219 MICHAEL FRANCIS A. DELA CRUZ PRESIDENT

(M) 566 SHAW BLVD. MANDALUYONG CITY 533-9740 PLANT: AGUINALDO HIWAY NR. GOVERNOR'S DRIVE (046)-4165070 TO 72 (46)416-4680 DASMARINAS, CAVITE [email protected] SWISS PHARMA RESEARCH LAB. 241-8501to 04 241-3846 ROSALINA D. NOLASCO SENIOR VICE PRESIDENT (M) 416 DASMARINAS ST., BINONDO, MANILA 241-8501 loc113 PLANT: BARRIO PITTLAND 049-549-2372 or 73 049-549-7210 CABUYAO, LAGUNA www.sprli.com [email protected] TECHNOMED INTERNATIONAL, INC. 744-8646 721-1850 JOSE RIZALDE V. LAVARRO EXEC. VICE PRES. (D) 4/F MEDECOR BLDG., ORTTIGAS AVENUE 721-1320 GREENHILLS, SAN JUAN , M.M. 721-1860 [email protected]



-97-


TYNOR DRUG HOUSE, INC. 807-2123 TO 25 807-2111 TOMAS VICTORINO A. MENESES PRESIDENT

(D) MENESES HOLDINGS BLDG. G. PUYAT COR. C. ARAGON STREETS BF COMM'L CENTER, SUCAT PARANAQUE,M.M. [email protected] UNITED LABORATORIES, INC. 631-8501 746-8892 VALENTIN M. CUSTODIO MANAGER (M) 66 UNITED STREET LOC 5026 MANDALUYONG CITY www.unilab.com.ph VENUTEK MEDICA, INC. 634-5679 636-5439 PATRICK A. YUSINGCHO MARKETING MANAGER (D) 3/F DISPOPHIL BLDG. 636-7774 BLESSED JOSE MARIA ESCRIVA STREET ORTIGAS CENTER, PASIG CITY [email protected] VIRGO PHARMACEUTICAL, INC. 740-1384 741-5903 ROSALINDA G. VILLANUEVA PRESIDENT (M) 270 N.S. AMORANTO AVE. 740-1385 STA . MESA HEIGHTS, QUEZON CITY [email protected] ZYLAN PHARMA, INC. 823-5662, 823-1104 823-1104 ABELARDO A. AQUINO PRESIDENT (D) 33 GERMANY STREET 824-4647 BETTERLIVING SUBD. PARANAQUE CITY [email protected]

(M) MANUFACTURERS (D) DISTRIBUTORS


- 98 -


- 99 -

ANNEX XIV

COMPANY/PRODUCT PROFILE FORMS


- 100 -


- 101 -

COMPANY / PRODUCT PROFILE FORM

“AsiaHealthCare 2004” Buyers/Sellers Meeting on Pharmaceuticals and Natural Products SINGAPORE 14-16 JULY 2004

Name and Title: Isagani B. Ocampo – Operations Manager

Company name ACE PHARMACEUTICALS, INC.

Street - POB 101Don Vicente St., Kon Antonio Hts., Bgy. Holy Spirit

City - Country Quezon City, Philippines Email: [email protected] Tel: 632.931.0540 Fax: 632.427.2577

Year established: 1975 Number of employees: 130 Bank Ref: BPI, PNB

Website address of company:

Activities

Exporter ⌧Wholesaler/Retailer ⌧Manufacturer/Producer Importer Trader Other: ______________

Countries previously imported/exported to:

Description (please give generic names and specify if the product is indigenous) I* E*

1. Anaesthetics: General ansesthetics and oxygen Local anaesthetics Preoperative medication and sedation

2. Analgesics, antipyretics, non-steroidal anti-inflammatory medicines (NSAIMs), medicines used to threat gout and disease modifying agents in rheumatoid disorders (DMARDs) NSAIMs Opioid analgesics Used to treat gout DMARDs

⌧

3. Antiallergics and medicines used in anaphylaxis 4. Antidotes and other substances used in poisoning: Non-specific Specific

5. Anticonvulstants/antiepileptics: 6. Anti-infective medicines: Anthelminthics Antibacterials Antifungal Antiviral Antiprotozoal Insect repellents

7. Antimigraine medicines: For treatment of acute attack For prophylaxis

8. Antineoplastic, immunosuppressives and medicines used in palliative care: Immunosuppressive Cytotoxic medicines Hormones and antihormones Medicines used in palliative care

9. Antiparkinsonism medicines 10. Medicines affecting the blood: Antianaemia medicines Medicines affecting coagulation

11. Blood products and plasma substitutes: Plasma substitutes Plasma fractions fro specific use

12. Cardiovascular medicines: Antianginal Antiarrhythmic Antihypertensive Used in heart failure Antithrombotic Lipid-lowering

13. Dermatological medicines (topical) Antifungal Anti-infective Anti-inflammatory/antipruritic Astringent Skin differentiation/proliferation Scabicides/pediculicides Ultraviolet

⌧ ⌧

14. Diagnostic agents: Ophthalmic Radio contrast media

15. Disinfectants and antiseptics: Antiseptics Disinfectants

⌧ ⌧ 16. Diuretics 17. Gastrointestinal medicines: Antacids Antiemetic Antihaemorrhoidal Anti-inflammatory Antispasmodic Laxatives Used in diarrhea Antidiarrhoeal (symptomatic)

⌧

18. Hormones, other endocrine medicines and contraceptives: Adrenal/synthetic substitutes Androgens Contraceptives Estrogens Insulin/other antidiabetic agents Ovulation inducers Progestogens Thyroid hormones/antithyroid medicines

19. Immunologicals: Diagnostic agents Sera and immunoglobulins Vaccines

20. Muscle relaxants (peripherally acting) and cholinesterase inhibitors 21. Ophthalmological preparations: Anti-infective Anti-inflammatory Local anesthetics Miotics and antiglaucoma Mydriatics


- 102 -

22. Oxytocics and antioxytocics: Oxytocics Antioxytocics

23. Peritoneal dialysis solution 24. Psychotherapeutic medicines: Psychotic disorders Mood disorders Generalized anxiety and sleep disorders Obsessive compulsive disorders

25. Medicines acting on the respiratory tract ⌧ 26. Solutions correcting water, electrolyte and acid-base disturbances: Oral Parenteral Miscellaneous

27. Vitamins and minerals 28. Natural ingredients for pharmaceuticals Crude raw materials such as roots, rhizomes, leaves, fruits, seeds and (root) barks to be used in herbal Medicines containing whole plant material or as raw material for the isolation of active substances or extracts Saps and extracts, tinctures, balsams, lacs, gums, resins and starches ⌧ Essential oils ⌧ Fatty oils, fats, waxes and their derivatives Colouring agents 29. Natural ingredients for cosmetics Plant Extracts Vitamins Proteins Waxes Oils Thickening Agents Other additives Perfumery oils Preservatives 30. Raw plant material Medicinal and aromatic plants Seaweed and algae 31. Vegetable saps and extracts Lacs, natural gums, resins, gum-resins and balsams Other vegetable saps and extracts Ephedrine and quinine 32. Vegetables (and animal) derived oils, fats and waxes Peanut oil & its fractions Coconut, palm kernel or babassu oil Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil Animal or vegetable fats and oils and their fractions Waxes Cocoa butter, fat and oil 33. Colouring matter of vegetable or animal origin 34. Essential oils and oleoresins 35. Biotech

I* = Import, E* = Export


- 103 -

COMPANY / PRODUCT PROFILE FORM “AsiaHealthCare 2004” Buyers/Sellers Meeting on Pharmaceuticals and Natural Products

SINGAPORE 14-16 JULY 2004

Name and Title: Ritchie C. Corpus – General Manager

Company name ALDRIZ CORPORATION

Street - POB 23 Alijis-Murcia Road

City - Country Bacolod City, Negros Occidental, Philippines Email: [email protected] Tel: 6334.432.3270 / 6334.433.8139 Fax: 632.433.8133

Year established: 1987 Number of employees: 72 Bank Ref:

Website address of company: www.aldriz.com

Activities

Exporter ⌧Wholesaler/Retailer ⌧Manufacturer/Producer ⌧Importer ⌧Trader ⌧ Other: Distributors / Marketing















16. Diuretics 17. Gastrointestinal medicines: Antacids Antiemetic Antihaemorrhoidal Anti-inflammatory Antispasmodic Laxatives Used in diarrhea Antidiarrhoeal (symptomatic)





- 104 -



25. Medicines acting on the respiratory tract 26. Solutions correcting water, electrolyte and acid-base disturbances: Oral Parenteral Miscellaneous

27. Vitamins and minerals 28. Natural ingredients for pharmaceuticals Crude raw materials such as roots, rhizomes, leaves, fruits, seeds and (root) barks to be used in herbal ⌧ Medicines containing whole plant material or as raw material for the isolation of active substances or extracts ⌧ Saps and extracts, tinctures, balsams, lacs, gums, resins and starches ⌧ Essential oils ⌧ Fatty oils, fats, waxes and their derivatives ⌧ Colouring agents ⌧ 29. Natural ingredients for cosmetics ⌧Plant ⌧Extracts ⌧Vitamins ⌧Proteins ⌧Waxes ⌧Oils ⌧ ⌧Thickening ⌧Agents Other additives ⌧Perfumery oils ⌧Preservatives ⌧ 30. Raw plant material Medicinal and aromatic plants Seaweed and algae 31. Vegetable saps and extracts Lacs, natural gums, resins, gum-resins and balsams Other vegetable saps and extracts Ephedrine and quinine 32. Vegetables (and animal) derived oils, fats and waxes Peanut oil & its fractions Coconut, palm kernel or babassu oil Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil Animal or vegetable fats and oils and their fractions Waxes Cocoa butter, fat and oil 33. Colouring matter of vegetable or animal origin 34. Essential oils and oleoresins 35. Biotech



- 105 -



Name and Title: Limuel Z. Razo

Company name ASIAN ANTIBIOTICS, INC.

Street - POB 130 Pioneer St.

City - Country Mandaluyong City, Philippines

Email: [email protected] Tel: 632.631.8501 Fax:



Activities

Exporter Wholesaler/Retailer ⌧Manufacturer/Producer Importer Trader Other: _____________

Countries previously imported/exported to: EUROPE, INDIA, CHINA, ITALY, GERMANY, FRANCE





5. Anticonvulstants/antiepileptics: 6. Anti-infective medicines: Anthelminthics ⌧Antibacterials Antifungal Antiviral Antiprotozoal Insect repellents

⌧ 7. Antimigraine medicines: For treatment of acute attack For prophylaxis





13. Dermatological medicines (topical) ⌧Antifungal Anti-infective Anti-inflammatory/antipruritic Astringent Skin differentiation/proliferation Scabicides/pediculicides Ultraviolet

⌧








- 106 -




27. Vitamins and minerals 28. Natural ingredients for pharmaceuticals Crude raw materials such as roots, rhizomes, leaves, fruits, seeds and (root) barks to be used in herbal Medicines containing whole plant material or as raw material for the isolation of active substances or extracts Saps and extracts, tinctures, balsams, lacs, gums, resins and starches Essential oils Fatty oils, fats, waxes and their derivatives Colouring agents 29. Natural ingredients for cosmetics Plant Extracts Vitamins Proteins Waxes Oils Thickening Agents Other additives Perfumery oils Preservatives 30. Raw plant material Medicinal and aromatic plants Seaweed and algae 31. Vegetable saps and extracts Lacs, natural gums, resins, gum-resins and balsams Other vegetable saps and extracts Ephedrine and quinine 32. Vegetables (and animal) derived oils, fats and waxes Peanut oil & its fractions Coconut, palm kernel or babassu oil Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil Animal or vegetable fats and oils and their fractions Waxes Cocoa butter, fat and oil 33. Colouring matter of vegetable or animal origin 34. Essential oils and oleoresins 35. Biotech



- 107 -



Name and Title: Teresita T. Chan

Company name BASIC PHAARMACEUTICAL CORP.

Street - POB 38 Barasoin St. Little Baguio

City - Country San Juan, Metro Manila, Philippines

Email: [email protected] Tel: 632.723.9942 / 632.723.4159 Fax: 632.723.4151

Year established: 1991 Number of employees: 50 Bank Ref: BPI / Metrobank

Website address of company: Basicpharma.mydestiny.net

Activities

Exporter Wholesaler/Retailer Manufacturer/Producer Importer Trader Other: _______________












⌧ 13. Dermatological medicines (topical) ⌧Antifungal ⌧Anti-infective ⌧Anti-inflammatory/antipruritic Astringent Skin differentiation/proliferation Scabicides/pediculicides Ultraviolet








- 108 -




27. Vitamins and minerals ⌧ ⌧ 28. Natural ingredients for pharmaceuticals Crude raw materials such as roots, rhizomes, leaves, fruits, seeds and (root) barks to be used in herbal Medicines containing whole plant material or as raw material for the isolation of active substances or extracts Saps and extracts, tinctures, balsams, lacs, gums, resins and starches Essential oils Fatty oils, fats, waxes and their derivatives Colouring agents 29. Natural ingredients for cosmetics Plant Extracts Vitamins Proteins Waxes Oils Thickening Agents Other additives Perfumery oils Preservatives 30. Raw plant material Medicinal and aromatic plants Seaweed and algae 31. Vegetable saps and extracts Lacs, natural gums, resins, gum-resins and balsams Other vegetable saps and extracts Ephedrine and quinine 32. Vegetables (and animal) derived oils, fats and waxes Peanut oil & its fractions Coconut, palm kernel or babassu oil Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil Animal or vegetable fats and oils and their fractions Waxes Cocoa butter, fat and oil 33. Colouring matter of vegetable or animal origin 34. Essential oils and oleoresins 35. Biotech



- 109 -



Name and Title: Sheila Mae M. Velilla – General Manager

Company name BIOLINK PHARMA

Street - POB Unit 1207 President Tower, 81 Timog Avenue


Year established: Number of employees: 20 Bank Ref: Metrobank, Union Bank

Website address of company: www.biolinkpharma.com

Activities

Exporter ⌧Wholesaler/Retailer Manufacturer/Producer ⌧Importer Trader Other: ______________




2. Analgesics, antipyretics, non-steroidal anti-inflammatory medicines (NSAIMs), medicines used to threat gout and disease modifying agents in rheumatoid disorders (DMARDs) ⌧NSAIMs Opioid analgesics Used to treat gout DMARDs

⌧


5. Anticonvulstants/antiepileptics: 6. Anti-infective medicines: ⌧Anthelminthics ⌧Antibacterials Antifungal Antiviral Antiprotozoal Insect repellents





12. Cardiovascular medicines: Antianginal Antiarrhythmic Antihypertensive Used in heart failure ⌧Antithrombotic Lipid-lowering

⌧ 13. Dermatological medicines (topical) Antifungal Anti-infective Anti-inflammatory/antipruritic Astringent Skin differentiation/proliferation Scabicides/pediculicides Ultraviolet



16. Diuretics 17. Gastrointestinal medicines: Antacids Antiemetic Antihaemorrhoidal Anti-inflammatory ⌧Antispasmodic Laxatives Used in diarrhea Antidiarrhoeal (symptomatic)

⌧





- 110 -

22. Oxytocics and antioxytocics: ⌧Oxytocics Antioxytocics

⌧ 23. Peritoneal dialysis solution 24. Psychotherapeutic medicines: Psychotic disorders Mood disorders Generalized anxiety and sleep disorders Obsessive compulsive disorders


27. Vitamins and minerals ⌧ 28. Natural ingredients for pharmaceuticals Crude raw materials such as roots, rhizomes, leaves, fruits, seeds and (root) barks to be used in herbal Medicines containing whole plant material or as raw material for the isolation of active substances or extracts Saps and extracts, tinctures, balsams, lacs, gums, resins and starches Essential oils Fatty oils, fats, waxes and their derivatives Colouring agents 29. Natural ingredients for cosmetics Plant Extracts Vitamins Proteins Waxes Oils Thickening Agents Other additives Perfumery oils Preservatives 30. Raw plant material Medicinal and aromatic plants Seaweed and algae 31. Vegetable saps and extracts Lacs, natural gums, resins, gum-resins and balsams Other vegetable saps and extracts Ephedrine and quinine 32. Vegetables (and animal) derived oils, fats and waxes Peanut oil & its fractions Coconut, palm kernel or babassu oil Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil Animal or vegetable fats and oils and their fractions Waxes Cocoa butter, fat and oil 33. Colouring matter of vegetable or animal origin 34. Essential oils and oleoresins 35. Biotech



- 111 -



Name and Title: Paulo P. Mamangun, Jr. - President

Company name COCONUT HAVEN PHILIPPINES, INC.

Street - POB C837 Turin, BF Homes, International

City - Country Las Piñas, Philippines Email: [email protected] Tel: 632.826.7571 Fax: 632.826.7571


Website address of company: www.coconuthaven.com

Activities

⌧Exporter Wholesaler/Retailer ⌧Manufacturer/Producer Importer Trader Other: ___________

Countries previously imported/exported to: U.S.A. (New York and New Jersey)



















- 112 -




27. Vitamins and minerals 28. Natural ingredients for pharmaceuticals Crude raw materials such as roots, rhizomes, leaves, fruits, seeds and (root) barks to be used in herbal Medicines containing whole plant material or as raw material for the isolation of active substances or extracts Saps and extracts, tinctures, balsams, lacs, gums, resins and starches Essential oils Fatty oils, fats, waxes and their derivatives Colouring agents 29. Natural ingredients for cosmetics Plant Extracts Vitamins Proteins Waxes Oils Thickening Agents Other additives Perfumery oils Preservatives 30. Raw plant material Medicinal and aromatic plants Seaweed and algae 31. Vegetable saps and extracts Lacs, natural gums, resins, gum-resins and balsams Other vegetable saps and extracts Ephedrine and quinine 32. Vegetables (and animal) derived oils, fats and waxes Peanut oil & its fractions Coconut, palm kernel or babassu oil ⌧ ⌧ Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil Animal or vegetable fats and oils and their fractions Waxes Cocoa butter, fat and oil 33. Colouring matter of vegetable or animal origin 34. Essential oils and oleoresins 35. Biotech



- 113 -



Name and Title: Ma. Carlita R. Doran - President

Company name CRD HERBAL PRODUCTS

Street - POB Lot 29 Blk. 54 Braceville St, Fairmont Park II, North Fairview


Year established: Number of employees: 20 Bank Ref: Metrobank


Activities





















- 114 -




27. Vitamins and minerals 28. Natural ingredients for pharmaceuticals Crude raw materials such as roots, rhizomes, leaves, fruits, seeds and (root) barks to be used in herbal ⌧ Medicines containing whole plant material or as raw material for the isolation of active substances or extracts ⌧ Saps and extracts, tinctures, balsams, lacs, gums, resins and starches ⌧ Essential oils ⌧ Fatty oils, fats, waxes and their derivatives ⌧ Colouring agents ⌧ 29. Natural ingredients for cosmetics Plant ⌧Extracts Vitamins Proteins Waxes Oils ⌧ Thickening Agents Other additives Perfumery oils Preservatives 30. Raw plant material Medicinal and aromatic plants ⌧ Seaweed and algae ⌧ 31. Vegetable saps and extracts Lacs, natural gums, resins, gum-resins and balsams Other vegetable saps and extracts Ephedrine and quinine 32. Vegetables (and animal) derived oils, fats and waxes Peanut oil & its fractions Coconut, palm kernel or babassu oil ⌧ Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil Animal or vegetable fats and oils and their fractions Waxes Cocoa butter, fat and oil 33. Colouring matter of vegetable or animal origin 34. Essential oils and oleoresins 35. Biotech



- 115 -



Name and Title: Marilou Buensuceso

Company name E.L. LABORATORIES, INC.

Street - POB 109 North Main Ave., Laguna Technopark

City - Country Laguna, Philippines

Email: Tel: 6349.541.3222 Fax: 6349.541.3221

Year established: 1997 Number of employees: 100 Bank Ref: Devt. Bank of the Phils.


Activities

Exporter Wholesaler/Retailer ⌧Manufacturer/Producer ⌧Importer Trader Other: ___________

Countries previously imported/exported to: VIETNAM, SINGAPORE


1. Anaesthetics: General ansesthetics and oxygen ⌧Local anaesthetics Preoperative medication and sedation

⌧ 2. Analgesics, antipyretics, non-steroidal anti-inflammatory medicines (NSAIMs), medicines used to threat gout and disease modifying agents in rheumatoid disorders (DMARDs) NSAIMs Opioid analgesics Used to treat gout DMARDs


5. Anticonvulstants/antiepileptics: 6. Anti-infective medicines: Anthelminthics ⌧Antibacterials ⌧Antifungal ⌧Antiviral Antiprotozoal Insect repellents

⌧ ⌧ 7. Antimigraine medicines: For treatment of acute attack For prophylaxis











20. Muscle relaxants (peripherally acting) and cholinesterase inhibitors 21. Ophthalmological preparations: ⌧Anti-infective ⌧Anti-inflammatory Local anesthetics Miotics and antiglaucoma Mydriatics

⌧


- 116 -




27. Vitamins and minerals ⌧ 28. Natural ingredients for pharmaceuticals Crude raw materials such as roots, rhizomes, leaves, fruits, seeds and (root) barks to be used in herbal Medicines containing whole plant material or as raw material for the isolation of active substances or extracts Saps and extracts, tinctures, balsams, lacs, gums, resins and starches Essential oils Fatty oils, fats, waxes and their derivatives Colouring agents 29. Natural ingredients for cosmetics Plant Extracts Vitamins Proteins Waxes Oils Thickening Agents Other additives Perfumery oils Preservatives 30. Raw plant material Medicinal and aromatic plants Seaweed and algae 31. Vegetable saps and extracts Lacs, natural gums, resins, gum-resins and balsams Other vegetable saps and extracts Ephedrine and quinine 32. Vegetables (and animal) derived oils, fats and waxes Peanut oil & its fractions Coconut, palm kernel or babassu oil Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil Animal or vegetable fats and oils and their fractions Waxes Cocoa butter, fat and oil 33. Colouring matter of vegetable or animal origin 34. Essential oils and oleoresins 35. Biotech LOOKING FOR : 1. CLIENTS FOR TOLL MANUFACTURING 2. SUPPLIERS OF PACKAGING MATERIALS Foil, Vials, Bottles


* GMP CONTRACT MANUFACTURER SPECIALIZING IN:

• CEPHALOSPHORIN ORAL PRODUCTS • NON SENSITIZING ORAL & LIQUID PRODUCTS • SMALL VOLUME PARENTERALS • OPHTAHLMIC SOLUTIONS


- 117 -



Name and Title: Virgilio V. Ecarma – Chief Executive Officer

Company name ECARMA HEALTH OPTIONS

Street - POB 259 Dona Soledad Extension, Better Living Subdivision

City - Country Parañaque City, Philippines 1711


Year established: 1997 Number of employees: 25 Bank Ref: Equitable PCI Bank

Website address of company: www.ecarma.net

Activities

⌧Exporter Wholesaler/Retailer ⌧Manufacturer/Producer Importer Trader Other: ______________

Countries previously imported/exported to: KENYA, UGAND, TANZANIA, JAPAN / U.S.A, INDIA –under process



2. Analgesics, antipyretics, non-steroidal anti-inflammatory medicines (NSAIMs), medicines used to threat gout and disease modifying agents in rheumatoid disorders (DMARDs) NSAIMs Opioid analgesics ⌧Used to treat gout DMARDs

⌧


5. Anticonvulstants/antiepileptics: 6. Anti-infective medicines: Anthelminthics Antibacterials ⌧Antifungal Antiviral Antiprotozoal Insect repellents


8. Antineoplastic, immunosuppressives and medicines used in palliative care: Immunosuppressive Cytotoxic medicines Hormones and antihormones ⌧Medicines used in palliative care

⌧ 9. Antiparkinsonism medicines 10. Medicines affecting the blood: Antianaemia medicines Medicines affecting coagulation


12. Cardiovascular medicines: Antianginal Antiarrhythmic Antihypertensive Used in heart failure Antithrombotic ⌧Lipid-lowering




16. Diuretics ⌧ 17. Gastrointestinal medicines: Antacids Antiemetic ⌧Antihaemorrhoidal Anti-inflammatory Antispasmodic Laxatives Used in diarrhea Antidiarrhoeal (symptomatic)

⌧

18. Hormones, other endocrine medicines and contraceptives: Adrenal/synthetic substitutes Androgens Contraceptives Estrogens ⌧Insulin/other antidiabetic agents Ovulation inducers Progestogens Thyroid hormones/antithyroid medicines

⌧




- 118 -







- 119 -



Name and Title: Marilou Buensuceso – President

Company name ELIN PHARMA INC.

Street - POB 10/F JMT Corporate Condominium, ADB Avenue, Ortigas Center

City - Country Pasig City, Philippines

Email: Tel: 632.633.7185 Fax: 632.633.7189

Year established: 1969 Number of employees: 100 Bank Ref: BPI


Activities

Exporter Wholesaler/Retailer Manufacturer/Producer ⌧Importer ⌧Trader Other: ___________

Countries previously imported to: (Raw Materials / Finished Products) INDIA, CROATIA, SPAIN, CHINA














16. Diuretics 17. Gastrointestinal medicines: Antacids Antiemetic Antihaemorrhoidal Anti-inflammatory ⌧Antispasmodic Laxatives Used in diarrhea Antidiarrhoeal (symptomatic)

⌧





- 120 -



25. Medicines acting on the respiratory tract ⌧ ⌧ 26. Solutions correcting water, electrolyte and acid-base disturbances: Oral Parenteral Miscellaneous

27. Vitamins and minerals ⌧ ⌧ 28. Natural ingredients for pharmaceuticals Crude raw materials such as roots, rhizomes, leaves, fruits, seeds and (root) barks to be used in herbal Medicines containing whole plant material or as raw material for the isolation of active substances or extracts Saps and extracts, tinctures, balsams, lacs, gums, resins and starches Essential oils Fatty oils, fats, waxes and their derivatives Colouring agents 29. Natural ingredients for cosmetics Plant Extracts Vitamins Proteins Waxes Oils Thickening Agents Other additives Perfumery oils Preservatives 30. Raw plant material Medicinal and aromatic plants Seaweed and algae 31. Vegetable saps and extracts Lacs, natural gums, resins, gum-resins and balsams Other vegetable saps and extracts Ephedrine and quinine 32. Vegetables (and animal) derived oils, fats and waxes Peanut oil & its fractions Coconut, palm kernel or babassu oil Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil Animal or vegetable fats and oils and their fractions Waxes Cocoa butter, fat and oil 33. Colouring matter of vegetable or animal origin 34. Essential oils and oleoresins 35. Biotech



- 121 -



Name and Title: Gelacio C. Cruz - President

Company name GERGREG PHARMACEUTICAL CORPORATION

Street - POB S1708 Antel Global Corporate Center, J. Vargas Ave., Ortigas Center


Email: Tel: 632.687.0706 Fax: 632.687.0875

Year established: 1986 Number of employees: 60 Bank Ref: Metropolitan Bank & Trust Co.


Activities

Exporter ⌧Wholesaler/Retailer Manufacturer/Producer Importer ⌧Trader Other: ______________





⌧


5. Anticonvulstants/antiepileptics: 6. Anti-infective medicines: Anthelminthics ⌧Antibacterials Antifungal ⌧Antiviral Antiprotozoal Insect repellents



9. Antiparkinsonism medicines 10. Medicines affecting the blood: ⌧Antianaemia medicines Medicines affecting coagulation

⌧ 11. Blood products and plasma substitutes: Plasma substitutes Plasma fractions fro specific use

12. Cardiovascular medicines: Antianginal Antiarrhythmic ⌧Antihypertensive Used in heart failure Antithrombotic ⌧Lipid-lowering




16. Diuretics 17. Gastrointestinal medicines: ⌧Antacids Antiemetic Antihaemorrhoidal Anti-inflammatory Antispasmodic Laxatives Used in diarrhea Antidiarrhoeal (symptomatic)

⌧





- 122 -







- 123 -



Name and Title: Lucita Yu Soriano – Exec. Director

Company name HIZON LABORATORIES, INC.

Street - POB Assumption Road, Sumulong Highway

City - Country Antipolo City, Philippines Email: [email protected] Tel: 632.697.5933 Fax: 632.697.5937

Year established: 1898 Number of employees: 500+ Bank Ref:


Activities

Exporter Wholesaler/Retailer ⌧Manufacturer/Producer ⌧Importer Trader Other: ___________

Countries previously imported/exported to: EUROPE, CHINA, INDIA, SINGAPORE



⌧ ⌧ 2. Analgesics, antipyretics, non-steroidal anti-inflammatory medicines (NSAIMs), medicines used to threat gout and disease modifying agents in rheumatoid disorders (DMARDs) ⌧NSAIMs ⌧Opioid analgesics ⌧Used to treat gout DMARDs

⌧ ⌧

3. Antiallergics and medicines used in anaphylaxis ⌧ 4. Antidotes and other substances used in poisoning: ⌧Non-specific Specific

⌧ ⌧ 5. Anticonvulstants/antiepileptics: 6. Anti-infective medicines: Anthelminthics ⌧Antibacterials Antifungal Antiviral Antiprotozoal Insect repellents





12. Cardiovascular medicines: ⌧Antianginal ⌧Antiarrhythmic ⌧Antihypertensive ⌧Used in heart failure ⌧Antithrombotic Lipid-lowering

⌧ ⌧


14. Diagnostic agents: ⌧Ophthalmic Radio contrast media

⌧ 15. Disinfectants and antiseptics: Antiseptics Disinfectants

16. Diuretics ⌧ ⌧ 17. Gastrointestinal medicines: ⌧Antacids Antiemetic Antihaemorrhoidal ⌧Anti-inflammatory Antispasmodic Laxatives Used in diarrhea ⌧Antidiarrhoeal (symptomatic)

⌧ ⌧



20. Muscle relaxants (peripherally acting) and cholinesterase inhibitors 21. Ophthalmological preparations: Anti-infective ⌧Anti-inflammatory Local anesthetics Miotics and antiglaucoma Mydriatics

⌧


- 124 -


⌧ ⌧ 23. Peritoneal dialysis solution 24. Psychotherapeutic medicines: Psychotic disorders Mood disorders Generalized anxiety and sleep disorders Obsessive compulsive disorders

25. Medicines acting on the respiratory tract 26. Solutions correcting water, electrolyte and acid-base disturbances: Oral ⌧Parenteral Miscellaneous

⌧ 27. Vitamins and minerals ⌧ ⌧ 28. Natural ingredients for pharmaceuticals Crude raw materials such as roots, rhizomes, leaves, fruits, seeds and (root) barks to be used in herbal ⌧ ⌧ Medicines containing whole plant material or as raw material for the isolation of active substances or extracts ⌧ ⌧ Saps and extracts, tinctures, balsams, lacs, gums, resins and starches ⌧ ⌧ Essential oils ⌧ ⌧ Fatty oils, fats, waxes and their derivatives Colouring agents ⌧ ⌧ 29. Natural ingredients for cosmetics ⌧Plant ⌧Extracts ⌧Vitamins ⌧Proteins ⌧Waxes Oils ⌧ ⌧ Thickening Agents ⌧Other additives ⌧Perfumery oils ⌧Preservatives ⌧ ⌧ 30. Raw plant material Medicinal and aromatic plants ⌧ Seaweed and algae ⌧ 31. Vegetable saps and extracts Lacs, natural gums, resins, gum-resins and balsams Other vegetable saps and extracts Ephedrine and quinine ⌧ 32. Vegetables (and animal) derived oils, fats and waxes Peanut oil & its fractions Coconut, palm kernel or babassu oil Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil Animal or vegetable fats and oils and their fractions Waxes Cocoa butter, fat and oil 33. Colouring matter of vegetable or animal origin 34. Essential oils and oleoresins 35. Biotech CONTRACT MANUFACTURING SERVICES ⌧


LOOKING FOR SUPPLIERS OF: 1. CELLO FOIL 2. BLISTER FOIL 3. PVDC / PVC FILM 4. REFERENCE BOOKS FOR HERBAL MEDICINE AND TEST PROCEDURES


- 125 -



Name and Title: Daisylinda S. Garcia – General Manager

Company name LAFAYETTE PHARMACEUTICAL LABORATORIES, INC.

Street - POB 132 13th Avenue, Cubao

City - Country Quezon City, Philippines


Year established: 1995 Number of employees: 150+ Bank Ref:

Website address of company: http://www. Lafayette.com.ph

Activities

Exporter Wholesaler/Retailer ⌧Manufacturer/Producer Importer ⌧Trader Other: ______________





⌧ ⌧

3. Antiallergics and medicines used in anaphylaxis ⌧ 4. Antidotes and other substances used in poisoning: Non-specific Specific




9. Antiparkinsonism medicines ⌧ 10. Medicines affecting the blood: Antianaemia medicines Medicines affecting coagulation







⌧ ⌧





- 126 -



⌧ 25. Medicines acting on the respiratory tract ⌧ ⌧ 26. Solutions correcting water, electrolyte and acid-base disturbances: Oral Parenteral Miscellaneous

27. Vitamins and minerals ⌧ ⌧ 28. Natural ingredients for pharmaceuticals Crude raw materials such as roots, rhizomes, leaves, fruits, seeds and (root) barks to be used in herbal Medicines containing whole plant material or as raw material for the isolation of active substances or extracts Saps and extracts, tinctures, balsams, lacs, gums, resins and starches Essential oils ⌧ Fatty oils, fats, waxes and their derivatives Colouring agents ⌧ 29. Natural ingredients for cosmetics Plant Extracts Vitamins Proteins Waxes Oils Thickening Agents Other additives Perfumery oils Preservatives 30. Raw plant material Medicinal and aromatic plants Seaweed and algae 31. Vegetable saps and extracts Lacs, natural gums, resins, gum-resins and balsams Other vegetable saps and extracts Ephedrine and quinine 32. Vegetables (and animal) derived oils, fats and waxes Peanut oil & its fractions Coconut, palm kernel or babassu oil Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil Animal or vegetable fats and oils and their fractions Waxes Cocoa butter, fat and oil 33. Colouring matter of vegetable or animal origin 34. Essential oils and oleoresins 35. Biotech



- 127 -



Name and Title: Nestor T. Mendoza – Business Development Manager

Company name LLOYD LABORATORIES, INC.

Street - POB Unit 2205 – A West Tower, Philippine Stock Exchange Center Building,

City - Country Ortigas Center, Pasig City, Philippines

Email: [email protected] Tel: 632.6362992 - 95 Fax: 632.636.3699

Year established: 1989 Number of employees: 264 Bank Ref: BPI

Website address of company: www.lloydlab.com/stats

Activities


Countries previously imported/exported to: INDIA, SINGAPORE



















- 128 -







- 129 -



Name and Title: Ma. Lourdes Jalandoon - Pharmacist

Company name MACROPHARMA CORPORATION

Street - POB 3204-B Tektite East Tower, Stock Exchange , Ortigas Center




Website address of company: www.macropharma.com.ph

Activities

Exporter Wholesaler/Retailer Manufacturer/Producer ⌧Importer ⌧Trader Other: _____________

Countries previously imported/exported to: SOUTH KOREA, NAMDAEMUN-NO, CHUNG-IT, SEOUL, KOREA











13. Dermatological medicines (topical)PIROXICAM PATCH Antifungal Anti-infective ⌧Anti-inflammatory/antipruritic Astringent Skin differentiation/proliferation Scabicides/pediculicides Ultraviolet

⌧





19. Immunologicals: EPOETIN - 2 Diagnostic agents ⌧Sera and immunoglobulins Vaccines

⌧ 20. Muscle relaxants (peripherally acting) and cholinesterase inhibitors 21. Ophthalmological preparations: Anti-infective Anti-inflammatory Local anesthetics Miotics and antiglaucoma Mydriatics


- 130 -




27. Vitamins and minerals HERBAL, GARLIC, HAWTHORN, LEMON BALM, GINKGO B. ⌧ 28. Natural ingredients for pharmaceuticals Crude raw materials such as roots, rhizomes, leaves, fruits, seeds and (root) barks to be used in herbal Medicines containing whole plant material or as raw material for the isolation of active substances or extracts Saps and extracts, tinctures, balsams, lacs, gums, resins and starches Essential oils Fatty oils, fats, waxes and their derivatives Colouring agents 29. Natural ingredients for cosmetics Plant Extracts Vitamins Proteins Waxes Oils Thickening Agents Other additives Perfumery oils Preservatives 30. Raw plant material Medicinal and aromatic plants Seaweed and algae 31. Vegetable saps and extracts Lacs, natural gums, resins, gum-resins and balsams Other vegetable saps and extracts Ephedrine and quinine 32. Vegetables (and animal) derived oils, fats and waxes Peanut oil & its fractions Coconut, palm kernel or babassu oil Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil Animal or vegetable fats and oils and their fractions Waxes Cocoa butter, fat and oil 33. Colouring matter of vegetable or animal origin 34. Essential oils and oleoresins 35. Biotech



- 131 -



Name and Title: Cesar Mercado – Exec. Vice President

Company name MEDGEN LABORATORIES, INC.

Street - POB 74 Mindanao Avenue


Email: [email protected] Tel: 632.456.0825 Fax: 632.920.0306

Year established: 1988 Number of employees: 70 Bank Ref: Banco de Oro


Activities

Exporter Wholesaler/Retailer ⌧Manufacturer/Producer ⌧Importer Trader Other: ______________

Countries previously imported/exported to: AUSTRALIA



⌧ 2. Analgesics, antipyretics, non-steroidal anti-inflammatory medicines (NSAIMs), medicines used to threat gout and disease modifying agents in rheumatoid disorders (DMARDs) MEFENAMIC ACID ⌧NSAIMs Opioid analgesics Used to treat gout DMARDs

⌧


5. Anticonvulstants/antiepileptics: 6. Anti-infective medicines: AMOXICILLIN, CHLORAMPHENICOL, PTERONIDAZOLE, CLOXACILLIN, COTRIMOXAZOLE Anthelminthics ⌧Antibacterials Antifungal Antiviral Antiprotozoal Insect repellents

⌧





12. Cardiovascular medicines: Antianginal Antiarrhythmic ⌧Antihypertensive Used in heart failure Antithrombotic ⌧Lipid-lowering




16. Diuretics 17. Gastrointestinal medicines: CICYCLOVERINE Antacids Antiemetic Antihaemorrhoidal Anti-inflammatory ⌧Antispasmodic Laxatives Used in diarrhea Antidiarrhoeal (symptomatic)

⌧


⌧




- 132 -







- 133 -



Name and Title: Benson Sian – General Manager

Company name NATURAL QUALITY CORP.

Street - POB No. 59 B.G. Belmonte ST., 2/F 88 Place, New Manila




Website address of company: www.natturalTM.com

Activities

⌧Exporter ⌧Wholesaler/Retailer ⌧Manufacturer/Producer Importer Trader Other: __________

Countries previously imported/exported to: MIDDLE EAST



















- 134 -




27. Vitamins and minerals 28. Natural ingredients for pharmaceuticals Crude raw materials such as roots, rhizomes, leaves, fruits, seeds and (root) barks to be used in herbal ⌧ ⌧ Medicines containing whole plant material or as raw material for the isolation of active substances or extracts ⌧ ⌧ Saps and extracts, tinctures, balsams, lacs, gums, resins and starches ⌧ Essential oils ⌧ Fatty oils, fats, waxes and their derivatives ⌧ Colouring agents 29. Natural ingredients for cosmetics ⌧Plant ⌧Extracts ⌧Vitamins Proteins Waxes Oils ⌧ Thickening Agents Other additives Perfumery oils Preservatives 30. Raw plant material Medicinal and aromatic plants ⌧ Seaweed and algae 31. Vegetable saps and extracts Lacs, natural gums, resins, gum-resins and balsams ⌧ Other vegetable saps and extracts ⌧ Ephedrine and quinine 32. Vegetables (and animal) derived oils, fats and waxes Peanut oil & its fractions Coconut, palm kernel or babassu oil Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil Animal or vegetable fats and oils and their fractions Waxes Cocoa butter, fat and oil 33. Colouring matter of vegetable or animal origin 34. Essential oils and oleoresins 35. Biotech ⌧



- 135 -



Name and Title: Arturo L. Xavier

Company name PAREN – PHARMA, INC.

Street - POB G/F Agchem Bldg., 197 Doña Soledad Ave., Ext., Bicutan

City - Country Parañaque City, Philippines Email: [email protected] Tel: Fax: 632.821.5022

Year established: Number of employees: 7 Bank Ref: Metrobank

Website address of company: c/o CFDMD.org

Activities

Exporter Wholesaler/Retailer Manufacturer/Producer ⌧Importer ⌧Trader Other: _____________

Countries previously imported/exported to: INDIA





5. Anticonvulstants/antiepileptics: 6. Anti-infective medicines: ⌧Anthelminthics ⌧Antibacterials Antifungal ⌧Antiviral Antiprotozoal Insect repellents


8. Antineoplastic, immunosuppressives and medicines used in palliative care: ⌧Immunosuppressive ⌧Cytotoxic medicines Hormones and antihormones Medicines used in palliative care

⌧ 9. Antiparkinsonism medicines 10. Medicines affecting the blood: Antianaemia medicines Medicines affecting coagulation











- 136 -




27. Vitamins and minerals 28. Natural ingredients for pharmaceuticals Crude raw materials such as roots, rhizomes, leaves, fruits, seeds and (root) barks to be used in herbal Medicines containing whole plant material or as raw material for the isolation of active substances or extracts Saps and extracts, tinctures, balsams, lacs, gums, resins and starches Essential oils Fatty oils, fats, waxes and their derivatives Colouring agents 29. Natural ingredients for cosmetics Plant Extracts Vitamins Proteins Waxes Oils Thickening Agents Other additives Perfumery oils Preservatives 30. Raw plant material Medicinal and aromatic plants Seaweed and algae 31. Vegetable saps and extracts Lacs, natural gums, resins, gum-resins and balsams Other vegetable saps and extracts Ephedrine and quinine 32. Vegetables (and animal) derived oils, fats and waxes Peanut oil & its fractions Coconut, palm kernel or babassu oil Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil Animal or vegetable fats and oils and their fractions Waxes Cocoa butter, fat and oil 33. Colouring matter of vegetable or animal origin 34. Essential oils and oleoresins 35. Biotech Comments : all types of injectibles only Antibiotics, antibacterials Wants to source from ASEAN countries



- 137 -



Name and Title: Cecilia C. Sison – Manager, Pharmaceuticals Department

Company name PHILIPPINE INTERNATIONAL TRADING CORPORATION (attached agency of the Department of Trade and Industry)

Street - POB 116 Tordesillas Street, Salcedo Village

City - Country Makati City, Philipines

Email: [email protected] Tel: 632.892.1061 Fax: 632.892.2054/2021

Year established: 1973 Number of employees: 150 Bank Ref: LBP, PNB


Activities

Exporter Wholesaler/Retailer Manufacturer/Producer ⌧Importer Trader Other: _______________






5. Anticonvulstants/antiepileptics: CARBAMAZEPINE, PHENYTOIN ⌧ 6. Anti-infective medicines: ALBENDAZOLE / COTRIMOXAZOLE/CIPROFLOXACIN/CEFALEXIN/COAMOCICLAV/ CEFUROXIME/CLINDAMYCYCIN ⌧Anthelminthics ⌧Antibacterials Antifungal Antiviral Antiprotozoal Insect repellents

⌧





12. Cardiovascular medicines: NIFEDIPINE/DILTIAZEM/ATENOLOL/METOPROLOL/GEMFIBROZIL ⌧Antianginal Antiarrhythmic ⌧Antihypertensive Used in heart failure Antithrombotic ⌧Lipid-lowering




16. Diuretics 17. Gastrointestinal medicines: HYOSCINE/LOPERAMIDE Antacids Antiemetic Antihaemorrhoidal Anti-inflammatory Antispasmodic Laxatives ⌧Used in diarrhea Antidiarrhoeal (symptomatic)

⌧

18. Hormones, other endocrine medicines and contraceptives: Adrenal/synthetic substitutes Androgens ⌧Contraceptives Estrogens Insulin/other antidiabetic agents Ovulation inducers Progestogens Thyroid hormones/antithyroid medicines

planned

19. Immunologicals: Diagnostic agents Sera and immunoglobulins ⌧Vaccines

planned 20. Muscle relaxants (peripherally acting) and cholinesterase inhibitors 21. Ophthalmological preparations: Anti-infective Anti-inflammatory Local anesthetics Miotics and antiglaucoma Mydriatics


- 138 -


23. Peritoneal dialysis solution 24. Psychotherapeutic medicines: HALOPERIDOL ⌧Psychotic disorders Mood disorders Generalized anxiety and sleep disorders Obsessive compulsive disorders

⌧ 25. Medicines acting on the respiratory tract TERBUTALINE SULFATE/SALBUTAMOL ⌧ 26. Solutions correcting water, electrolyte and acid-base disturbances: Oral Parenteral Miscellaneous




- 139 -



Name and Title: Tess E. Santos - President

Company name PROSOURCE INTERNATIONAL, INC.

Street - POB Platinum 2000, 7 Annapolis, Greenhills

City - Country San Juan, Metro Manila, Philippines Email: [email protected] Tel: 632.727.3768 Fax: 632.727.3766

Year established: Number of employees: 12 Bank Ref: Asia United Bank


Activities

⌧Exporter ⌧Wholesaler/Retailer Manufacturer/Producer ⌧Importer ⌧Trader Other: __________

Countries previously imported/exported to: U.S.A / U.S.A., SINGAPORE



















- 140 -




27. Vitamins and minerals GRAPE EXTRACT, SKIN TABLE ⌧ 28. Natural ingredients for pharmaceuticals Crude raw materials such as roots, rhizomes, leaves, fruits, seeds and (root) barks to be used in herbal Medicines containing whole plant material or as raw material for the isolation of active substances or extracts Saps and extracts, tinctures, balsams, lacs, gums, resins and starches Essential oils Fatty oils, fats, waxes and their derivatives Colouring agents 29. Natural ingredients for cosmetics Plant Extracts Vitamins Proteins Waxes Oils Thickening Agents Other additives Perfumery oils Preservatives 30. Raw plant material Medicinal and aromatic plants Seaweed and algae 31. Vegetable saps and extracts Lacs, natural gums, resins, gum-resins and balsams Other vegetable saps and extracts Ephedrine and quinine 32. Vegetables (and animal) derived oils, fats and waxes Peanut oil & its fractions Coconut, palm kernel or babassu oil – VIRGIN COCONUT OIL, - INDEGENOUS ⌧ Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil Animal or vegetable fats and oils and their fractions Waxes Cocoa butter, fat and oil 33. Colouring matter of vegetable or animal origin 34. Essential oils and oleoresins 35. Biotech



- 141 -



Name and Title: Rommel dela Cruz – Vice President / Operations Manager

Company name RCC AMAZING TOUCH INTERNATIONAL, INC.

Street - POB 1-5 Teachers Bliss Condo 2, Balon Bato


Year established: Number of employees: 37 Bank Ref: BPI

Website address of company: www.rccamazingtouch.com

Activities

⌧Exporter Wholesaler/Retailer ⌧Manufacturer/Producer Importer ⌧Trader Other: __________

Countries previously imported/exported to: MALAYSIA, SINGAPORE, USA











13. Dermatological medicines (topical) ⌧Antifungal Anti-infective Anti-inflammatory/antipruritic Astringent ⌧Skin differentiation/proliferation Scabicides/pediculicides Ultraviolet

⌧ ⌧








- 142 -




27. Vitamins and minerals 28. Natural ingredients for pharmaceuticals Crude raw materials such as roots, rhizomes, leaves, fruits, seeds and (root) barks to be used in herbal Medicines containing whole plant material or as raw material for the isolation of active substances or extracts Saps and extracts, tinctures, balsams, lacs, gums, resins and starches Essential oils Fatty oils, fats, waxes and their derivatives Colouring agents 29. Natural ingredients for cosmetics ⌧Plant ⌧Extracts Vitamins Proteins Waxes Oils ⌧ ⌧ Thickening Agents Other additives Perfumery oils Preservatives 30. Raw plant material Medicinal and aromatic plants Seaweed and algae 31. Vegetable saps and extracts Lacs, natural gums, resins, gum-resins and balsams Other vegetable saps and extracts Ephedrine and quinine 32. Vegetables (and animal) derived oils, fats and waxes Peanut oil & its fractions Coconut, palm kernel or babassu oil Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil Animal or vegetable fats and oils and their fractions Waxes Cocoa butter, fat and oil 33. Colouring matter of vegetable or animal origin 34. Essential oils and oleoresins 35. Biotech ANTI-VIRAL HERBAL CREAM PREPARATIONS ⌧



- 143 -



Name and Title: Go, Thelma Tobias – General Manager

Company name SCHEELE LABORATORIES PHILS., INC.

Street - POB 08 Lope de Guzman St.

City - Country Valenzuela City, Philippines

Email: [email protected] Tel: 632.293.7151 / 293.7152 Fax: 632.983.7929



Activities


Countries previously imported/exported to: Raw Materials only CHINA, HONGKONG, SINGAPORE, ISRAEL, GERMANY



2. Analgesics, antipyretics, non-steroidal anti-inflammatory medicines (NSAIMs), medicines used to threat gout and disease modifying agents in rheumatoid disorders (DMARDs) ⌧NSAIMs Opioid analgesics ⌧Used to treat gout DMARDs

⌧

3. Antiallergics and medicines used in anaphylaxis 4. Antidotes and other substances used in poisoning: Non-specific ⌧Specific

⌧ 5. Anticonvulstants/antiepileptics: ⌧ 6. Anti-infective medicines: ⌧Anthelminthics ⌧Antibacterials Antifungal ⌧Antiviral ⌧Antiprotozoal ⌧Insect repellents

⌧ ⌧ 7. Antimigraine medicines: ⌧For treatment of acute attack ⌧For prophylaxis

⌧ 8. Antineoplastic, immunosuppressives and medicines used in palliative care: ⌧Immunosuppressive ⌧Cytotoxic medicines ⌧Hormones and antihormones ⌧Medicines used in palliative care

⌧ 9. Antiparkinsonism medicines ⌧ 10. Medicines affecting the blood: ⌧Antianaemia medicines Medicines affecting coagulation

⌧ 11. Blood products and plasma substitutes: ⌧Plasma substitutes ⌧Plasma fractions fro specific use

⌧ 12. Cardiovascular medicines: ⌧Antianginal ⌧Antiarrhythmic ⌧Antihypertensive ⌧Used in heart failure ⌧Antithrombotic ⌧Lipid-lowering

⌧ ⌧

13. Dermatological medicines (topical) ⌧Antifungal ⌧Anti-infective ⌧Anti-inflammatory/antipruritic Astringent Skin differentiation/proliferation ⌧Scabicides/pediculicides Ultraviolet

⌧


15. Disinfectants and antiseptics: ⌧Antiseptics ⌧Disinfectants

⌧ 16. Diuretics 17. Gastrointestinal medicines: ⌧Antacids Antiemetic Antihaemorrhoidal Anti-inflammatory ⌧Antispasmodic Laxatives ⌧Used in diarrhea ⌧Antidiarrhoeal (symptomatic)

⌧


⌧

19. Immunologicals: ⌧Diagnostic agents ⌧Sera and immunoglobulins ⌧Vaccines

⌧ 20. Muscle relaxants (peripherally acting) and cholinesterase inhibitors 21. Ophthalmological preparations: ⌧Anti-infective ⌧Anti-inflammatory ⌧Local anesthetics ⌧Miotics and antiglaucoma ⌧Mydriatics

⌧


- 144 -



25. Medicines acting on the respiratory tract 26. Solutions correcting water, electrolyte and acid-base disturbances: Oral ⌧Parenteral Miscellaneous

⌧ 27. Vitamins and minerals ⌧ 28. Natural ingredients for pharmaceuticals Crude raw materials such as roots, rhizomes, leaves, fruits, seeds and (root) barks to be used in herbal Medicines containing whole plant material or as raw material for the isolation of active substances or extracts Saps and extracts, tinctures, balsams, lacs, gums, resins and starches Essential oils ⌧ Fatty oils, fats, waxes and their derivatives Colouring agents 29. Natural ingredients for cosmetics Plant Extracts ⌧Vitamins Proteins Waxes Oils ⌧ Thickening Agents Other additives ⌧Perfumery oils Preservatives ⌧ 30. Raw plant material Medicinal and aromatic plants ⌧ Seaweed and algae 31. Vegetable saps and extracts Lacs, natural gums, resins, gum-resins and balsams Other vegetable saps and extracts Ephedrine and quinine 32. Vegetables (and animal) derived oils, fats and waxes Peanut oil & its fractions Coconut, palm kernel or babassu oil Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil Animal or vegetable fats and oils and their fractions Waxes Cocoa butter, fat and oil 33. Colouring matter of vegetable or animal origin 34. Essential oils and oleoresins ⌧ 35. Biotech


LOOKING FOR : • SOURCES OF PACKAGING MATERIALS (CHEAPER) ALUMINUM FOIL / PVC / ALUMINUM CAPS • BOOKS ON HERBAL MEDICINES – TECHNICAL SPECS / ANALYSIS, ETC. • CHEAPER SOURCE OF QUALITY PHARMACEUTICAL RAW MATERIALS


- 145 -



Name and Title: Michael Francis A. Dela Cruz

Company name SYDENHAM LABORATORIES, INC.

Street - POB E. Aguinaldo Hi-way corner Governors Drive

City - Country Dasmariñas Cavite, Philippines

Email: Tel: 6346.416.4678 Fax: 6346.529.8100

Year established: 1975 Number of employees: 177 Bank Ref: Land Bank


Activities






⌧


⌧ 5. Anticonvulstants/antiepileptics: ⌧ 6. Anti-infective medicines: Anthelminthics Antibacterials Antifungal Antiviral Antiprotozoal Insect repellents


⌧ 8. Antineoplastic, immunosuppressives and medicines used in palliative care: Immunosuppressive Cytotoxic medicines Hormones and antihormones Medicines used in palliative care

⌧ 9. Antiparkinsonism medicines ⌧ 10. Medicines affecting the blood: Antianaemia medicines Medicines affecting coagulation


⌧ 12. Cardiovascular medicines: Antianginal Antiarrhythmic Antihypertensive Used in heart failure Antithrombotic Lipid-lowering



⌧ 15. Disinfectants and antiseptics: Antiseptics Disinfectants

⌧ 16. Diuretics ⌧ 17. Gastrointestinal medicines: Antacids Antiemetic Antihaemorrhoidal Anti-inflammatory Antispasmodic Laxatives Used in diarrhea Antidiarrhoeal (symptomatic)

⌧


⌧


⌧ 20. Muscle relaxants (peripherally acting) and cholinesterase inhibitors ⌧ 21. Ophthalmological preparations: Anti-infective Anti-inflammatory Local anesthetics Miotics and antiglaucoma Mydriatics

⌧


- 146 -


⌧ 23. Peritoneal dialysis solution ⌧ 24. Psychotherapeutic medicines: Psychotic disorders Mood disorders Generalized anxiety and sleep disorders Obsessive compulsive disorders

⌧ 25. Medicines acting on the respiratory tract ⌧ 26. Solutions correcting water, electrolyte and acid-base disturbances: Oral Parenteral Miscellaneous

⌧ 27. Vitamins and minerals ⌧ 28. Natural ingredients for pharmaceuticals Crude raw materials such as roots, rhizomes, leaves, fruits, seeds and (root) barks to be used in herbal Medicines containing whole plant material or as raw material for the isolation of active substances or extracts Saps and extracts, tinctures, balsams, lacs, gums, resins and starches Essential oils Fatty oils, fats, waxes and their derivatives Colouring agents 29. Natural ingredients for cosmetics Plant Extracts Vitamins Proteins Waxes Oils Thickening Agents Other additives Perfumery oils Preservatives 30. Raw plant material Medicinal and aromatic plants Seaweed and algae 31. Vegetable saps and extracts Lacs, natural gums, resins, gum-resins and balsams Other vegetable saps and extracts Ephedrine and quinine 32. Vegetables (and animal) derived oils, fats and waxes Peanut oil & its fractions Coconut, palm kernel or babassu oil Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil Animal or vegetable fats and oils and their fractions Waxes Cocoa butter, fat and oil 33. Colouring matter of vegetable or animal origin 34. Essential oils and oleoresins 35. Biotech NOTE: WE IMPORT ACTIVE RAW MATERIAL THEN CONVERT IT TO TABLETS, CAPSULES, ETC. AND SELL LOCALLY.



- 147 -



Name and Title: Racquel P. Villanueva – AVP Manufacturing Operations

Company name VIRGO PHARMACEUTICAL LABORATORY

Street - POB 17 Hernani St., Sta. Mesa Heights

City - Country Quezon City, Philippines 1114


Year established: 1971 Number of employees: 80 Bank Ref: MBTC


Activities


Countries previously imported/exported to: CHINA, INDIA, SINGAPORE, HONGKONG, SPAIN, BULGARIA




⌧


5. Anticonvulstants/antiepileptics: 6. Anti-infective medicines: ⌧Anthelminthics ⌧Antibacterials Antifungal Antiviral ⌧Antiprotozoal Insect repellents



9. Antiparkinsonism medicines 10. Medicines affecting the blood: Antianaemia medicines ⌧Medicines affecting coagulation


12. Cardiovascular medicines: Antianginal Antiarrhythmic ⌧Antihypertensive Used in heart failure Antithrombotic Lipid-lowering

⌧ 13. Dermatological medicines (topical) Antifungal Anti-infective Anti-inflammatory/antipruritic Astringent Skin differentiation/proliferation ⌧Scabicides/pediculicides Ultraviolet

⌧


15. Disinfectants and antiseptics: ⌧Antiseptics Disinfectants

⌧ 16. Diuretics ⌧ 17. Gastrointestinal medicines: ⌧Antacids Antiemetic Antihaemorrhoidal ⌧Anti-inflammatory ⌧Antispasmodic Laxatives Used in diarrhea ⌧Antidiarrhoeal (symptomatic)

⌧





- 148 -



25. Medicines acting on the respiratory tract ⌧ 26. Solutions correcting water, electrolyte and acid-base disturbances: Oral Parenteral Miscellaneous



Documents

SOUTH-SOUTH TRADE PROMOTION PROGRAMMEs3.amazonaws.com/zanran_storage/ · RP’s Top importers of pharmaceutical products ... Ten leading causes of morbidity, ... PHAP Pharmaceutical